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1. Introduction 
1.1 Transition Metal-Catalyzed Cross-Couplings and C–H Functionalizations 
Although the concept of green chemistry—which is also known as sustainable 
chemistry—was introduced by Ciamician as early as the beginning of the 20th century,[1] 
today we have to face the global problem of environmental pollution. Chemical industries 
have contributed a significant proportion to the contaminants. Therefore, sustainable 
chemistry should not only be an urgent discipline, but more important to be the ultimate 
goal of all chemists.[2] 
Besides the twelve principles of sustainable chemistry,[3] another two points should be 
especially noted: High selectivity and low cost. The first aspect will definitely reduce 
chemical wastes by inhibiting the generation of side products. The second aspect should be 
very important for industries where profits are always concerned. For example, industrial 
methanol synthesis commonly utilizes the inelegant syngas processes rather than the more 
atom economic catalytic oxidation of methane.[4] Thus, economically acceptable catalytic 
systems will facilitate the innovation of more environmentally-benign chemical processes. 
Arenes are important in human life as key structural components of numerous natural 
products, pharmaceutical agents, and organic materials.[5] Therefore, it is quite reasonable 
and essential to study the synthesis and modification of arenes.[6] The Wurtz-Fittig reaction 
of aryl halides with alkyl halides and sodium provided a way to synthesize alkylated arenes.[7] 
At the beginning of the 20th century, Ullmann and Goldberg developed the C–C, C–N, and 
C–O couplings with aryl halides using stoichiometric or catalytic amounts of copper at a 
reaction temperature of more than 200 °C.[8-11]  
The combination of transition metal and organometallic reagents facilitated arene–arene 
coupling processes. During the 1940s, Kharasch et al. observed that catalytic amounts of 
CoCl2, MnCl2, FeCl3 or NiCl2 allowed for efficient homo-couplings of Grignard reagents 1.
[12] 
Organic halides 2, such as bromo or chlorobenzene acted as terminal oxidants in these 
reactions. 
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Scheme 1.1: Transition metal-catalyzed homo-coupling of Grignard reagents 1. 
The sudden boom of transition metal-catalyzed cross-couplings started in the 1960s. In 1965, 
van Helden and Verberg reported the palladium-mediated intermolecular oxidative 
homo-coupling between arenes.[13] In the same year, Heck reported palladium-mediated 
oxidative arylation of alkenes employing toxic organomercury reagent.[14] In 1969, Fujiwara 
and Moritani discovered the oxidative coupling of alkenes with arenes using catalytic 
amounts of palladium complexes.[15] Mizoroki[16] and Heck[17] independently developed the 
palladium(0)-catalyzed arylation of alkene with iodoarene in the early 1970s. In 1972, 
Kumada, Tamao,[18] and Corriu[19] discovered the cross-coupling between arene halides and 
Grignard reagents with nickel or palladium as the catalysts. The palladium- and 
copper-catalyzed Sonogashira-Hagihara coupling between terminal alkynes and iodoarenes 
was invented in 1975.[20] The palladium-catalyzed cross-couplings between aryl and alkenyl 
halides and other organometallic reagents, such as organoaluminium,[21] organozinc,[22] 
organotin,[23] organoboron,[24] or organosilicon,[25] were developed by Negishi, Stille, Suzuki, 
and Hiyama, respectively. 
A generalized catalytic cycle of palladium-catalyzed cross-couplings is shown below (Scheme 
1.2). The key steps are oxidative addition, transmetalation, and reductive elimination. The 
Mizoroki-Heck reaction involves oxidative addition, migratory insertion, and β-H elimination. 
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Scheme 1.2: Proposed mechanism for palladium-catalyzed cross-couplings (left cycle) and 
Mizoroki-Heck reaction (right cycle). 
As one of the greatest innovations of the 20th century,[26] transition metal-catalyzed 
cross-coupling is not a perfect tool mainly due to the organometallic reagents which need 
prior preparation and careful handling. In comparison with cross-coupling reactions, C–H 
functionalization is definitely more atom-economic. For a long period, C–H bond has only 
been considered as an inert bond because of relatively high dissociation energy (methane: 
439 kJ/mol; benzene: 473 kJ/mol) as well as low acidity. Therefore, it is a formidable task and 
was defined as one of the 'Holy Grails' in chemistry in the 1990s.[27]  
Strong bases can be utilized for the metalations of some heteroarens bearing acidic C–H 
bonds. Concerning the less acidic aryl C–H bonds, a coordinating group will site-selectively 
direct the more alkaline organometallic bases, such as organo lithium reagents, to its ortho 
position.[28] However, aryl halides maybe converted to arynes under strongly alkaline 
reaction conditions, which will bring about chemo- and site-selectivity problems. 
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Scheme 1.3: Deprotonation and metalation with strong base. 
An alternative for achieving mild C–H metalations is to use catalytic amounts of transition 
metals. The last 20 years have witnessed the great development of C–H bond 
functionalizations.[29-41] As a robust synthetic tool, C–H bond functionalizations utilizing 
various transition metal catalysts have been applied in the synthesis of natural products, 
pharmaceuticals, and materials synthesis.[42-48]  
It is important to understand how the C–H bond is cleaved by transition metals. There are 
three generally recognized categories of C–H bond metalation mechanism (Scheme 1.4):[49] (i) 
The most common mechanism involves oxidative addition (OA), which starts by coordination 
of the C–H bond to the vacant site of the metal. This mechanism is typical for electron-rich 
and low-valent complexes of the late transition metals. As oxidative process is not possible 
for early transition metals with d0 electron configuration, the predominant mechanism is (ii) 
σ-bond metathesis (SBM). (iii) A C–H bond can be cleaved by late- or post-transition metals 
in strong polar medium in an electrophilic activation (EA) manner. 
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Scheme 1.4: C–H bond metalation mechanisms. 
Recent mechanistic studies indicated a base-assisted C–H bond metalation mechanism, of 
which the determining factor is the assistance of a bifunctional ligand bearing an additional 
Lewis-basic heteroatom, such as secondary phosphine oxides (SPOs) or carboxylates.[50] This 
mechanism will be comprehensively discussed in the next section. 
 
Scheme 1.5: SPOs- or carboxylates-assisted C–H bond metalation. 
Different pathways have been proposed for the base-assisted C–H bond metalations (Figure 
1.1): Fagnou proposed a concerted-metalation-deprotonation (CMD) process.[51] DFT 
calculations from Davies and Macgregor were rationalized by an ambiphilic metal ligand 
activation process (AMLA).[52,53] Agostic interaction enhances the acidity of hydrogen which 
will then readily transfer to the ligand. Metals with a monodentate Lewis base ligand favor 
an internal electrophilic substitution pathway (IES).[54] The lone pair on ligand X forms an 
X–H bond, while the orbital making up the M–X bond turns into a coordinating lone pair.  
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Figure 1.1: Proposed transition states of base-assisted methalation. 
 
1.2 Carboxylate-Assisted C–H Bond Cleavage 
1.2.1 Carboxylate-Assisted C–H Metalation 
In 1980, Roberts and coworkers performed detailed kinetic studies on the mercuration of 
arenes by Hg(O2CCF3).
[55] Previous kinetic isotope effects (KIE) studies by Kresge et al. 
indicated the proton transfer to be the rate determining step.[56] However, Roberts doubted 
the formation of a discrete σ-complex, therefore they rationalized their observations with 
transition state 4 involving a synchronous bond cleavage and bond formation which was 
suggested by Winstein and Traylor in a study of the reverse reaction, namely 
protodemercuration of diphenylmercury.[57] 
 
Figure 1.2: Proposed transition state 4 of arene mercuration. 
It was recognized in the 1960s that there is a strong resemblance between the palladation 
and mercuration of benzene.[58] Shaw and coworkers performed pioneering studies in the 
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synthesis of cyclometalated compounds in the early 1970s.[59] For instance, the 
cyclometalation with a palladium complex of N,N-dimethylaminomethylferrocene 5 
occurred efficiently with the assistance of NaOAc (Scheme 1.6).[60] The effect of 
carboxylate-assisted intramolecular deprotonation was verified again in the amino acid 
salts-promoted palladation of amine 5 by Sokolov, Troitskaya, and Reutov in 1979.[61] It was 
proposed that the key C–H bond metalation occurred in a concerted fashion, as illustrated in 
transition-state structure 7. 
 
Scheme 1.6: Effect of stoichiometric NaOAc on the cyclopalladation of amine 5. 
Ryabov and coworkers investigated the mechanism of ortho-palladation reactions with 
N,N-dimethylbenzylamines 8 through kinetic studies. A KIE of kH/kD = 2.2 indicated that the 
C–H bond metalation is the rate-limiting step.[62,63] DFT calculations on the cyclometalation 
of N,N-dimethylbenzylamines 8 by Pd(OAc)2 were later performed by Macgregor (Scheme 
1.7). The AMLA mechanism was favored rather than a δ-intermediate pathway to allow for a 
facile proton transfer, thereby delivering cyclometalated complex 12.[64]  
 
Scheme 1.7: DFT calculations on the cyclometalation of N,N-dimethylbenzylamines. (Values 
in kcal/mol) 
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NaOAc can also facilitate C–H bond ruthenations under mild reaction conditions (Scheme 
1.8). It was discovered by Davies et al. that with the assistance of NaOAc, solely 
N-alkyl-substituted imines could provide the desired ruthenacycles with [RuCl2(p-cymene)]2 
at ambient reaction temperature in a stoichiometric fashion.[65]  
 
Scheme 1.8: Cycloruthenation with the assistance of NaOAc. 
1.2.2 Carboxylate-Assisted Catalytic Reactions 
Lewis as well as Murai conducted pioneering studies in chelation-assisted 
ruthenium(0)-catalyzed C–H bond functionalizations.[66,67] During recent years, the 
Ackermann group and other groups have made stupendous contributions developing 
ruthenium(II) catalysis.[48, 68-72]  
Primary studies from the Ackermann group highlighted a significant reaction rate 
acceleration applying secondary phosphine oxides (SPOs) as bifunctional preligands in 
ruthenium-catalyzed direct arylations (Scheme 1.9).[73-76]  
 
Scheme 1.9: SPOs-assisted ruthenium-catalyzed C–H arylations. 
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Later, Fagnou and coworkers tested different catalytic amounts of carboxylic acids in 
palladium-catalyzed direct arylations of unactivated arenes. The yield of the desired product 
was strongly affected by both the quantity and the nature of the acid (Scheme 1.10).[77] A 
concerted metalation-deprotonation (CMD) pathway was proposed in which pivalate served 
as a proton shuttle between arene and base. 
 
base additive conversion 
(GC-MS) 
K2CO3 — 0% 
KOPiv — 41% 
K2CO3 AcOH 11% 
K2CO3 iPrCO2H 13% 
K2CO3 PivOH 82% 
Scheme 1.10: Effect of base and additive on palladium-catalyzed direct arylation. 
Site-selective direct C2 arylations of indoles were achieved at ambient temperature with aryl 
iodides as the substrates and Ag2O as the base (Scheme 1.11). Different carboxylic acids 
were tested, of which electron-poor benzoic acids 21 delivered better yields than 









Scheme 1.11: Carboxylic acid-promoted palladium-catalyzed C2 arylation of indoles 18. 
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Based on the successful development of SPOs-assisted C–H functionalizations, the 
Ackermann group endeavored for general phosphine-free ruthenium-catalyzed direct 
arylations employing carboxylates as potential cocatalysts (Scheme 1.12).[79] Ligands such as 
tertiary phosphines or NHC precursors only performed poorly. While the sterically hindered 
SPO preligand (1-Ad)2P(O)H derived ruthenium complex showed efficient catalytic activity. 
Interestingly, carboxylic acids were found to be effective cocatalysts with optimal results 
employing MesCO2H.  
 
Scheme 1.12: Effect of additives on ruthenium-catalyzed direct arylations. 
Several ruthenium(II) biscarboxylate complexes have been prepared by the Ackermann 
group, which turned out to be catalytically competents for C–H bond functionalizations 
(Scheme 1.13). Notably, well-defined ruthenium(II) complex 27 was applied in the direct 
arylation of various arenes with differently substituted (hetero)aryl chlorides in a highly 
regioselective fashion.[80] Another sterically hindered carboxylic acid AdCO2H derived 
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ruthenium(II) complex 31 was found to be an effective catalyst in the first direct arene 
alkylations with unactivated alkylhalides.[68,81]  
 
Scheme 1.13: The application of well-defined ruthenium complex 27 and 31 in the direct 
arylation of arenes. 
Based on experimental studies, Ackermann et al. proposed the catalytic cycle of 
carboxylate-assisted ruthenium(II)-catalyzed C–H arylation as shown in Scheme 1.14. First, 
reversible cyclometalation forms ruthenium(II) complex 35 through carboxylate-assisted 
deprotonation. Second, the ruthenium(II) complex 35 reacts in the rate limiting step with 
aryl halide to yield intermediate 36. Third, reductive elimination releases the desired product 
and regenerates the active catalyst 33.[80]  
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Scheme 1.14: Proposed mechanism for base-assisted ruthenium-catalyzed direct arylations, 
p-cymene was omitted, X = Cl or Br. 
 
1.3 Transition Metal-Catalyzed Oxidative Coupling with Alkenes and Alkynes 
1.3.1 Transition Metal-Catalyzed Oxidative Alkenylation 
Palladium-catalyzed oxidative cross-coupling reactions were discovered by Fujiwara and 
Moritani in the late 1960s.[82] Recent years have witnessed its wide application in the 
preparation of numerous synthetically and practically useful heterocycles, such as 
isoquinolines, isoquinolones, isocoumarins, α-pyrones and 2-pyridines.[71,83,84]  
In 1979, Hong et al. reported rhodium-catalyzed styrene synthesis using simple arenes and 
ethylene in the presence of CO.[85] In 2007, Satoh and Miura reported the rhodium-catalyzed 
oxidative alkenylation of easily accessible benzoic acid employing acrylates, acryl amides or 
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nitriles as alkenylating reagent. The oxidant was stoichiometric amount of Cu(OAc)2·H2O or 
air in the presence of catalytic Cu(OAc)2·H2O.
[86] Later, Glorius and coworkers reported the 
rhodium-catalyzed alkenylations of acetanilides,[87] acetophenones and benzamides.[88]  
In 2001, Milstein and coworkers reported the ruthenium(0)-catalyzed oxidative alkenylation 
using arenes and acrylic esters.[89,90] In 2011, Ackermann et al. reported the first successful 
ruthenium(II)-catalyzed direct alkenylation of benzoic acids in non-toxic water.[91] Later, 
Ackermann and Miura independently developed the efficient ruthenium-catalyzed direct 
oxidative alkenylation of benzamides.[92,93] The ruthenium(II)-catalyzed alkenylation worked 
effectively with the chelation assistance of various directing groups, such as anilides,[92] 
N-containing hyterocycles,[94,95] carbamates,[96] esters,[97,98] phenones,[99] aldehydes,[100] or 
sulfonyls.[101] 
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1.3.2 Transition Metal-Catalyzed Oxidative Alkyne Annulation 
Larock et al. in 1991 discovered the efficient palladium-catalyzed alkyne annulation with 
substituted haloarenes.[102] Thus, a number of synthetically valuable protocols have been 
developed based on the Larock-type heterocyle synthesis.[103]  
 
Scheme 1.16: Larock-type alkyne annulation. 
It has become a challenging research target to combine transition metal-catalyzed C–H bond 
metalation and alkyne annulation in a one pot fashion. Various procedures have been 
reported with rhodium as the catalyst and Cu(OAc)2·H2O as the oxidant (Scheme 1.17).
[104]  
 
Scheme 1.17: Selected recent examples of rhodium(III)-catalyzed oxidative alkyne 
annulations. 
Ackermann et al. in 2011 developed the first ruthenium(II)-catalyzed oxidative alkyne 
annulations by C–H activation.[105] Afterwards, the Ackermann group as well as other groups 
explored ruthenium(II)-catalyzed oxidative alkyne annulations with various directing groups 
(Scheme 1.18).[71]  
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Scheme 1.18: Selected recent examples of ruthenium(II)-catalyzed oxidative alkyne 
annulations. 
Very recently, Ackermann and coworkers published an elegant work in which alkyne 
annulation with benzoic acid was performed at 45 °C employing 1 atm of O2 or air as the sole 
oxidant, thus avoiding the use of any copper(II) or silver(I) salts (Scheme 1.19).[106]  
 
Scheme 1.19: Ruthenium(II)-catalyzed alkyne annulation using O2 as the sole oxidant. 
1.3.3 Transition Metal-Catalyzed Alkenylation and Alkyne Annulation by C–H/N–O 
Cleavage 
Subsequent to the development of oxidative alkenylation and alkyne annulations, attempts 
utilized C−H/N−O bond cleavages in preceding couplings. The advantage is that the substrate 
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itself acts as an 'internal oxidant', thus external oxidants such as Cu(OAc)2·H2O are no longer 
needed. 
Fagnou and coworkers initiated the rhodium(III)-catalyzed C−H alkyne annulation with 
hydroxamic acid esters 40 and 42 as the substrates.[107,108] Later, the Fagnou group as well as 
the Glorius group accomplished the rhodium(III)-catalyzed direct C–H olefinations of 
benzhydroxamic acid esters 40 and 42 with oxidizing directing groups.[108,109]  
 
Scheme 1.20: Rhodium(III)-catalyzed alkenylation and alkyne annulaiton by C–H/N–O bond 
functionalization. 
Ruthenium(II)-catalyzed alkyne annulations were independently discovered by the research 
group of Ackermann as well as the group of Li and Wang in 2011.[110,111] Oximes 45 proved to 
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be effective internal oxidants. In 2012, Ackermann and coworkers reported cationic 
ruthenium(II) catalysts for alkyne annulations with oximes through C–H/N–O clevages.[112] 
Ruthenium(II)-catalyzed oxidative C–H bond alkenylation of N-methoxybenzamides was 
reported by Li and Wang employing both activated and unactivated alkenes.[113]  
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1.4 Transition Metal-Catalyzed Arene Hydroxylations 
Oxygenated aromatic molecules are key intermediates in organic synthesis and important 
structural components of useful pharmaceuticals, agrochemicals, polymers, and biologically 
active compounds.[70]  
 
Figure 1.3: Selected bioactive compounds with phenol components. 
For instance, phenol is a central commodity chemical in industry, which is produced in a 
three step synthesis (cumene process) starting from benzene and propylene. However, this 
protocol has the limitations of its high reaction temperature and low functional group 
tolerance. Although during recent years transition metal-catalyzed conversion of 
halogenated or boronated arenes to phenol has been discovered,[114-116] direct C–H 
oxygenation should be the optimal choice considering the atom-economy aspect. 
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Scheme 1.22: Different routes of metal-catalyzed phenol synthesis. 
In the early 1990s, Jintoku and Fujiwara reported the palladium-catalyzed transformation of 
benzene and molecular oxygen to phenol (Scheme1.23).[117] The palladium precursor was 
modified by the addition of 1,10-phenanthroline and dissolved in a mixture of benzene and 
acetic acid. The reaction proceeded at 180 °C under an atmosphere of oxygen (15 atm) and 
carbon monoxide (15 atm). The acetylated phenol 48 was monitored as a major side 
product.  
 
Scheme 1.23: Palladium-catalyzed phenol synthesis using O2 as the oxidant. 
Early examples of palladium-catalyzed ligand-directed C(sp2)–H bond oxygenation were 
reported by Sanford and coworkers with PhI(OAc)2 as the stoichiometric oxidant (Scheme 
1.24).[118-122] A variety of pyridine derivatives and other nitrogen-based substituents served 
as excellent directing groups, delivering ortho-acetoxylated products in good yields. In 
contrast, simple ketones and aldehydes did not undergo ortho-acetoxylation under these 
conditions, presumably because these are weakly-coordinating ligands for palladium. 
Moreover, PhI(OAc)2 could also be utilized in palladium-catalyzed ligand-directed C(sp
3)–H 
bond oxygenation.  
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Scheme 1.24: Palladium-catalyzed ligand-directed C(sp2)–H bond oxygenation using 
PhI(OAc)2 as the oxidant. 
Based on mechanistic studies,[123] Sanford and coworkers proposed the catalytic cycle of 
palladium-catalyzed ortho-acetoxylation as shown in Scheme 1.25: First, ligand-directed C–H 
activation generates a cyclopalladated intermediate 50. Second, two-electron oxidation of 
the palladacycle generates a palladium(IV) species 51. Third, reductive elimination releases 
the product 52 and regenerates the palladium(II) catalyst 49. 
 
Scheme 1.25: Proposed mechanism of palladium-catalyzed ortho-acetoxylation. 
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Although other oxgenations have been investegated using inorganic peroxides, such as 
Oxone and K2S2O8,
[122] molecular oxygen is indubitable the optimal oxygen source 
considering the atom-economy aspect. Recently, the group of Yu described a 
palladium(II)-based catalytic system that performed the regioselective ortho-hydroxylation 
of potassium benzoates with the environmentally friendly molecular oxygen as the oxidant 
(Scheme 1.26).[124] The presence of stoichiometric benzoquinone (BQ) significantly increased 
the reaction rates and thereby converted substrates into desired ortho-hydroxylated 
product 53 in satisfying yield with 1 atm of O2. Labeling experiments with 
18O2 confirmed 
that the oxygen-atom incorporated into the hydroxylated product originated from molecular 
oxygen. 
 
Scheme 1.26: Palladium-catalyzed chelation-assisted C(sp2)-H bond oxygenation using O2 as 
the oxidant. 
Recently, ruthenium-catalyzed hydroxylations of C–H bonds have been developed. Early 
studies probed the RuO4-mediated hydroxylation of unactivated tertiary C(sp
3)–H bonds in 
hydrocarbons.[125,126] Du Bois and coworkers disclosed the C(sp3)–H hydroxylation with 
catalytic RuCl3·nH2O employing KBrO3 as the stoichiometric oxidant, allowing the 
oxygenation of the weakest C–H bonds (Scheme 1.27).[127] Thus, this method is largely 
limited to tertiary alkyl C–H bonds.  
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Scheme 1.27: Ruthenium-catalyzed C(sp3)–H bond oxygenation. 
The past few years have witnessed a tremendous development in the ruthenium-catalyzed 
direct hydroxylation of stronger C(sp2)–H bonds in (hetro)arenes.[70] Rao and coworkers 
disclosed ruthenium-catalyzed ortho-hydroxylation with benzoic acid using K2S2O8 or HIO3 as 
the oxidant,[128] while Ackermann and coworkers employed the well-defined ruthenium(II) 
biscarboxylate complex [Ru(O2CMes)2(p-cymene)] (27) as well as inexpensive RuCl3·nH2O in 
the hydroxylation reactions with PhI(OAc)2 as the oxidant.
[129] The strong acidic reaction 
medium turned out to be crucial for chelation-assisted ortho-hydroxylations on 
(hetro)arenes with esters, amides, or even weakly-coordinated ketones[130,131] as the 
directing groups. 
 
Scheme 1.28: Ruthenium(II)-catalyzed C(sp2)–H bond oxygenation on arenes bearing 
electron-withdrawing directing groups. 
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Whilst previous studies had focused on the use of arenes bearing electron-withdrawing 
directing groups, the Ackermann group[132] and the Rao group[133] have respectively explored 
ruthenium-catalyzed carbamate- and aniline-directed ortho-hydroxylation with excellent 
site-selectivities. 
 
Scheme 1.29: Ruthenium(II)-catalyzed C(sp2)–H bond oxygenation on arenes bearing 
electron-donating directing groups. 
 
1.5 Photo-Induced Transition Metal-Catalyzed C–H Functionalizations 
Due to the limited fossil fuels storage on this planet, it is urgent to establish new energy 
sources. As we know, fossil fuels together with wind energy, water energy, and biomass 
energy, ultimately originate from solar irradiation. Therefore, photo energy has been 
considered as one of the most promising alternatives for fossil fuels.[134] The discovery of the 
photovoltaic effect in 1839 demonstrated that people already tried to transform photo 
energy into other forms of energy at that time.[135] 
Photo-induced synthesis was introduced into chemistry field by Ciamician who believed it 
was the sun light that would bring about real green synthetic pathways. Although he could 
not achieve his goal, because actually NADPH and ATP are the driving force in synthesis of 
plants, he discovered a range of interesting photochemical processes.[1]  
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In comparison with thermal reactions, photochemical transformations are characterized by 
the fact that absorbing light causes a change in electronic configuration, and consequently 
alters the reactivity of a chemical compound. Generally, electron transfer is facilitated under 
photochemical conditions, which will considerably extend the reaction spectrum of organic 
molecules.[136]  
Recently Noyori suggested that young chemists should ''develop a 'photo-synthetic' catalyst 
that facilitates a thermally unachievable, energetically uphill reaction.''[137] Actually, 
photochemical reactions like photocyclizations, photocycloadditions, photoclevages, and 
photorearrangements have already become important tools in organic chemistry.[138]  
The thermal reaction conditions and photo-induced reaction conditions were, for example, 
compared in the Vollhardt-type[139] pyridine synthesis (Scheme 1.30).[140,141] The 
photo-induced cyclization at 25 °C under ambient pressure proceeded faster than the 
thermal synthesis at 110 °C under higher pressure. 
 
method [Co(cod)Cp] [mol %] T [°C] p [atm] t [h] yield [%] 
hv (420 nm) 0.5 25 1 4 90 
thermal 3.2 110 14 22 82 
Scheme 1.30: Comparison between thermal and photochemical conditions for [2+2+2] 
cycloaddition of acetylene 67 to chiral pyridine 68. 
Norbornene derivate 69 underwent copper-catalyzed intermolecular [2+2] 
photodimerization efficiently and stereoselectively (Scheme 1.31).[142] No further 
functionalized alkene was obtained.  
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Scheme 1.31: Photo-induced copper-catalyzed [2+2] photodimerization of norbornene 
derivate 69. 
Very recently, Fu and Peters have utilized irradiation in the Ullmann-type couplings (Scheme 
1.32). Thus, C–N,[143-145] C–O,[146] C–S,[147] and C–CN[148] bonds were formed at ambient 
temperature or 0 °C. 
 
Scheme 1.32: Photo-induced copper-catalyzed Ullmann-type couplings. 
Visible light-induced photoredox catalysis has become very attractive during recent 
years.[149,150] Coordination compounds such as [Ru(bpy)3]
2+ or [Ir(bpy)(ppy)2]
+ are among the 
most frequently used photocatalysts because of their relatively long excited states as well as 
chemically robust nature. For many transformations, organic dyes are also used as 
photoredox catalysts. Various light sources, such as compact fluorescent lamp (CFL), 
light-emitting diode (LED), and even sunlight, could be utilized in photo-induced catalytic 
reactions.  
Despite the excellent photoredox properties, the above-mentioned transition metal 
complexes have until very recently attracted very little attention from synthetic organic 
chemists. One of the earliest examples was reported by Deronzier and coworkers in 1984,[151] 
demonstrating a photocatalytic Pschorr reaction[152] for the synthesis of phenanthrene and 
substituted phenanthrenes (Scheme 1.33).  
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Scheme 1.33: Photo catalytic Pschorr reaction for the synthesis of phenanthrenes. 
Based on the success of organo-SOMO catalysis,[153] MacMillan and coworkers turned to the 
merging of photoredox catalysis with organocatalysis in the enantioselective alkylation of 
aldehydes.[154] This reaction included two catalytic cycles, namely photoredox catalytic cycle 
and organocatalytic cycle (Scheme 1.34). 
The photoredox cycle consists of the following steps: First, visible light irradiation excites 
Ru(bpy)3
2+ to Ru(bpy)3 
2+*. Second, Ru(bpy)3 
2+* is reductively quenched by α-amino radical 
79 to form Ru(bpy)3
+. Third, single electron transfer from Ru(bpy)3
+ to the α-bromocarbonyl 
compound 74 delivers an electron-deficient radical 75 and regenerates Ru(bpy)3
2+. 
The organo catalytic cycle consists of the following steps: First, the coupling of electron 
deficient radical 75 with enamine 78 forms the key C–C bond and generates the α-amino 
radical 79. Second, Ru(bpy)3
2+* oxidizes 79 to iminium cation 80. Third, hydrolysis of the 
iminium cation 80 regenerates the amine catalyst 76 while delivering the desired 
enantioselective α-alkylated aldehyde 81. 
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Scheme 1.34: Proposed mechanism for photoredox catalytic asymmetric α-alkylation of 
aldehydes. 
An elegant way is to combine photoredox catalysis with transition metal-catalyzed coupling 
reactions. The research from Deronzier indicated that a free radical could be generated from 
photoredox catalysis of aryldiazonium at room temperature.[151] Thus, Sanford and 
coworkers successfully combined the radical generation process with palladium-catalyzed 
C–H metalation (Scheme 1.35).[155] In comparison with previous report of Chan,[156] this 
reaction occurred under milder conditions.  
 
Scheme 1.35: Merging photoredox and palladium catalysis in C(sp2)–H arylations. 
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More transition metal catalysis and photoredox catalysis have been emerged in 
cross-coupling reactions. Inspired by MacMillan ś trifluoromethalation under photoredox 
catalytic conditions,[157] Sanford and coworkers developed the trifluoromethylation of 
arylboronic acids by photo-induced copper-catalyzed Suzuki-Miyaura coupling (Scheme 
1.36).[158]  
 
Scheme 1.36: Visible light-induced copper-catalyzed trifluorometalation with boronic acids. 
In 2014 MacMillan and coworkers reported the nickel-catalyzed decarboxylative arylation 
reaction,[159] meanwhile Tellis and Primer as well as Molander and coworkers independently 
disclosed the photo-induced nickel-catalyzed Suzuki-Miyaura cross-couplings (Scheme 
1.37).[160,161] In the three reports, the organic halides were included in metal catalytic cycles, 
while in Schemes 1.34 and 1.36, the organic halides were included in photoredox cycles. 
 
Scheme 1.37: Merging photoredox and nickel catalysis in cross-couplings. 
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2 Objectives 
Oxidative annulations of alkynes by C–H/N–H cleavages have recently emerged as a useful 
strategy for the sustainable preparation of N-heterocycles. To avoid the use of excess amount 
of oxidants, transition metal-catalyzed C–H/N–O bond functionalizations with N-substituted 
benzamides was reported by Fagnou and coworkers recently.[107,108] The Ackermann group 
have devised a green isoquinolone synthesis by ruthenium(II)-catalyzed C–H/N–O bond 
functionalizations.[110] Although performed in H2O, this reaction will generate MeOH as the 
byproduct with N-methoxybenzamide as the substrate. The use of N-hydroxybenzamide will 
generate H2O as the sole byproduct. Therefore, a real green isoquinolone synthesis by 
ruthenium-catalyzed C–H/N–O functionalizations should be achieved. 
 
Scheme 2.1: Ruthenium-catalyzed C–H/N–O functionalizations towards a green isoquinolone 
synthesis. 
Step-economical chelation-assisted C–H oxygenations were accomplished with the aid of 
various directing groups utilizing transition metal catalysts. Very recently, the Ackermann 
group and the Rao group developed ruthenium(II)-catalyzed C–H oxygenations.[70] The easily 
accessible N-methoxy-N-methylamides, also known as Weinreb amides have thus far proven 
elusive for metal-catalyzed C–H bond functionalizations and direct oxygenations. With the 
additional hetero atom in the directing group, Weinreb amides have stronger coordinating 
ability than alkyl-substituted benzamides, and therefore should facilitate the 
ruthenium(II)-catalyzed C–H oxygenations. 
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Scheme 2.2: Ruthenium(II)-catalyzed C–H oxygenation on Weinreb amides 89 at a more 
environmentally benign temperature. 
The C–H oxygenation with weakly coordinating directing groups is a challenging project.[45,72] 
Although the Ackermann group has developed weakly coordinated ketones for site-selective 
C–H oxygenations, aldehyde is doubtless much more challenging as a substrate in C–H 
oxygenations. Ruthenium(II)-catalyzed C–H oxygenations by formyl group assistance has 
proven thus far elusive. Taking advantage of the unique characteristics of ruthenium catalysis, 
the formyl group could possibly serve as a directing group rather than a substrate in the 
ruthenium-catalyzed C–H oxygenations. 
 
Scheme 2.3: Ruthenium(II)-catalyzed challenging C–H oxygenation on aldehydes. 
The copper-catalyzed C–H arylation of heteroarenes always requires high reaction 
temperatures of more than 100 °C.[162] The C–H metalation is feasible for relatively more 
acidic HetAr–H bonds under alkaline reaction conditions. Hence, the dissociation of 
carbon–halogen bond should be the rate-limiting step in a number of copper-catalyzed C–H 
arylations. The photo irradiation could facilitate the C–I bond dissociation and therefore 
accelerate the copper-catalyzed heterocycle arylations. 
 
Scheme 2.4: Photo-induced copper-catalyzed C–H arylation.
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3 Ruthenium(II)-Catalyzed C–H/N–O Functionalizations 
Oxidative annulations of alkynes by C–H/N–O cleavages have recently emerged as a useful 
strategy for the sustainable preparation of nitrogen-containing heterocycles. The main 
drawback is the use of excess amount of oxidants—for example: AgOAc or 
Cu(OAc)2·H2O—which might bring about high costs as well as high environmental risks. 
However, transition metal-catalyzed C–H/N–O bond functionalizations with N-substituted 
benzamides provided the means to avoid the use of external oxidants. In 2011, Ackermann et 
al. devised a green isoquinolone synthesis in H2O using ruthenium(II)-catalyzed alkyne 
annulations by C–H/N–O cleavages,[110]  while Li and Wang independently disclosed effective 
ruthenium(II)-catalyzed alkyne annulations in methanol.[111]  
In the previous work of the Ackermann group,[110] N-methoxybenzamides 40 were employed 
as the reactants, which generated MeOH as the byproduct. A more atom-economical and 
sustainable approach to the synthesis of isoquinolones was established with the use of 
N-hydroxybenzamides 88, thereby generating H2O as the sole byproduct.
[163]  
 
Scheme 3.1: A green isoquinolone synthesis by C–H/N–O functionalizations. 
In the previous work, only few examples were listed utilizing MesCO2K as the only 
carboxylate ligand. Since carboxylate assisted C–H bond founctionalization has become an 
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important section in metal catalysis,[50,71] we decided to explore this subject further.  
 
3.1 Optimization of Ruthenium(II)-Catalyzed C–H/N–O Functionalizations 
To optimize the reaction conditions, we first tested different solvents and found H2O to be 
the best reaction medium for this dehydrative transformation (Table 3.1, entry 5). Lower 
yield was obtained without MesCO2K (entry 6). [RuCl2(cod)]n and RuCl2(PPh3)3 delivered no 
product (entries 7 and 8), while [RuCl2(p-cymene)]2 was found to be the ruthenium 
precatalyst of choice. Different additives were then explored (entries 9-12), such as simple 
base K2CO3, phase-transfer catalyst TBAB, or commonly used additives like KPF6 and AgSbF6. 
However, these additives delivered lower yields. 
Table 3.1: Optimization of ruthenium(II)-catalyzed C–H/N–O functionalizations.[a] 
 
entry additive solvent yield [%] entry additive solvent yield [%] 
1 MesCO2K 1,4-dioxane 7 7
[b] MesCO2K H2O trace
 
2 MesCO2K tAmOH 11 8
[c] MesCO2K H2O trace
 
3 MesCO2K DMF 12 9 K2CO3 H2O 13 
4 MesCO2K PhMe 6 10 TBAB H2O 27 
5 MesCO2K H2O 62 11 KPF6 H2O 23 
6 — H2O 25 12 AgSbF6 H2O 38 
[a] Reaction conditions: 88a (0.5 mmol), 38a (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), additive 
(30.0 mol %), solvent (2.0 mL), 100 °C, 18 h, average isolated yields of two independent runs. [b] 
[RuCl2(cod)]n (5.0 mol %). [c] RuCl2(PPh3)3 (5.0 mol %). 
In order to investigate carboxylate-assisted C–H bond activation in this C–H/N–O bond 
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functionalization, we tested various carboxylate additives (Table 3.2). Potassium acetate and 
potassium benzoate could not improve the yield (entries 1 and 2). Afterwards we probed 
different potassium benzoates with various substituents. Generally, benzoates with 
electron-withdrawing substituents delivered better yields than those with electron-donating 
substituents (entries 3-10). Among all the potassium benzoates, 3-(F3C)C6H4CO2K gave the 
best results, delivering 41aa in 76% yield (entry 10). We also tested sodium and caesium 
benzoates and obtained similar results (entries 11 and 12). Yields decreased with lower 
reaction temperature, lower catalyst loading, or lower amounts of the additive (entries 
13-15). 
Table 3.2: Optimization of ruthenium(II)-catalyzed C–H/N–O functionalization with different 
additives.[a] 
 
Entry Additive Yield [%] Entry Additive Yield [%] 
1 KOAc 55 9 3,4,5-F3C6H4CO2K 66 
2 PhCO2K 66 10 3-(F3C)C6H4CO2K 76 
3 2-(MeO)C6H4CO2K 59 11 3-(F3C)C6H4CO2Na 74 
4 4-(MeO)C6H4CO2K 61 12 3-(F3C)C6H4CO2Cs 74 
5 4-FC6H4CO2K 68 13
[b] 3-(F3C)C6H4CO2K 69 
6 4-(O2N)C6H4CO2K 71 14
[c] 3-(F3C)C6H4CO2K 34 
7 2,6-(F3C)2C6H4CO2K 66 15
[d] 3-(F3C)C6H4CO2K 60 
8 3,5-(F3C)2C6H4CO2K 70    
[a] Reaction conditions: 88a (0.5 mmol), 38a (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), additive 
(30.0 mol %), H2O (2.0 mL), 100 °C, 18 h, average isolated yields of two independent runs. [b]
 
Reaction at 80 °C. [c] [RuCl2(p-cymene)]2 (2.5 mol %). [d]
 Additive (20.0 mol %). 
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3.2 Scope of Ruthenium(II)-Catalyzed C–H/N–O Functionalizations 
With the optimal conditions in hand, we next explored the substrate scope in the 
dehydrative alkyne annulation by C–H/N–O cleavages (Table 3.3). First we screened different 
substituted N-hydroxybenzamides 88. The yields of the desired products 41 were good, and 
valuable functional groups, such as fluoro, chloro, bromo, iodo, and nitro substituents, were 
well tolerated. While the site selectivity was largely controlled by steric interactions, the 
inductive effect of a meta-fluoro substituent[49] led to the exclusive C–C bond formation at 
the C2 position of N-hydroxybenzamide 88k. 
Table 3.3: Scope of substituted N-hydroxybenzamides 88 with diphenylacetylene 38a.[a] 
 



















R = H (88a) 
R = Me (88b) 
R = OMe (88c) 
R = F (88d) 
R = Cl (88e) 
R = Br (88f) 
R = I (88g) 
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R = Me (88i) 
R = CF3 (88j) 
41ia 
41ja 









[a] Reaction conditions: 88 (0.5 mmol), 38a (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), 
3-(F3C)C6H4CO2K (30.0 mol %), H2O (2.0 mL), 100 °C, 18 h. [b] 120 °C. 
With water as the reaction medium, the interaction between solvent, reactant and catalyst 
may have a significant influence on catalytic efficacy. Therefore, sufficient stirring is essential 
for this reaction. As shown in Table 3.4, alkynes 38b and 38c could deliver moderate to good 
yields. However, we found the stirring was very difficult in the reactions with alkynes 38d and 
38e. As a result, no product was generated in entries 3 and 4. 
Table 3.4: Scope of N-hydroxybenzamide 88a with aromatic alkynes 38.[a] 
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R = OMe (38b) 
R = F (38c) 
R = Cl (38d) 





[a] Reaction conditions: 88a (0.5 mmol), 38 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), 
3-(F3C)C6H4CO2K (30.0 mol %), H2O (2.0 mL), 100 °C, 18 h. 
Alkyl-substituted alkynes 38 were also converted with high catalytic efficacy (Table 3.5). With 
the considerable tolerance of electrophilic functional groups, it became apparent that 
isoquinolones 41 bearing useful functionalities could be readily prepared (entries 5 and 6). 
Table 3.5: Scope of N-hydroxybenzamides 88 with aliphatic alkynes 38.[a] 
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R2 = Et (38f) 
R2 = nPr (38g) 

















R1 = OMe (41cg) 
R1 = F (41dg) 








[a] Reaction conditions: 88 (0.5 mmol), 38 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), 
3-(F3C)C6H4CO2K (30.0 mol %), H2O (2.0 mL), 100 °C, 18 h. [b] 80 °C. 
The regioselectivity of the C–H/N–O functionalization with unsymmetrically-substituted 
alkynes 38 was well controlled, generally placing the less steric hindered aliphatic substituent 
distal to nitrogen (Table 3.6). Notably, the robust ruthenium(II) catalyst proved to be tolerant 
of an unprotected hydroxyl group and a thiophene moiety (entries 5 and 6). 
Table 3.6: Scope of N-hydroxybenzamide 88a with unsymmetrically-substituted alkynes 38.[a] 
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R2 = H (38i) 
R2 = OMe (38j) 
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[a] Reaction conditions: 88a (0.5 mmol), 38 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), 
3-(F3C)C6H4CO2K (30.0 mol %), H2O (2.0 mL), 100 °C, 18 h. 
It is noteworthy that the dehydrative C–H/N–O functionalization strategy was not restricted 
to transformations of alkynes. Hence, this strategy also enabled the efficient intermolecular 
alkenylation with N-hydroxybenzamides 88 to furnish the corresponding styrene derivatives 
44 in an atom- and step-economical manner (Table 3.7). 
Table 3.7: Scope of alkenylation by C–H/N–O functionalization.[a] 
 












R1 = H (44aa) 
R1 = Me (44ba) 






3. Ruthenium(II)-Catalyzed C–H/N–O Functionalizations 
- 40 - 
 
entry 88 37 44 
yield 
[%] 












[a] Reaction conditions: 88 (0.5 mmol), 37 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), 
3-(F3C)C6H4CO2K (30.0 mol %), H2O (2.0 mL), 60 °C, 18 h. 
 
3.3 Mechanistic Studies 
3.3.1 Competition Experiments 
Within competition experiments between aryl- and alkyl-substituted alkynes, more 
alkyl-substituted isoquinoline was generated than aryl-substituted isoquinoline in the 
one-pot reaction (Scheme 3.2). 
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Scheme 3.2: Intermolecular competitition experiment between alkyenes 38a and 38g. 
We compared the reactivity of alkynes bearing electron-donating or electron-withdrawing 
groups in a one-pot reaction (Scheme 3.3). The later one was found to be more reactive. 
 
Scheme 3.3: Intermolecular competition experiment between alkynes 38b and 38c. 
We compared the reactivity of N-hydroxybenzamides 88 bearing electron-donating and 
electron-withdrawing substituents, and found the later to be more reactive (Scheme 3.4). 
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Scheme 3.4: Intermolecular competitition experiment between N-hydroxybenzamides 88b 
and 88d. 
To investigate the influence of the tolane substituents on the regioselectivity, we performed 
the intramolecular competition experiment with 38p (Scheme 3.5). The equal amount of 
products indicated that there is no electronic influence on regioselectivity. 
 
Scheme 3.5: Regioselectivity of alkyne 38p bearing ends with different electron density. 
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We were also eager to investigate the relative reactivity between N-methoxybenzamides 40 
and N-hydroxybenzamides 88 (Scheme 3.6). The result indicated that N-hydroxybenzamides 
88 are more reactive than N-methoxybenzamides 40. 
 
 
Scheme 3.6: Intermolecular competitition experiments between N-methoxybenzamides 40 
and N-hydroxybenzamides 88. 
3.3.2 Studies with Isotopically Labeled Compounds 
In order to gain insights into the reaction mechanism, we performed a series of isotope 
studies (Scheme 3.7). In the absence of an alkyne, 8% hydrogen on each ortho position was 
incorporated by deuterium, indicating an irreversible deprotonation. In another experiment 
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employing [D5]-88a, a minor D/H scrambling in the product was abserved. 
 
Scheme 3.7: C–H/N–O functionalization with isotopically labeled solvent and substrate 
[D5]-88a. 
The kinetic isotope effect (KIE) experiment with 88a and [D5]-88a in a one-pot reaction 
showed that the C–H activation should be the rate-limiting step (Scheme 3.8). 
 
Scheme 3.8: Kinetic isotope efect of C−H/N−O functionalizations. 
Furthermore, a crossover experiment was performed with substrates 95 and 88c, indicating 
the re-oxidation of the ruthenium catalyst to occur in an intramolecular manner (Scheme 
3.9). 
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Scheme 3.9: Crossover experiment. 
Based on our mechanistic studies, we propose the catalytic cycle as shown in Scheme 3.10: 
First, the in situ-generated ruthenium(II)-carboxylate complex 96 is coordinated by 
N-hydroxybenzamide to form ruthenium(II) complex 97. Second, carboxylate-assisted C–H 
ruthenation occurs to generate complex 98 and carboxylic acid. Third, migratory insertion of 
alkyne 38 with cyclometalated complex 98 delivers the ruthenium(II) complex 99. Fourth, 
inspired by a previous report of the Ackermann group,[106] we suppose that the reductive 
elimination generates ruthenium(0) intermediate 100. Fifth, oxidative addition of 
ruthenium(0) species onto the N–O bond in an intramolecular fashion to yield ruthenium(II) 
amide 101. Finally, protodeamidation releases the desired product 41 and at the same time 
regenerates the catalytically active ruthenium(II) biscarboxylate catalyst 96. 
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Scheme 3.10: Proposed catalytic cycle of ruthenium(II)-catalyzed C−H/N−O functionalization. 
(L = p-cymene, Ar = 3-(F3C)C6H4) 
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4 Ruthenium(II)-Catalyzed C–H Oxygenation on Weinreb Amides 
Because of their considerable importance, many synthetic procedures toward phenols have 
been developed. During recent years, step-economical chelation-assisted C–H oxygenations 
were accomplished with the aid of various directing groups utilizing transition metal catalysts. 
Very recently, the Ackermann group and the Rao group developed ruthenium-catalyzed C–H 
bond activations leading to the formation of C–O bonds.[70] 
The easily accessible N-Methoxy-N-methylamides, also known as Weinreb amides, are 
important functional groups in organic synthesis, because they can be chemoselectively 
transformed into the corresponding ketones or aldehydes.[164] Therefore, Weinreb amides 
89 have been widely applied in organic synthesis of naturally occurring bioactive 
compounds.[165] In contrast, Weinreb amides have unfortunately been less explored for 
metal-catalyzed C–H bond functionalizations, and direct oxygenations of aryl Weinreb 
amides have thus far proven elusive. Herein, we developed site-selective C(sp2)–H bond 
oxygenations on aryl Weinreb amides 89 under remarkably mild reaction conditions.[166] 
4.1 Optimization of Ruthenium(II)-Catalyzed C–H Oxygenation on Weinreb Amides 
At the outset, we tested different oxidants, of which copper(II) or silver(I) salts were found to 
be ineffective, while mCPBA and K2S2O8 proved to be promising candidates (Table 4.1, entries 
2-6). The hypervalent iodine(III) reagent PhI(OAc)2 was found to be the optimal oxidant at a 
reaction temperature of 50 °C (entry 7). It is important to note that it should be the lowest 
reaction temperature reported so far for ruthenium-catalyzed C(sp2)–H oxygenations. 
[RuCl2(PPh3)3] provided a diminished yield (entry 9). With a lower catalyst loading, the 
well-defined ruthenium(II) biscarboxylate complex 27 delivered 80% yield (entry 10). We 
changed the ratio of TFA/TFAA solvents and found TFAA to be the essential component 
(entries 14-17). Generally, the ruthenium catalysts were found to be highly robust, as 
showcased by all catalytic reactions being performed without strict exclusion of moisture 
under an atmosphere of air. Yet, the C–H bond oxygenation also occurred readily under an 
inert N2 atmosphere (entry 18). 
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Table 4.1: Optimization of ruthenium(II)-catalyzed C–H oxygenation on Weinreb amide 89a.[a] 
 
entry oxidant TFA/TFAA T [°C] yield [%] 
1 — 3:1 50 — 
2 K2S2O8 3:1 50 57 
3[b] K2S2O8 3:1 50 — 
4 AgOAc 3:1 50 < 5[c] 
5 Cu(OAc)2∙H2O 3:1 50 — 
6 mCPBA 3:1 50 39 
7 PhI(OAc)2 3:1 50 84 
8[d] PhI(OAc)2 3:1 50 76
 
9[e] PhI(OAc)2 3:1 50 57 
10[f] PhI(OAc)2 3:1 50 80 
11 PhI(OAc)2 3:1 100 54 
12 PhI(OAc)2 3:1 80 60 
13 PhI(OAc)2 3:1 30 30 
14 PhI(OAc)2 1:1 50 73 
15 PhI(OAc)2 2:1 50 74 
16 PhI(OAc)2 9:1 50 76 
17 PhI(OAc)2 1:0 50 < 5
[c] 
18[g] PhI(OAc)2 3:1 50 79 
[a] Reaction conditions: 89a (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), oxidant (0.5 mmol), TFA/TFAA 
(2.0 mL); isolated yields. [b] No catalyst. [c] GC-conversion with 1,3,5-trimethoxybenzene as the internal 
standard. [d] [RuCl2(p-cymene)]2 (1.3 mol %). [e] RuCl2(PPh3)3 (5.0 mol %). [f] [Ru(O2CMes)2(p-cymene)] 
(2.5 mol %). [g] Under N2. 
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4.2 Scope of Ruthenium(II)-Catalyzed C–H Oxygenation on Weinreb Amides 
With an effective catalytic system in hand, we studied the influence of the amide 
N-substitution pattern on the efficacy of the C–H bond oxygenation (Table 4.2). Notably, a 
variety of functional groups on the amides were well tolerated by the catalytic system to 
furnish the corresponding products 90, even when being sterically hindered (entry 7). 
Table 4.2: Scope of ruthenium(II)-catalyzed C–H oxygenation on different N-substituted 
Weinreb amides 89.[a] 
 
















R = H (89b) 
R = Me (89c) 
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[a] Reaction conditions: 89 (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), PhI(OAc)2 (0.5 mmol), 
TFA/TFAA (2.0 mL), 50 °C, 16 h. 
Then we evaluated the versatility of the C–H oxygenation with 
N-methoxy-N-methylbenzamides 89 bearing substituents on the aromatic ring (Table 4.3). 
Generally, the catalytic system showed high chemoselectivity. Important electrophilic 
functional groups, including fluoro, chloro, iodo substituents as well as benzyl chloride were 
well tolerated (entries 5-8). 
Table 4.3: Scope of ruthenium(II)-catalyzed C–H oxygenation on different arene-substituted 
Weinreb amides 89.[a] 
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R = H (89a) 
R = Me (89i) 
R = Et (89j) 
R = CF3 (89k) 
R = F (89l) 
R = Cl (89m) 














[a] Reaction conditions: 89 (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), PhI(OAc)2 (0.5 mmol), 
TFA/TFAA (2.0 mL), 50 °C, 16 h. 
 
4.3 Mechanistic Studies 
4.3.1 Competition Experiments 
Intramolecular competition experiments with meta-methyl-substituted Weinreb amides 89p 
highlighted steric effects to primarily influence on the site selectivity of the C–H bond 
functionalization. In contrast, meta-fluoro-substituted arene 89q led to the formation of 
significant amounts of product 90q' (Scheme 4.1). 
4. Ruthenium(II)-Catalyzed C–H Oxygenation on Weinreb Amides 
- 52 - 
 
 
Scheme 4.1: Intramolecular competition experiments with substrates 89p and 89q. 
The intermolecular competition experiment was performed with 
N-methoxy-N,4-dimethylbenzamide (89i) and 4-fluoro-N-methoxy-N-methylbenzamide (89l) 
(Scheme 4.2). It showed electron-rich substrates to be preferentially functionalized. 
 
Scheme 4.2: Intermolecular competition experiment between substrates 89i and 89l. 
4.3.2 Studies with Isotopically Labeled Compounds 
Deuterium labeled Weinreb amide [D5]-89a was utilized in catalytic oxygenations (Scheme 
4.3). Two parallel reactions were performed for 3 h and 16 h, respectively. Only trace 
hydrogen incorporation was detected on the desired product and reisolated starting material 
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which is in line with an irreversible C–H metalation. 
 
 
Scheme 4.3: C–H oxygenation on labeled substrate [D5]-89a. 
Additionally, the kinetic isotope effect (KIE) was studied with substrates 89a and [D5]-89a 
(Scheme 4.4). The KIE value of kH/kD ≈ 3.0 provided strong support for a kinetically relevant 
C–H metalation step. 
 
Scheme 4.4: Kinetic isotope effect studies with Weinreb amides 89a and [D5]-89a. 
 
4.4 Diversification of Product 
To the best of our knowledge, salicylaldehydes 92 were until recently not accessible via direct 
C–H bond oxygenation methods. With LiAlH4 as the reducing agent, salicylaldehyde 92a 
could be easily prepared from ortho-hydroxylated Weinreb amides 90a (Scheme 4.5), thus 
illustrating the practical importance of the ruthenium(II)-catalyzed C–H bond oxygenations 
on Weireb amides. 
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Scheme 4.5: Synthesis of salicylaldehyde 92a using ortho-hydroxylated Weinreb amide 90a. 
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5 Ruthenium(II)-Catalyzed C–H Oxygenation on Aldehydes 
It is a challenging project for C–H oxygenations with weakly coordinating directing 
groups.[45,72] Although the Ackermann group has made great achievements by utilizing 
ketones for site-selective ruthenium(II)-catalyzed C–H oxygenations, the formyl group is 
much more challenging as a substrate in C–H oxygenations and has unfortunately proven 
elusive thus far.[118] As an alternative method, protecting groups are introduced to avoid 
unwanted oxidation.[167] The lack of available C–H activation methods is likely due to the 
inherent tendency of aldehydes to undergo facile oxidation under the strongly oxidizing 
reaction conditions of metal-catalyzed C–H functionalizations. 
Herein we disclose the first aldehyde-directed C–H oxygenation, in which the versatile 
ruthenium(II) catalysts overrode the inherent substrate-controlled formyl oxidation by 
chelation-controlled aromatic C–H activation.[168] It is noteworthy that the salicylaldehyde 
products can be easily converted to other useful building blocks in organic synthesis. 
 
Scheme 5.1: Ruthenium(II)-catalyzed challenging C–H oxygenation on aldehydes. 
5.1 Optimization of Ruthenium(II)-Catalyzed C–H Oxygenation on Aldehydes 
It is known that aldehydes are relatively volatile, thus benzaldehyde (91a) was not the best 
substrate for optimization. Therefore, we chose 4-methoxybenzaldehyde (91b) which has a 
higher boiling point of 248 °C (Table 5.1). The previously used PhI(OAc)2/TFA/TFAA system 
delivered the acid 21b rather than the desired phenol product 92b (entries 1-3). Afterwards, 
we changed the solvent to DCE. With Cu(OAc)2·H2O, BQ, or K2S2O8 we could get neither 
phenol nor acid product (entries 4-6), while PhI(OAc)2 again delivered the acid 21b as the 
sole product (entry 7). 
The breakthrough was achieved by utilizing PhI(OTFA)2 as the oxidant in DCE as the solvent at 
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80 °C, generating 43% of phenol 92b and 9% of acid 21b (entry 8). Subsequently, we tested 
several additives, of which KOAc significantly reversed the chemo-selectivity with the 
formation of 5% of phenol 92b and 32% of acid 21b (entry 10). Other additives showed 
significantly lower efficiency (entries 11 and 12). 
Table 5.1: Optimization of ruthenium(II)-ctalyzed C–H oxygenation on aldehyde 91b with 
different additives and oxidants.[a] 
 
entry additive oxidant solvent 
yield [%] 
91b 92b 21b 
1 — PhI(OAc)2 
TFA/TFAA 
(3:1) 
33 0 41 
2 — PhI(OTFA)2 
TFA/TFAA 
(3:1) 
37 0 20 
3 — K2S2O8 
TFA/TFAA 
(3:1) 
0 0 89 
4 — Cu(OAc)2∙H2O DCE 93 0 0 
5 — BQ DCE 91 0 0 
6 — K2S2O8 DCE 88 0 0 
7 — PhI(OAc)2 DCE 38 0 39 
8 — PhI(OTFA)2 DCE 32 43 9 
9[b] — PhI(OTFA)2 DCE 69 0 5 
10 KOAc PhI(OTFA)2 DCE 44 5 32 
11 AgSbF6 PhI(OTFA)2 DCE 51 15 9 
12 KPF6 PhI(OTFA)2 DCE 35 39 3 
[a] Reaction conditions: 91b (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), additive (20.0 mol %), 
oxidant (1.0 equiv), solvent (2.0 mL), 8 h, isolated yields. [b] No catalyst. 
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As shown in Table 5.2, we screened other ruthenium catalysts and different solvents, but 
could not get any better yields. Several reaction temperatures were tested, of which 100 °C 
was found to be optimal. We got 72% of 2-hydroxy benzaldehyde (92b) and only 2% of acid 
21b by using 1.5 equivalent amount of PhI(OTFA)2. This was an ideal result, concerning both 
yield and chemo-selectivity. It is noteworthy that under the same conditions, other metals, 
such as palladium, rhodium, or nickel, could only generate the acid 21b (entries 12-14). 
Table 5.2: Optimization of ruthenium(II)-ctalyzed C–H oxygenation on aldehydes with 
PhI(OTFA)2 as the oxidant.
[a] 
 
entry [M] solvent T [°C] 
yield [%] 
91b 92b 21b 
1 RuCl2(PPh3)3 DCE 80 51 5 16 
2 RuCl3 DCE 80 51 0 34 
3 [RuCl2(p-cymene)]2 PhMe 80 66 21 1 
4 [RuCl2(p-cymene)]2 PhCl 80 62 9 3 
5 [RuCl2(p-cymene)]2 1,4-dioxane 80 70 3 14 
6 [RuCl2(p-cymene)]2 DME 80 73 0 1 
7 [RuCl2(p-cymene)]2 DCE 50 73 <2 9 
8 [RuCl2(p-cymene)]2 DCE 100 26 47 3 
9 [RuCl2(p-cymene)]2 DCE 120 26 40 3 
10[b] [RuCl2(p-cymene)]2 DCE 100 12 72 2 
11[b,c] [RuCl2(p-cymene)]2 DCE 100 16 43 13 
12[b] Pd(OAc)2 DCE 100 37 0 38 
13[b] [RhCp*Cl2]2 DCE 100 70 0 11 
14[b] Ni(acac)2 DCE 100 79 0 14 
[a] Reaction conditions: 91b (0.5 mmol), [TM] (5.0 mol %), PhI(OTFA)2 (1.0 equiv), solvent (2.0 mL), 8 h, 
isolated yields. [b] PhI(OTFA)2 (1.5 equiv). [c] [RuCl2(p-cymene)]2 (1.25 mol %). 
5. Ruthenium(II)-Catalyzed C–H Oxygenation on Aldehydes 
- 58 - 
 
5.2 Scope of Ruthenium(II)-Catalyzed C–H Oxygenation on Aldehydes 
With the optimal reaction conditions in hand, we probed the scope of the aldehyde-assisted 
C–H oxygenation on various substituted benzaldehydes 91 (Table 5.3). Useful functional 
groups, such as fluoro, chloro, or silyl ether, were well tolerated by the highly chemoselective 
ruthenium(II) catalyst (entries 12-14). Generally, in para-substituted benzaldehydes, the 
electron-donating groups implanted positive effect to the C(sp2)–H oxygenation, while 
electron-withdrawing groups led to reduced yields. 
Table 5.3: Scope of ruthenium(II)-ctalyzed C–H oxygenation on para-substituted aldehydes 
91.[a] 
 
















R = H (91a) 
R = Me (91c) 
R = Et (91d) 
R = iPr (91e) 
R = tBu (91f) 
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R = Me (91b) 
R = Et (91i) 
R = nHex (91j) 



















R = F (91m) 






[a] Reaction conditions: 91 (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), PhI(OTFA)2 (1.5 equiv), DCE 
(2.0 mL), 100 °C, 8 h. [b] PhI(OTFA)2 (2.0 equiv). [c] [RuCl2(p-cymene)]2 (5.0 mol %), PhI(OTFA)2 
(2.5 equiv). 
Afterwards we investigated the site-selectivity of the ruthenium(II)-catalyzed oxygenation 
using meta-substituted benzaldehydes 91 (Scheme 5.2). The steric factor was found 
important for controlling the site-selectivities. With the less sterically hindered methoxy 
group, both isomers 92o and 92o' were generated, while with the more congested phenoxy 
group, improved selectivities were obtained. 
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Scheme 5.2: Ruthenium(II)-ctalyzed C–H oxygenation on meta-substituted aldehydes 91. 
In contrast to the ruthenium(II)-catalyzed oxygenation on Weinreb amides 89, this reaction 
system could efficiently convert the more sterically hindered ortho-substituted 
benzaldehydes 91 into the desired salicyaldehydes 92 (Table 5.4). It is noteworthy that the 
synthetically useful 2-chloro and 2-bromobenzaldehydes 91t and 91u delivered comparable 
yields (entries 4 and 5). 
Table 5.4: Scope of ruthenium(II)-catalyzed C–H oxygenation on ortho-substituted aldehydes 
91.[a] 
 




   
53 
91q 92q 
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R = Et (91r) 








R = Cl (91t) 
R = Br (91u) 
92t 
92u 
[a] Reaction conditions: 91 (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), PhI(OTFA)2 (2.0 equiv), DCE 
(2.0 mL), 100 °C, 8 h. 
Interestingly, 2-phenyl-benzaldehyde (91v) delivered the desired ortho-hydroxylated product 
92v with good yield (Scheme 5.3), while Glorius and coworkers reported the formation of 
fluorenone 102 with the substrate 91v when employing Et4NBr as the catalyst and K2S2O8 as 
the oxidant.[169]  
 
Scheme 5.3: Different chemo-selectivities in the oxidation of 91v. 
The double-substituted benzaldehydes 91 were also employed in the ruthenium(II)-catalyzed 
C–H oxygenation reactions with useful functional group tolerance (Table 5.5). A higher 
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catalyst loading was required in the synthesis of salicylaldehydes 92x and 92y. 
Table 5.5: Scope of ruthenium(II)-ctalyzed C–H oxygenation on double-substituted aldehydes 
91.[a] 
 



















[a] Reaction conditions: 91 (0.5 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), PhI(OTFA)2 (2.0 equiv), DCE 
(2.0 mL), 100 °C, 8 h. [b] [RuCl2(p-cymene)]2 (5.0 mol %), PhI(OTFA)2 (2.5 equiv). 
 
5.3 Mechanistic Studies 
5.3.1 Competition Experiments 
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Competition experiments were carried out between aldehydes 91 bearing electron-donating 
and electron-withdrawing substituents (Scheme 5.4). In the competition experiment 
between 4-methoxybenzaldehyde (91b) and 4-fluorobenzaldehyde (91m), we found the 
2-hydroxy-4-methoxybenzalde (92b) to be the major product with 64% yield. In another 
competition experiment between 3-isopropoxybenzaldehyde (91z) and 
3-(trifluoromethyl)benzaldehyde (91aa), we isolated 50% of 92z but could only detect trace 




Scheme 5.4: Intermolecular competition experiments between different aldehydes 91. 
We compared the coordinating capabilities between aldehydes and other directing groups, 
such as amide, Weinreb amide, and ketone (Scheme 5.5). In all the intermolecular 
competition reactions, salicylaldehyde (92a) was found to be the minor product. 
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Scheme 5.5: Intermolecular comparison of directing group power. 
The results from intramolecular competition reactions with arenes 103 bearing two different 
directing groups once more confirmed the aldehyde moiety to be the weakest carbonyl 
coordinating group so far (Scheme 5.6). 
 
Scheme 5.6: Intramolecular comparison of directing group power. 
5.3.2 Studies with Isotopically Labeled Compound 
The independent kinetic isotope effect (KIE) was studied with substrates 91r and [D4]-91r 
(Scheme 5.7). The KIE value was found to be 3.1, which indicated a kinetically relevant C–H 
metalation step. 
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Scheme 5.7: Independent kinetic isotope effect studies. 
In the intramolecular kinetic isotope effect studies, we utilized mono ortho-deuterated 
benzaldehyde ([D1]-91a). The KIE value was found to be 4.3 (Scheme 5.8). The considerably 
different inter- and intramolecular KIEs strongly suggest the formation of an intermediate in 
which the aldehyde carbonyl group is pre-coordinated to the active ruthenium catalyst. 
 
Scheme 5.8: Intramolecular kinetic isotope effect. 
 
5.4 Diversification of Salicylaldehydes 
Salicylaldehyde is a useful starting material in the synthesis of many natural products. We 
explored the unique utility of the formyl group for the late-stage diversification (Schemes 
5.9-5.12): 
First, 2H-chromen-2-one (107) was synthesized in three steps with 79% overall yield. 
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Scheme 5.9: Synthesis of 2H-chromen-2-one (107). 
Second, the synthesis of 2-n-butyl-4H-chromen-4-one (110) required three steps with 73% 
overall yield. It is noteworthy that no purification was needed until the last step. 
 
Scheme 5.10: Synthesis of 2-butyl-4H-chromen-4-one (110). 
Third, 2-nitrobenzofuran (113) could be synthesized in three steps with 51% overall yield. 
 
Scheme 5.11: Synthesis of 2-nitrobenzofuran (113). 
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Fourth, the Lautens's method[170] was utilized for the synthesis of 2-phenylbenzofuran (115) 
which was accomplished in two steps with 69% overall yield. 
 
Scheme 5.12: Synthesis of 2-phenylbenzofuran (115). 
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6 Photo-Induced Copper(I)-Catalyzed C(sp2)–H Arylations 
The copper-promoted biaryl synthesis was disclosed by Ullmann more than one hundred 
years ago.[8] Recent years have witnessed the successful application of heteroarenes in 
copper-catalyzed C–H arylations.[171-173] However, these reactions always required high 
temperatures of at least 100 °C. 
 
Scheme 6.1: Copper(I)-catalyzed C–H arylation. 
The development of transition metal-catalyzed C–H arylation at ambient temperature 
remains a major challenge in the field.[83] As shown in Scheme 6.1, C–H metalation is feasible 
for heteroarenes with relatively acidic C–H bonds, and therefore, the dissociation of 
carbon–halogen bond should be the rate-limiting step. In a previous study, Kim and 
coworkers have shown that UV irradiation of 140 nm could break the C–I bond in 
2,5-diiodothiophene with the assistance of copper thus generating thienyl radicals.[174] 
Inspired by the above mentioned studies, we hypothesized that the rate of the 
copper(I)-catalyzed heteroarne arylation could be accelerated by UV light, and therefore, the 
reaction could perform at a more environmentally-benign temperature. 
 
Scheme 6.2: Photo-induced copper(I)-catalyzed heterocyclic arylation. 
6.1 Optimization of Photo-Induced Copper(I)-Catalyzed C(sp2)–H Arylations 
We started the optimization with the commonly used solvent acetonitrile, obtaining only 10% 
yield (Table 6.1, entry 1). Afterwards we changed to DMF and found that the yield could 
reach 33% using 3-iodotoluene as the arylation reagent and LiOtBu as the base (entry 3). 
Other bases, such as KOtBu or K3PO4, delivered lower conversion (entries 4 and 5). Copper(I) 
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acetate did work as the catalyst, but with a slightly lower yield (entry 6). Later we found that 
the reaction proceeded better in DMA as the solvent, delivering 39% yield (entry 8). Higher 
reaction temperature did not increase the yield (entry 9). A second metal catalyst, such as 
Pd(OAc)2 or AgOAc, proved powerless in the reaction (entries 10 and 11). 
Thereafter we changed to etherial solvents, and obtained some inspiring results. The yield 
with Et2O as solvent reached 48% (entry 14), but significantly dropped with THF or 
1,4-dioxane as the solvent (entries 12 and 13). Therefore, Et2O was identified the optimal 
solvent. We tried to reduce the amount of iodoarene, but the yield dropped to 39% (entry 
15). A moderate yield of 57% was obtained with 20 mol % of CuI (entry 16). Higher yield was 
obtained with more CuI (entry 17). However, the catalyst loading and yield were not in linear 
correlation, indicating a catalytic reaction. Thus, the catalyst loading was set to 20 mol %. The 
in-situ temperature was found to be about 28 °C during the first 6 hours. 
Table 6.1: Optimization of photo-induced copper(I)-catalyzed C(sp2)–H arylations with 












1 1.5 CuI (10) LiOtBu (1.0) MeCN 10 
2 1.5 CuI (10) LiOtBu (1.0) DMF 21[b] 
3 5.0 CuI (10) LiOtBu (3.0) DMF 33[b] 
4 5.0 CuI (10) KOtBu (3.0) DMF 13 
5 1.5 CuI (10) K3PO4 (1.0) DMF 5 
6 5.0 CuOAc (10) LiOtBu (3.0) DMF 28[b] 
7 5.0 CuI (10) LiOtBu (3.0) DMPU < 2 
8 5.0 CuI (10) LiOtBu (3.0) DMA 39[b] 
9[c] 5.0 CuI (10) LiOtBu (3.0) DMA 37 
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10 5.0 Pd(OAc)2 (10) + CuI (10) LiOtBu (3.0) DMA 30 
11 5.0 AgOAc (10) + CuI (10) LiOtBu (3.0) DMA 37[b] 
12 5.0 CuI (10) LiOtBu (3.0) THF 30 
13 5.0 CuI (10) LiOtBu (3.0) 1,4-dioxane 10 
14 5.0 CuI (10) LiOtBu (3.0) Et2O 48
[b] 
15 2.0 CuI (10) LiOtBu (3.0) Et2O 39
[b] 
16 5.0 CuI (20) LiOtBu (3.0) Et2O 57
[b] 
17 5.0 CuI (50) LiOtBu (3.0) Et2O 80
[b] 
[a] Reaction conditions: 93a (0.25 mmol), 19b (5.0 equiv), catalyst (10 mol %), base (3.0 equiv), 
solvent (1.5 mL), 28 °C under 254 nm irradiation for 16 h, 1H-NMR conversion with 
1,3,5-trimethoxybenzene as the internal standard. [b] Isolated yield. [c] 50 °C. 
Thereafter, we screened different additives (Table 6.2). DCN and fluorescein showed no or 
limited effect (entries 1 and 2). Nitrogen-containing ligands and carboxylate showed 
apparent negative impact on the reactions (entries 3-6), while picolinic acid containing both 
nitrogen and carboxylate showed a slightly positive effect (entry 7). Then, we tried various 
amino acid ligands, among which L-Alanine (L-Ala) and N,N-dimethylglycine (DMG) showed 
the best results (entry 11 and 17). Finally, we chose the N-protected DMG as the optimal 
ligand. The reaction delivered the product in 73% yield with 1.0 mL of Et2O as the solvent 
(entry 20). 
Table 6.2: Optimization of photo-induced copper(I)-catalyzed C(sp2)–H arylations with 
different additives.[a] 
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entry additive yield [%] entry additive yield [%] 
1 DCN 57 15 N-Ac-Gly 63 
2 Fluoresein 61 16 N-PI-Gly 64 
3 TMEDA 36 17 DMG 67[b] 
4 bpy 39 18 DMG (20 mol %) 62 
5 2-Ph-Pyr 32 19 DMG (50 mol %) 58 
6 AdCO2H 28 20
[c] DMG 73[b] 
7 Pyr-2-CO2H 62 21
[d] DMG 55 
8 L-Pro 62[b] 22[c, e] DMG 0 
9 N-Boc-Pro 65 23[c, f] DMG 0 
10 Gly 64 24[c, g] DMG 0 
11 L-Ala 67[b] 25[c, h] DMG 0 
12 L-Ile 63 26[c, i] DMG 0 
13 2-Ph-Gly 61 27[c, j] DMG 29 
14 N-Me-Gly 63    
[a] Reaction conditions: Benzothiazole 93a (0.25 mmol), 3-iodotoluene 19b (5.0 equiv), CuI 
(20 mol %), additive (30 mol %), LiOtBu (3.0 equiv), Et2O (1.5 mL), 28 °C under 254 nm irradiation for 
16 h, 1H-NMR conversion with 1,3,5-trimethoxybenzene as the internal standard. [b] Isolated yield. [c] 
Et2O (1.0 mL). [d] Et2O (2.5 mL). [e] No CuI. [f] No base. [g] 30 °C in dark environment. [h] Et3N 
(3.0 equiv) as the base. [i] LiOAc (3.0 equiv) as the base. [j] Ni(acac)2 (20 mol %) as the catalyst. 
We set out to achieve copper(I)-catalyzed arylations under visible light at ambient 
temperature (Table 6.3). Thus, we tested different photo catalysts, including Ir(ppy)3, 
Ru(bpy)3Cl2·6H2O, fluorescein, and DCN; solvents, such as Et2O, MeCN, DMF, and DMSO; and 
light sources. The optimal conditions employed CuI as the C–H activation catalyst and Ir(ppy)3 
as the photocatalyst in DMF under blue light irradiation (entry 4). Due to the thermal 
radiation of blue light, the reaction temperature could reach 35 °C. 
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Table 6.3: Optimization of visible light-induced copper(I)-catalyzed C(sp2)–H arylation.[a] 
 
entry photoredox catalyst [mol %] solvent light source yield [%] 
1 Ir(ppy)3 (2.0) Et2O blue LED 0 
2 Ir(ppy)3 (2.0) MeCN blue LED trace 
3 Ir(ppy)3 (2.0) DMSO blue LED 38 
4 Ir(ppy)3 (2.0) DMF blue LED 50
[b] 
5 — DMF blue LED 20 
6[c] Ir(ppy)3 (2.0) DMF blue LED 0 
7 Ir(ppy)3 (2.0) DMF 18W CFL 18 
8 Ru(bpy)3Cl2∙6H2O (2.0) DMF blue LED 6 
9 Ru(bpy)3Cl2∙6H2O (2.0) DMF green LED trace 
10 Fluorescein (20) DMF blue LED 9 
11 DCN (20) DMF blue LED 5 
[a] Reaction conditions: 93a (0.25 mmol), 19b (5.0 equiv), CuI (20 mol %), photoredox catalyst, LiOtBu 
(3.0 equiv), solvent (1.0 mL), 35 °C under visible light irradiation for 16 h, 1H-NMR conversion with 
1,3,5-trimethoxybenzene as the internal standard. [b] Isolated yield. [c] No CuI. 
 
6.2 Scope of Photo-Induced Copper(I)-Catalyzed C(sp2)–H Arylations 
The photo-induced copper(I)-catalyzed C–H arylation on benzothiazole delivered high yields 
(Table 6.4). Various useful functional substituents, such as fluoro, chloro, and trifluoromethyl, 
were well tolerated (entries 3, 4, 7, 9, 10). The coupling between benzothiazole (93a) and 
iodo-substituted benzoic ester 19f delivered the desired product 94af, but in somehow lower 
yield (entry 5). Benzoxazole (93b) and 5-methylbenzoxazole (93c) could efficiently convert to 
the desired products 94ba, 94bb, and 94cb, respectively. However, only 33% of desired 
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product 94db was obtained with 5-chlorobenzoxazole (93d). 
Table 6.4: Scope of photo-induced copper(I)-catalyzed C(sp2)–H arylations with 
benzannulated heteroarenes 93.[a] 
 


















R = H (19a) 
R = OMe (19c) 
R = CF3 (19d) 
R = Cl (19e) 





















R = Me (19b) 
R = CF3 (19g) 
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R = F (19i) 






















R = H (94ba) 
R = Me (94bb) 
 
6. Photo-Induced Copper(I)-Catalyzed C(sp2)–H Arylations 
- 74 - 
 
 










R = Me (93c) 




[a] Reaction conditions: 93 (0.25 mmol), 19 (5.0 equiv), CuI (20 mol %), DMG (30 mol %), LiOtBu 
(3.0 equiv), Et2O (1.0 mL), 28 °C under 254 nm irradiation for 16 h. 
  
The substituted heteroarenes showed comparable efficacy in this catalytic C–H arylation, 
despite of higher pKa values (Table 6.5). Thiazole and oxazole with alkyl or aryl substituents 
all delivered moderate to good results. While oxadiazole with different substituents on two 
carbon atoms could be synthesized with moderate yields (entries 12 and 13). 
With the photo-induced copper(I)-catalyzed C–H arylation method, balsoxin (94ka) was 
synthesized in 2 steps with the total yield of 47% (entry 11). Hodgetts and coworkers 
required 7 steps on the synthesis of the same compound.[175] Although Greaney et al. 
reported a 2 step balsoxin synthesis with a higher yield, each step required a particular type 
of expensive palladium catalyst at higher reaction temperature.[176]  
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R = 4-CF3 (94fd) 



















R = H (94ha) 
R = 4-Cl (94he) 
R = 3-Me (94hb) 








R = 3-OMe (93i) 












Balsoxin (94ka) 53 
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R = Me (94lb) 
R = Cl (94lj) 
54 
51 
[a] Reaction conditions: 93 (0.25 mmol), 19 (5.0 equiv), CuI (20 mol %), DMG (30 mol %), LiOtBu 
(3.0 equiv), Et2O (1.0 mL), 28 °C under 254 nm irradiation for 16 h. 
 
The scope is not limited to heteroarenes. Indeed, the non-aromatic oxazolines 116 could also 
furnish good yields with different iodo arenes 19 (Table 6.6). To the best of our knowledge, 
this is the first C2 arylation of oxazolines using photo catalysis. 
Table 6.6: Scope of photo-induced copper-catalyzed C(sp2)–H arylations with non-aromatic 
heterocycles 116.[a] 
 














R = 4-OMe (117ac) 
R = 3-Me (117ab) 
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[a] Reaction conditions: 116 (0.25 mmol), 19 (5.0 equiv), CuI (20 mol %), DMG (30 mol %), LiOtBu 
(3.0 equiv), Et2O (1.0 mL), 28 °C under 254 nm irradiation for 16 h. 
We explored the substrate scope of visible light-induced copper(I)-catalyzed C–H arylation 
and found only 93a could be arylated in moderate yield (Table 6.7). Other substituted 
heterocycles 93 as well as oxazoline 116 delivered low yields, indicating the characteristics of 
heterocycles are important for the visible light-induced copper(I)-catalyzed C–H arylation. 
Table 6.7: Scope of visible light-induced copper(I)-catalyzed C(sp2)–H arylation.[a] 
 




























[a] Reaction conditions: 93 or 116 (0.25 mmol), 19 (5.0 equiv), CuI (20 mol %), Ir(ppy)3 (2.0 mol %), 
LiOtBu (3.0 equiv), DMF (1.0 mL), 35 °C under 450-500 nm irradiation for 16 h. 
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6.3 Mechanistic Studies 
6.3.1 Competition Experiments 
We performed intermolecular competition experiment between iodobenzenes 19 with 
electron-donating and electron-withdrawing groups (Scheme 6.3), indicating electron-rich 
iodoarene to be more reactive under the optimal reaction conditions. 
 
Scheme 6.3: Competition experiment between iodoarenes 19h and 19g. 
Furthermore, a competition experiment was performed between benzothiazole (93a) and 
substituted thiazole 93f, revealing that the benzannulated heteroarene 93a to be more 
reactive. 
 
Scheme 6.4: Competition experiment between heteroarenes 93a and 93f. 
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6.3.2 Studies with Isotopically Labeled Compounds 
We performed H/D exchange experiments with LiOtBu as the base and tBuOD as the additive 
(Scheme 6.5). With CuI (20 mol %) the H/D ratio was determined to be 48/52 as estimated by 
1H-NMR, while in the absence of CuI the same H/D ratio was observed. Thus copper iodide 
was not essential for the H/D scrambling. 
 
Scheme 6.5: H/D scrambling experiment with 93a. 
6.3.3 Studies with Radical Scavenger 
The mechanisms of copper-catalyzed reactions have been previously studied by Koyama,[177] 
Hartwig,[178,179] Buchwald,[180] as well as Fu and Peters[143] using different strategies. 
We performed the radical trap experiment employing a radical scavenger (Scheme 6.6). We 
did not use TEMPO because of the potential photoreactivity of its N–O bond. Alernatively, 
galvinoxyl was chosen for this experiment. We obtained a slightly lower yield with 20 mol % 
of galvinoxyl being used. However, galvinoxyl did not capture the desired aryl radical. Instead, 
the hydrogenated galvinoxyl was observed. We would ascribe the fact that no galvinoxyl–aryl 
product generated to the steric factors of the radical scavenger. To exclude the possibility 
that radical scavengers may react with metal hydrido complexes,[181] we performed the 
reaction with 1 equivalent of galvinoxyl and isolated 44% of the arylation product 94ab. The 
arylation was completely inhibited with 3 equivalent of the radical scavenger. Taken together, 
a radical pathway was hereby indicated. 
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Scheme 6.6: Mechanistic study with galvinoxyl as the radical scavenger. 
Base on the mechanistic studies, we propose the catalytic cycle depicted in Scheme 6.7: First, 
the cycle starts from irradiation of iodoarene, the iodo–carbon bond absorbs the energy 
from UV light and dissociates with the assistance of copper(I) complex 118 to generate the 
aryl radical 119 and the iodine anion. Second, C–H activation occurs with base-assistance. 
Third, the intermediate 121 is attacked by the aryl radical 119 to form the arylated 
benzothiazole 94 and regenerate copper(I) complex 118. 
 
Scheme 6.7: Proposed catalytic cycle of photo-induced copper(I)-catalyzed C–H arylations. 
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7 Summary and Outlook 
Transition metal-catalyzed cross-coupling reaction as one of the greatest chemical 
innovations of 20th century has to utilize stoichiometric amounts of prefunctionalized 
reagents. In comparison, the transition metal-catalyzed direct C–H functionalization provided 
a more atom- and step-economical pathway for the synthesis and modification of arenes. 
Within this thesis, several new synthetic methods based on transition metal-catalyzed C–H 
functionalization have been developed. 
Oxidative annulations of alkynes by C–H/N–H cleavages have recently emerged as a useful 
strategy for the sustainable preparation of N-heterocycles. To avoid the use of excess 
amounts of sacrificial oxidants, transition metal-catalyzed C–H/N–O bond functionalizations 
with N-substituted benzamides have been investigated. In the first project, a novel 
isoquinolone synthesis has been achieved utilizing ruthenium(II)-catalyzed C–H/N–O 
functionalization (Scheme 7.1). This green approach employed H2O as the reaction medium, 
and generated H2O as the sole byproduct. The catalytic system also proved applicable for 
oxidative alkenylations. 
 
Scheme 7.1: Ruthenium(II)-catalyzed C–H/N–O functionalization. 
The carboxylate-assisted C–H bond founctionalization was also investigated. Various 
carboxylate additives were probed, of which the electron-deficient carboxylate 
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3-(F3C)C6H4CO2K was found to be the optimal additive for the ruthenium(II)-catalyzed 
C–H/N–O functionalization in water. Due to the different effects of carboxylates (Scheme 7.2), 
next generation ruthenium(II) carboxylate catalysts should be designed and synthesized 
specifically for different novel transformations. 
 
Scheme 7.2: Carboxylates as cocatalysts in ruthenium-catalyzed C–H/N–O functionalization. 
The second project refers to ruthenium(II)-catalyzed C–H oxygenations on synthetically useful 
Weinreb amides 89. With hypervalent iodine(III) reagent PhI(OAc)2 as the oxidant, the 
ortho-selective C–O formation efficiently took place at a reaction temperature of 50 °C 
(Scheme 7.3), which should be the lowest reaction temperature reported thus far for 
ruthenium(II)-catalyzed C(sp2)–H bond oxygenations. 
 
Scheme 7.3: Ruthenium(II)-catalyzed C–H oxygenation on Weinreb amides 89. 
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Furthermore, the practical importance of C–H bond oxygenations on aryl Weinreb amides 89 
was illustrated by the high-yielding preparation of the corresponding salicylaldehyde 92 
(Scheme 7.4). 
 
Scheme 7.4: Preparation of salicylaldehyde 92a from ortho-hydroxylated Weinreb amide 
90a. 
A more atom- and step-economical pathway for salicylaldehyde synthesis would directly start 
from benzaldehyde 91, representing a challenging project. The intra- and intermolecular 
competition experiments between different carbonyl group-containing substrates showed 
aldehydes to be the weakest directing group so far. Meanwhile, aldehyde has the inherent 
tendency to be readily oxidized to the corresponding acid. Utilizing the unique catalytic 
activity of [RuCl2(p-cymene)]2, we successfully accomplished the chelation-directed 
ortho-oxygenation on benzaldehydes with PhI(OTFA)2 as the oxidant (Scheme 7.5). The use of 
molecular O2 in the ruthenium-catalyzed ortho-oxygenation on benzaldehydes will be the 
'Mount Everest' in this field. 
 
Scheme 7.5: Ruthenium (II)-catalyzed C–H oxygenation on benzaldehydes 91. 
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Salicylaldehydes 92 are useful starting materials in the synthesis of many natural products. 
We explored the unique utility of the formyl group for the late-stage diversification (Scheme 
7.6). 
 
Scheme 7.6: Late-stage diversification of salicyaldehyde 92. 
Despite the tremendous achievements during recent years, transition metal-catalyzed direct 
C–H functionalizations have been somewhat limited because of the commonly used high 
reaction temperatures. Thus in the fourth project, we turned to photo-catalysis. Various 
heteroarenes as well as natural products were synthesized utilizing photo-induced 
copper(I)-catalyzed C–H arylations at ambient temperature (Scheme 7.7). Non-aromatic 
oxazolines 116 were also viable substrates in this C–H arylation reaction. Visible light catalysis 
was also probed with thus far somewhat limited success. 
 
Scheme 7.7: Photo-induced copper(I)-catalyzed C(sp2)–H arylations. 
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Photo-induced transition metal-catalyzed C–H functionalizations have provided a charming 
future for the facile synthesis of tremendous compounds and materials which cannot be 
achieved by thermal synthesis. I would suppose great development in this field with various 
transition metals, photo reagents, as well as irradiation sources. 
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8 Experimental Sections 
8.1 General Remarks 
All reactions involving moisture- or air-sensitive reagents or products were performed under 
a N2 atmosphere using pre-dried glassware and standard Schlenk techniques. Syringes for 
handling of dry solvents were flushed with dry nitrogen threefold prior to use. 
Vacuum 
The following pressures were measured on the used vacuum pump and are uncorrected: oil 
pump vacuum (OPV): 0.1 mbar, membrane pump vacuum (MPV): 5.0 mbar. 
Melting Points  
Melting points were measured using a Stuart® Melting Point Apparatus SMP3 from 
BARLOWORLD SCIENTIFIC. The reported values are not corrected. 
Chromatography  
Analytical thin layer chromatography (TLC) was performed on 0.25 mm silica gel 60F-plates 
(MACHEREY-NAGEL) with 254 nm fluorescent indicator from MERCK. Plates were visualized 
under UV-light and developed by treatment with a KMnO4 solution followed by careful 
applying a heat gun. 
Chromatographic purification of products was accomplished by flash column 
chromatography on MERCK silica gel, grade 60 (0.040–0.063 mm and 0.063–0.200 mm, 
70–230 mesh astimated). 
Gas Chromatograpgy 
The conversion of the reactions was monitored applying coupled gas chromatography/mass 
spectrometry using G1800C GCDplus with mass detector HP 5971, 5890 Series II with mass 
detector HP 5972 from HEWLETT-PACKARD and 7890A GC-System with mass detector 5975C 
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(Triplex-Axis-Detector) from AGILENT TECHNOLOGIES equipped with HP-5MS columns (30 m 
× 0.25 mm × 0.25 µm) were used. 
Nuclear Magnetic Resonance Spectroscopy  
Nuclear magnetic resonance (NMR) spectroscopy was performed at 300 or 600 MHz 
(1H-NMR), 75.5 or 125 MHz (13C-NMR, APT) and 282 MHz (19F-NMR) on BRUKER AM 250, 
VARIAN Unity-300 and Inova 500 instruments. Chemical shifts are reported as δ-values in 
ppm relative to the residual proton peak of the deuterated solvent or its carbon atom, 
respectively. 
 1H-NMR 13C-NMR 
CDCl3: 7.26 ppm 77.0 ppm 
DMSO-d6: 2.49 ppm 49.5 ppm 
For characterization of the observed resonance multiplicities the following abbrevations 
were applied: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of 
doublet), dt (doublet of triplet), or analogue representations. The coupling constants J are 
reported in Hertz (Hz). Analyses of the recorded spectra were carried out using MestReNova 
10.0 software. 
Mass Spectrometry  
EI- and EI-HR-MS spectra were measured on a Time-of-Flight mass spectrometer AccuTOF 
from JOEL. ESI-mass spectra were recorded on an Ion-Trap mass spectrometer LCQ from 
FINNIGAN or on a Time-of-Flight mass spectrometer microTOF from BRUKER. ESI-HRMS 
spectra were recorded on a BRUKER APEX IV or a BRUKER DALTONIC (7T, Transform Ion 
Cyclotron Resonance (FTICR)) mass spectrometer. The ratios of mass to charge are indicated, 
intensities relative to the base peak (I = 100) are written in parentheses. 
Infrared Spectroscopy  
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Infrared spectra were recorded on a BRUKER Alpha-P ATR-spectrometer. Liquid probes have 
been measured as film and solid probes neat. Analysis of the spectral data has been done by 
using the OPUS 6 software from BRUKER, respectively OPUS 6. Absorption is given in wave 
numbers (cm–1). Spectra were recorded in the range of 4000 to 400 cm–1.  
Solvents  
All solvents for reactions involving moisture-sensitive reagents were dried, distilled and 
stored under inert atmosphere (argon or nitrogen) according to the following standard 
procedures: 
Solvent Drying Method 
Acetonitrile was dried over 4Å MS, filtrated through an alumina 
column, and degassed using Freeze-Pump-Thaw 
procedure. 
tert-Amylalcohol was stirred over sodium chips for 5 h at 120 °C and 
distilled under ambient pressure. 
Chlorobenzene was used as received. 
1,2-Dichloroethane was dried over CaH2 for 8 h, degassed and distilled under 
ambient pressure. 
Diethyl ether was purified using a solvent purification system (SPS-800) 
from MBRAUN. 
1,2-Dimethoxyethane was distilled from sodium benzophenone ketyl. 
N,N-Dimethylacetamide was dried over CaH2 for 12 h, degassed and distilled under 
reduced pressure. 
N,N-Dimethylformamide was dried over CaH2 for 8 h, degassed and distilled under 
reduced pressure. 
N,Nʹ-Dimethylpropyleneurea was used as received and stored under inert atmosphere. 
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1,4-Dioxane was dried by distillation from sodium benzophenone ketyl. 
Tetrahydrofuran was purified using a solvent purification system (SPS-800) 
from MBRAUN. 
Toluene was purified using a solvent purification system (SPS-800) 
from MBRAUN. 
Trifluoroacetic acid was used as received and stored at 4 °C under inert 
atomsphere. 
Trifluoroacetic anhydride was used as received and stored at 4 °C under inert 
atmosphere. 
Water was degassed using Freeze-Pump-Thaw procedure. 
 
Reagents 
Chemicals obtained from commercial sources (with a purity > 95%) were used without 
further purification. The following compounds were synthesized according to known 
literature procedures and were pure by comparison with the published analytical data: 
N-Hydroxybenzamides (88),[182] N-methoxybenzamides (40),[107] alkynes 38b-c,[183] alkynes 
38j-o,[184] 2-methoxy-6-methyl-3,4-diphenylisoquinolin-1(2H)-one (95),[108] Weinreb amides 
89,[185] 4'-(trifluoromethyl)-[1,1'-biphenyl]-4-carbaldehyde (91h),[186] 
4-[(triisopropylsilyl)oxy]benzaldehyde (91l),[187] N,N-diisopropylbenzamide (56a),[188] 
5-phenylthiazole (93f),[189] 5-areneoxazoles 93i-k,[190] 2-phenyl-1,3,4-oxadiazole (93l),[191] 
oxazolines 116b-c,[192] tert-butyl 4-iodobenzoate (19f).[193]  
The following compounds were obtained by the generous grant of the persons named 
below: 
Karsten Rauch: [RuCl2(p-cymene)]2, [Ru(O2CMes)2(p-cymene)]; Dr. Marvin Schinkel: 
MesCO2K, RuCl2(PPh3)3; Dr. Christoph Kornhaaß: 1-Phenyl-1-hexyne (38i); MSc Katharina 
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Kettelhoit: 4-(hexyloxy)benzaldehyde (91j), 4-phenoxybenzaldehyde (91k). 
 
8.2 General Procedures 
General Procedure A: Ruthenium(II)-Catalyzed C–H/N–O Alkyne Annulations of 
N-hydroxybenzamides 88 with Alkynes 38. 
To a pre-dried 25 mL Schlenk tube were added N-hydroxybenzamide 88 (0.50 mmol), alkyne 
38 (0.75 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), potassium 
3-(trifluoromethyl)benzoate (34 mg, 30.0 mol %), and H2O (2 mL) under a N2 atmosphere. 
The mixture was vigorously stirred at 100 °C for 16 h. At ambient temperature, the reaction 
mixture was diluted with H2O (25 mL) and extracted with EtOAc (3 × 25 mL). The combined 
organic phase was washed with brine (50 mL) and dried over Na2SO4. After filtration and 
evaporation of the solvent under reduced pressure, the crude product was purified by 
column chromatography on silica gel (n-pentane/EtOAc) to yield the desired product 41. 
General Procedure B: Ruthenium(II)-Catalyzed C–H/N–O Alkenylations of 
N-hydroxybenzamides 88 with Alkenes 37. 
To a pre-dried 25 mL Schlenk tube were added N-hydroxybenzamide 88 (0.50 mmol), alkene 
37 (0.75 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), potassium 
3-(trifluoromethyl)benzoate (34 mg, 30.0 mol %), and H2O (2 mL) under a N2 atmosphere. 
The mixture was vigorously stirred at 60 °C for 16 h. At ambient temperature, the reaction 
mixture was diluted with H2O (25 mL) and extracted with EtOAc (3 × 25 mL). The combined 
organic phase was washed with brine (50 mL) and dried over Na2SO4. After filtration and 
evaporation of the solvent under reduced pressure, the crude product was purified by 
column chromatography on silica gel (CH2Cl2/EtOAc) to yield the desired product 44. 
General Procedure C: Ruthenium(II)-Catalyzed C–H Oxygenation on Weinreb Amides 89. 
8. Experimental Sections 
- 91 - 
 
To a pre-dried 25 mL Schlenk tube were added Weinreb amide 89 (0.50 mmol), 
[RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), PhI(OAc)2 (161 mg, 0.50 mmol), and TFA/TFAA 
(2.0 mL, 3/1) under an ambient atmosphere of air. The tube was sealed tightly and the 
reaction mixture was stirred at 50 °C for 16 h. At ambient temperature, aqueous NaHCO3 
(25 mL) was slowly added to the reaction mixture and extracted with EtOAc (3 × 25 mL). The 
combined organic phase was washed with brine (50 mL) and dried over Na2SO4. After 
filtration and evaporation of the solvent under reduced pressure, the crude product was 
purified by column chromatography on silica gel (n-pentane/EtOAc) to yield the desired 
product 90. 
General Procedure D: Ruthenium(II)-Catalyzed C–H Oxygenation on Arylaldehydes 91. 
To a pre-dried 25 mL Schlenk tube equipped with a condenser were added arylaldehyde 91 
(0.5 mmol), [RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), [bis(trifluoroacetoxy)iodo]benzene 
(323 mg, 0.75 mmol), and DCE (2.0 mL) under a N2 atmosphere. The mixture was stirred at 
100 °C for 8 h. At ambient temperature, HCl (1N, 0.5 mL) was added to the reaction mixture, 
stirred for another 0.5 h, and then purified by column chromatography on silica gel 
(n-pentane/Et2O). The eluent was carefully removed by Vigreux distillation to yield the 
corresponding salicylaldehyde 92. 
General Procedure E: Photo-Induced Copper(I)-Catalyzed C–H Arylation of Hererocycles 93 
or 116. 
To a pre-dried 10 mL quartz tube were added heterocycle 93 or 116 (0.25 mmol), iodoarene 
19 (1.25 mmol), copper(I) iodide (9.5 mg, 20 mol %), dimethylglycine (7.7 mg, 30 mol %), 
LiOtBu (60 mg, 0.75 mmol), and Et2O (1.0 mL) under a N2 atmosphere. The tube was sealed 
tightly and the mixture was stirred under 254 nm irradiation in a Luzchem LZC-ICH2 
photoreactor for 16 h at ambient temperature. Then, the reaction mixture was filtrated 
through a pad of silica gel and washed with Et2O (20 mL). The solvent was removed under 
reduced pressure and the residue was purified by column chromatography on silica gel 
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(n-pentane/Et2O) to yield the desired product 94 or 117. 
General Procedure F: Visible Light-Induced Copper(I)-Catalyzed C–H Arylation of 
Hererocycles 93 or 116. 
To a pre-dried 25 mL Schlenk tube were added heterocycle 93 or 116 (0.25 mmol), iodoarene 
19 (1.25 mmol), copper(I) iodide (9.5 mg, 20 mol %), Ir(ppy)3 (3.3 mg, 2.0 mol %), LiOtBu 
(60 mg, 0.75 mmol), and DMF (1.0 mL) under a N2 atmosphere. The mixture was stirred 
under 450-500 nm irradiation with a blue LED set for 16 h at ambient temperature (35 °C). 
Then, to the reaction was added H2O (10 mL) and extracted with Et2O (3 x 20 mL). The 
combined organic solvents were washed with brine (5 x 10 mL) and dried over Na2SO4. The 
solvent was removed under reduced pressure and the residue was purified by column 
chromatography on silica gel (n-pentane/Et2O) to yield the desired product 94 or 117. 
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9 Analytical Data 
9.1 Analytical Data for Ruthenium(II)-Catalyzed C–H/N–O Functionalizations 
Synthesis of 3,4-Diphenylisoquinolin-1(2H)-one (41aa) 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41aa 
(113 mg, 76%) as a colorless solid. 
M.p. = 253–255 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.48 (s, 1H), 8.33 (dd, J = 8.0, 1.5 Hz, 1H), 7.63 (ddd, J = 
8.4, 7.1, 1.6 Hz, 1H), 7.51 (ddd, J = 8.1, 7.2, 1.3 Hz, 1H), 7.36–7.11 (m, 11H). 
13C-NMR (75 MHz, DMSO-d6): δ = 161.6 (Cq), 138.5 (Cq), 138.0 (Cq), 135.8 (Cq), 134.5 (Cq), 
132.3 (CH), 131.6 (CH), 129.7 (CH), 128.1 (CH), 128.0 (CH), 127.5 (CH), 126.9 (CH), 126.7 (CH), 
126.1 (CH), 124.9 (Cq), 124.8 (CH), 115.3 (Cq). 
IR (neat): 3161, 3017, 2885, 1641, 1606, 1446, 1343, 693 cm-1. 
MS (EI) m/z (relative intensity): 297 ([M+] 100), 296 (55), 278 (21), 190 (5), 165 (15), 139 (7), 
77 (8). 
HR-MS (EI) m/z calcd for C21H15NO
+ [M+] 297.1154, found 297.1156. 
The analytical data are in accordance with those reported in the literature.[108]  
Synthesis of 6-Methyl-3,4-diphenylisoquinolin-1(2H)-one (41ba)  
9. Analytical Data 
- 94 - 
 
 
The general procedure A was followed using N-hydroxy-4-methylbenzamide (88b) (76 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41ba (103 mg, 66%) as a colorless solid. 
M.p. = 277–279 °C. 
1H-NMR (300 MHz, CDCl3): δ = 9.17 (s, 1H), 8.37 (d, J = 8.2 Hz, 1H), 7.35–7.12 (m, 12H), 2.38 
(s, 3H). 
13C-NMR (75 MHz, CDCl3): δ = 162.6 (Cq), 143.3 (Cq), 138.7 (Cq), 137.1 (Cq), 135.8 (Cq), 135.2 
(Cq), 131.8 (CH), 129.2 (CH), 128.5 (CH), 128.3 (CH), 128.3 (CH), 128.2 (CH), 127.5 (CH), 127.2 
(CH), 125.3 (CH), 122.9 (Cq), 117.0 (Cq), 22.1 (CH3). 
IR (neat): 3171, 3021, 2898, 1648, 1614, 1488, 1161, 698 cm-1. 
MS (EI) m/z (relative intensity): 311 ([M+] 100), 310 (54), 292 (12), 178 (11), 104 (7), 77 (16). 
HR-MS (EI) m/z calcd for C22H17NO
+ [M+] 311.1310, found 311.1297. 
The analytical data are in accordance with those reported in the literature.[111]  
Synthesis of 6-Methoxy-3,4-diphenylisoquinolin-1(2H)-one (41ca) 
 
The general procedure A was followed using N-hydroxy-4-methoxybenzamide (88c) (84 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1 → 1/1 → 
1/2) yielded 41ca (96 mg, 59%) as an off-white solid. 
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M.p. = 292–294 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.38 (s, 1H), 8.23 (d, J = 8.8 Hz, 1H), 7.37–7.05 (m, 11H), 
6.49 (d, J = 2.5 Hz, 1H), 3.65 (s, 3H). 
13C-NMR (75 MHz, DMSO-d6): δ = 162.2 (Cq), 161.2 (Cq), 140.0 (Cq), 139.1 (Cq), 135.8 (Cq), 
134.6 (Cq), 131.6 (CH), 129.7 (CH), 129.0 (CH), 128.1 (CH), 128.0 (CH), 127.5 (CH), 126.9 (CH), 
118.8 (Cq), 115.0 (Cq), 114.4 (CH), 107.1 (CH), 55.1 (CH3). 
IR (neat): 3020, 2979, 2884, 1639, 1608, 1275, 1027, 694 cm-1. 
MS (EI) m/z (relative intensity): 327 ([M+] 100), 326 (50), 283 (7), 254 (7), 152 (12), 104 (6), 
77 (8). 
HR-MS (EI) m/z calcd for C22H17NO2
+ [M+] 327.1259, found 327.1266. 
The analytical data are in accordance with those reported in the literature.[108]  
Synthesis of 6-Fluoro-3,4-diphenylisoquinolin-1(2H)-one (41da) 
 
The general procedure A was followed using 4-fluoro-N-hydroxybenzamide (88d) (78 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41da (128 mg, 81%) as a colorless solid. 
M.p. = 251–253 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.58 (s, 1H), 8.37 (dd, J = 8.9, 6.1 Hz, 1H), 7.38–7.13 (m, 
11H), 6.73 (dd, J = 10.9, 2.5 Hz, 1H). 
13C-NMR (125 MHz, DMSO-d6): δ = 164.3 (d, JC-F = 249.2 Hz, Cq), 160.7 (Cq), 140.5 (d, JC-F = 9.7 
Hz, Cq), 140.0 (Cq) , 135.1 (Cq), 134.0 (Cq), 131.3 (CH), 130.3 (CH), 130.2 (CH), 129.5 (CH), 
128.2 (CH), 127.5 (CH), 127.1 (CH), 121.7 (d, JC-F = 1.6 Hz, Cq), 114.7 (d, JC-F = 3.4 Hz, Cq), 114.5 
(d, JC-F = 23.6 Hz, CH), 109.4 (d, JC-F = 23.2 Hz, CH). 
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19F-NMR (283 MHz, DMSO-d6) δ = -106.4 (ddd, J = 10.9, 8.4, 6.3 Hz). 
IR (neat): 3116, 3030, 2917, 1644, 1610, 1450, 1178, 695 cm-1. 
MS (EI) m/z (relative intensity): 315 ([M+] 60), 314 (36), 296 (12), 183 (9), 98 (22), 57 (32), 43 
(100). 
HR-MS (EI) m/z calcd for C21H14FNO
+ [M+] 315.1059, found 315.1064. 
The analytical data are in accordance with those reported in the literature.[110]  
Synthesis of 6-Chloro-3,4-diphenylisoquinolin-1(2H)-one (41ea) 
 
The general procedure A was followed using 4-chloro-N-hydroxybenzamide (88e) (86 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41ea (103 mg, 62%) as a colorless solid.  
M.p. = 270–272 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.65 (s, 1H), 8.31 (d, J = 8.5 Hz, 1H), 7.54 (dd, J = 8.6, 
2.0 Hz, 1H), 7.36–7.13 (m, 10H), 7.05 (d, J = 2.0 Hz, 1H). 
13C-NMR (125 MHz, DMSO-d6): δ = 160.8 (Cq), 140.1 (Cq), 139.5 (Cq), 137.4 (Cq), 134.9 (Cq), 
134.0 (Cq), 131.4 (CH), 129.5 (CH), 129.1 (CH), 128.2 (CH), 128.2 (CH), 127.5 (CH), 127.1 (CH), 
126.1 (CH), 123.6 (CH), 123.4 (Cq), 114.3 (Cq). 
IR (neat):3155, 3022, 2882, 1644, 1594, 1442, 1080, 696 cm-1. 
MS (EI) m/z (relative intensity): 331 ([M+] 100), 330 (50), 295 (15), 267 (12), 163 (15), 77 (15). 
HR-MS (EI) m/z calcd for C21H14ClNO
+ [M+] 331.0764, found 331.0762. 
The analytical data are in accordance with those reported in the literature.[110]   
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Synthesis of 6-Bromo-3,4-diphenylisoquinolin-1(2H)-one (41fa)  
 
The general procedure A was followed using 4-bromo-N-hydroxybenzamide (88f) (108 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41fa (138 mg, 73%) as a colorless solid. 
M.p. = 285–286 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.69 (s, 1H), 8.21 (d, J = 8.6 Hz, 1H), 7.66 (dd, J = 8.6, 
1.9 Hz, 1H), 7.39–7.09 (m, 11H). 
13C-NMR (75 MHz, DMSO-d6): δ = 161.1 (Cq), 140.2 (Cq), 139.8 (Cq), 135.1 (Cq), 134.1 (Cq), 
131.5 (CH), 129.6 (CH), 129.2 (CH), 129.0 (CH), 128.3 (CH), 127.6 (CH), 127.3 (CH), 126.8 (CH), 
126.7 (Cq), 123.8 (Cq), 114.3 (Cq). 
IR (neat): 3164, 3020, 2902, 1645, 1588, 1438, 1066, 696 cm-1. 
MS (EI) m/z (relative intensity): 376 ([M+] 95), 375 (100), 295 (28), 267 (16), 239 (13), 163 
(25), 77 (20). 
HR-MS (EI) m/z calcd for C21H14
79BrNO+ [M+] 375.0259, found 375.0272. 
The analytical data are in accordance with those reported in the literature.[108]  
Synthesis of 6-Iodo-3,4-diphenylisoquinolin-1(2H)-one (41ga) 
 
The general procedure A was followed using N-hydroxy-4-iodobenzamide (88g) (132 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
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18 h, purification by column chromatography on silica gel (n-pentane/CH2Cl2/EtOAc: 2/1/1) 
yielded 41ga (81 mg, 38%) as a colorless solid.  
M.p. = 311–312 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.67 (s, 1H), 8.03 (d, J = 8.4 Hz, 1H), 7.83 (dd, J = 8.4, 
1.6 Hz, 1H), 7.43 (d, J = 1.6 Hz, 1H), 7.36–7.09 (m, 10H). 
13C-NMR (125 MHz, DMSO-d6): δ =
 161.3 (Cq), 139.9 (Cq), 139.7 (Cq), 135.1 (Cq), 134.7 (CH), 
134.2 (Cq), 133.1 (CH), 131.6 (CH), 129.7 (CH), 128.7 (CH), 128.3 (CH), 128.3 (CH), 127.6 (CH), 
127.2 (CH), 124.1 (Cq), 114.1 (Cq), 101.1 (Cq). 
IR (neat): 3160, 3020, 2934, 1648, 1597, 1437, 1154, 697 cm-1. 
MS (EI) m/z (relative intensity): 423 ([M+] 100), 422 (28), 295 (14), 267 (11), 239 (9), 163 (15), 
77 (10). 
HR-MS (EI) m/z calcd for C21H14INO
+ [M+] 423.0120, found 423.0123. 
The analytical data are in accordance with those reported in the literature.[111]   
Synthesis of 6-Nitro-3,4-diphenylisoquinolin-1(2H)-one (41ha) 
 
The general procedure A was followed using N-hydroxy-4-nitrobenzamide (88h) (91 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41ha (114 mg, 67%) as a yellow solid. 
M.p. = 260–262 °C. 
1H-NMR (300 MHz, CDCl3): δ = 10.12 (s, 1H), 8.65–8.50 (m, 1H), 8.31–8.15 (m, 2H), 7.42–7.23 
(m, 8H), 7.22–7.14 (m, 2H). 
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13C-NMR (75 MHz, CDCl3): δ = 161.7 (Cq), 150.6 (Cq), 139.7 (Cq), 139.5 (Cq), 134.3 (Cq), 134.1 
(Cq), 131.6 (CH), 129.6 (CH), 129.2 (CH), 129.2 (CH), 128.9 (CH), 128.6 (Cq), 128.5 (CH), 128.1 
(CH), 121.2 (CH), 120.1 (CH), 117.1 (Cq). 
IR (neat): 3332, 3022, 1664, 1611, 1525, 1340, 701 cm-1. 
MS (EI) m/z (relative intensity): 342 ([M+] 100), 341 (18), 295 (16), 268 (14), 190 (12), 165 
(12), 121 (15). 
HR-MS (EI) m/z calcd for C21H14N2O3
+ [M+] 342.1004, found 342.1001. 
The analytical data are in accordance with those reported in the literature.[108]  
Synthesis of 7-Methyl-3,4-diphenylisoquinolin-1(2H)-one (41ia) 
 
The general procedure A was followed using N-hydroxy-3-methylbenzamide (88i) (76 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 120 °C for 
18 h, purification by column chromatography on silica gel (CH2Cl2/Et2O: 5/1) yielded 41ia 
(94 mg, 60%) as a colorless solid. 
M.p. = 292–293 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.38 (s, 1H), 8.12 (dd, J = 1.9, 0.9 Hz, 1H), 7.47 (dd, J = 
8.3, 2.0 Hz, 1H), 7.33–7.19 (m, 8H), 7.17–7.10 (m, 2H), 7.06 (d, J = 8.3 Hz, 1H), 2.45 (s, 3H). 
13C-NMR (75 MHz, DMSO-d6): δ = 161.0 (Cq), 138.0 (Cq), 136.5 (Cq), 136.3 (Cq), 136.3 (Cq), 
135.1 (Cq), 134.2 (CH), 132.1 (CH), 130.3 (CH), 128.6 (CH), 128.5 (CH), 128.1 (CH), 127.4 (CH), 
126.8 (CH), 125.5 (Cq), 125.4 (CH), 115.8 (Cq), 21.3 (CH3). 
IR (neat): 3138, 3026, 2911, 1642, 1616, 1444, 1342, 696 cm-1. MS (EI) m/z (relative 
intensity): 311 ([M+] 100), 310 (48), 292 (9), 178 (7), 104 (5), 77 (12). 
HR-MS (EI) m/z calcd for C22H17NO
+ [M+] 311.1310, found 311.1313. 
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The analytical data are in accordance with those reported in the literature.[109]  
Synthesis of 7-(Trifluoromethyl)-3,4-diphenylisoquinolin-1(2H)-one (41ja) 
 
The general procedure A was followed using N-hydroxy-3-(trifluoromethyl)benzamide (88j) 
(103 mg, 0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 
100 °C for 18 h, purification by column chromatography on silica gel (CH2Cl2/Et2O: 10/1) 
yielded 41ja (76 mg, 42%) as a colorless solid. 
M.p. = 234–235 °C. 
1H-NMR (300 MHz, CDCl3): δ = 9.90 (s, 1H), 8.77–8.67 (m, 1H), 7.76 (dd, J = 8.6, 2.0 Hz, 1H), 
7.47 (d, J = 8.6 Hz, 1H), 7.38–7.23 (m, 8H), 7.21–7.14 (m, 2H). 
13C-NMR (125 MHz, CDCl3): δ = 162.1 (Cq), 141.0 (Cq), 139.5 (Cq), 134.9 (Cq), 134.3 (Cq), 131.6 
(CH), 129.1 (CH), 129.0 (CH), 128.6 (CH), 128.5 (CH), 128.4 (CH), 128.3 (d, JC-F = 33.3 Hz, Cq), 
127.6 (CH), 126.5 (CH), 125.1 (dd, JC-F = 8.2, 4.0 Hz, CH), 124.8 (Cq), 123.8 (d, JC-F = 271.7 Hz, 
Cq), 116.7 (Cq). 
19F-NMR (283 MHz, CDCl3) δ = -62.4 (s).  
IR (neat): 3153, 3034, 2929, 1653, 1618, 1320, 1121, 697 cm-1.  
MS (EI) m/z (relative intensity): 365 ([M+] 100), 364 (55), 346 (19), 267 (8), 239 (5), 163 (5), 
77 (13).   
HR-MS (EI) m/z calcd for C22H14F3NO
+ [M+] 365.1027, found 365.1024.  
The analytical data are in accordance with those reported in the literature.[108]  
Synthesis of 5-Fluoro-3,4-diphenylisoquinolin-1(2H)-one (41ka) 
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The general procedure A was followed using 3-fluoro-N-hydroxybenzamide (88k) (78 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (CH2Cl2/Et2O: 5/1) yielded 41ka 
(91 mg, 58%) as a colorless solid.  
M.p. = 250–252 °C.  
1H-NMR (300 MHz, CDCl3): δ = 9.50 (s, 1H), 8.29 (dd, J = 7.9, 1.3 Hz, 1H), 7.44 (td, J = 8.0, 
4.5 Hz, 1H), 7.34–7.12 (m, 11H).  
13C-NMR (125 MHz, CDCl3): δ = 161.6 (d, JC-F = 3.1 Hz, Cq), 158.6 (d, JC-F = 255.5 Hz, Cq), 138.5 
(Cq), 137.4 (d, JC-F = 3.9 Hz, Cq), 134.8 (Cq), 131.0 (d, JC-F = 3.7 Hz, CH), 129.3 (CH), 128.7 (CH), 
128.2 (CH), 127.5 (CH), 127.4 (d, JC-F = 2.5 Hz, Cq), 127.3 (d, JC-F = 8.4 Hz, CH), 127.3 (d, JC-F = 
8.8 Hz, Cq), 126.9 (CH), 123.7 (d, JC-F = 4.0 Hz, CH), 119.8 (d, JC-F = 22.6 Hz, CH), 113.3 (d, JC-F = 
2.1 Hz, Cq).  
19F-NMR (283 MHz, CDCl3) δ = -107.3 (dd, J = 12.4, 4.5 Hz).  
IR (neat): 3165, 3016, 2888, 1652, 1613, 1444, 1253, 697 cm-1.  
MS (EI) m/z (relative intensity): 315 ([M+] 100), 314 (20), 296 (7), 183 (12), 104 (4), 77 (8).  
HR-MS (EI) m/z calcd for C21H14FNO
+ [M+] 315.1059, found 315.1071.  
The analytical data are in accordance with those reported in the literature.[110]   
Synthesis of 3,4-Diphenylbenzo[g]isoquinolin-1(2H)-one (41la) 
 
9. Analytical Data 
- 102 - 
 
The general procedure A was followed using N-hydroxy-2-naphthamide (88l) (94 mg, 
0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41la (126 mg, 73%) as a pale green solid. 
M.p. = 287–289 °C.  
1H-NMR (300 MHz, DMSO-d6): δ = 11.29 (s, 1H), 9.02 (s, 1H), 8.28–8.13 (m, 1H), 7.88–7.80 
(m, 1H), 7.63 (s, 1H), 7.61–7.50 (m, 2H), 7.41–7.16 (m, 10H).  
13C-NMR (75 MHz, DMSO-d6): δ =
 162.1 (Cq), 137.3 (Cq), 136.0 (Cq), 134.8 (Cq), 134.7 (Cq), 
134.6 (Cq), 131.7 (CH), 130.7 (Cq), 129.7 (CH), 129.0 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 
128.0 (CH), 127.7 (CH), 127.6 (CH), 127.0 (CH), 126.0 (CH), 123.8 (Cq), 123.3 (CH), 115.2 (Cq).  
IR (neat): 3051, 3024, 2884, 1649, 1616, 1596, 1357, 697 cm-1.  
MS (EI) m/z (relative intensity): 347 ([M+] 100), 346 (22), 328 (12), 251 (12), 158 (6), 77 (5).  
HR-MS (EI) m/z calcd for C25H17NO
+ [M+] 347.1310, found 347.1301.  
The analytical data are in accordance with those reported in the literature.[111]   
Synthesis of 3,4-Bis(4-methoxyphenyl)isoquinolin-1(2H)-one (41ab)  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 1,2-bis(4-methoxyphenyl)ethyne (38b) (179 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1 → 1/1 → 
1/3) yielded 41ab (103 mg, 58%) as an off-white solid. 
M.p. = 265–267 °C.  
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1H-NMR (300 MHz, DMSO-d6): δ = 11.42 (s, 1H), 8.27 (dd, J = 8.0, 1.5 Hz, 1H), 7.65–7.56 (m, 
1H), 7.46–7.51 (m, 1H), 7.15–7.12 (m, 3H), 7.04 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 
6.77 (d, J = 8.6 Hz, 2H), 3.72 (s, 3H), 3.69 (s, 3H).  
13C-NMR (75 MHz, DMSO-d6): δ =
 161.7 (Cq), 158.8 (Cq), 157.9 (Cq), 138.5 (Cq), 138.3 (Cq), 
132.7 (CH), 132.2 (CH), 131.0 (CH), 127.9 (Cq), 126.9 (Cq), 126.6 (CH), 125.8 (CH), 124.8 (CH), 
124.8 (Cq), 114.7 (Cq), 113.7 (CH), 113.0 (CH), 55.0 (CH3), 54.9 (CH3).  
IR (neat): 3156, 3003, 2834, 1645, 1603, 1509, 1243, 1031 cm-1.  
MS (EI) m/z (relative intensity): 357 ([M+] 100), 356 (14), 342 (11), 282 (7), 152 (7), 77 (3).  
HR-MS (EI) m/z calcd for C23H19NO3
+ [M+] 357.1365, found 357.1366.  
The analytical data are in accordance with those reported in the literature.[111]  
Synthesis of 3,4-Bis(4-fluorophenyl)isoquinolin-1(2H)-one (41ac) 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 1,2-bis(4-fluorophenyl)ethyne (38c) (161 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 
41ac (105 mg, 63%) as a colorless solid. 
M.p. = 296–298 °C.  
1H-NMR (300 MHz, DMSO-d6): δ = 11.58 (s, 1H), 8.30 (dd, J = 8.0, 1.5 Hz, 1H), 7.64 (ddd, J = 
8.4, 7.2, 1.6 Hz, 1H), 7.51 (ddd, J = 8.1, 7.0, 1.2 Hz, 1H), 7.31–7.03 (m, 9H).  
13C-NMR (125 MHz, DMSO-d6): δ = 161.5 (d, JC-F = 245.4 Hz, Cq), 161.4 (Cq), 160.9 (d, JC-F = 
243.8 Hz, Cq), 137.8 (Cq) , 137.7 (Cq), 133.4 (d, JC-F = 8.1 Hz, CH), 132.4 (CH), 131.9 (d, JC-F = 
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8.5 Hz, CH), 131.8 (d, JC-F = 3.3 Hz, Cq), 130.7 (d, JC-F = 3.3 Hz, Cq), 126.6 (CH), 126.1 (CH), 
124.9 (Cq), 124.6 (CH), 114.8 (d, JC-F = 21.3 Hz, CH), 114.5 (d, JC-F = 21.7 Hz, CH), 114.4 (Cq).  
19F-NMR (283 MHz, DMSO-d6) δ = -113.1 (tt, J = 9.0, 5.5 Hz), -115.1 (tt, J = 8.9, 5.7 Hz).  
IR (neat): 3160, 3066, 2916, 1648, 1613, 1506, 1223, 773 cm-1.  
MS (EI) m/z (relative intensity): 333 ([M+] 100), 332 (52), 314 (22), 183 (16), 122 (7), 95 (7).  
HR-MS (EI) m/z calcd for C21H13F2NO
+ [M+] 333.0965, found 333.0961.  
The analytical data are in accordance with those reported in the literature.[110]   
Synthesis of 3,4-Diethylisoquinolin-1(2H)-one (41af) 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and hex-3-yne (38f) (62 mg, 0.75 mmol). After stirring at 80 °C for 18 h, purification by 
column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41af (87 mg, 86%) as a 
colorless solid . 
M.p. = 178–180 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.31 (s, 1H), 8.48 (dt, J = 7.8, 1.1 Hz, 1H), 7.77–7.62 (m, 2H), 
7.44 (ddd, J = 8.1, 5.8, 2.3 Hz, 1H), 2.68–2.81 (m, 4H), 1.34 (t, J = 7.6 Hz, 3H), 1.22 (t, J = 
7.5 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ =
 164.0 (Cq), 139.3 (Cq), 138.3 (Cq), 132.4 (CH), 127.8 (CH), 
125.3 (CH), 125.2 (Cq), 122.9 (CH), 114.0 (Cq), 24.5 (CH2), 19.7 (CH2), 15.2 (CH3), 14.3 (CH3).  
IR (neat): 3163, 2966, 2872, 1648, 1631, 1474, 1163, 769 cm-1.  
MS (EI) m/z (relative intensity): 201 ([M+] 43), 187 (15), 186 (100), 168 (10), 128 (10), 115 
(20), 77 (6).  
HR-MS (EI) m/z calcd for C13H15NO
+ [M+] 201.1154, found 201.1152.  
9. Analytical Data 
- 105 - 
 
The analytical data are in accordance with those reported in the literature.[111]   
Synthesis of 3,4-Di-(n-propyl)isoquinolin-1(2H)-one (41ag)  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and oct-4-yne (38g) (83 mg, 0.75 mmol). After stirring at 100 °C for 18 h, purification by 
column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41ag (86 mg, 75%) as a 
colorless solid. 
M.p. = 188–190 °C.  
1H-NMR (300 MHz, CDCl3): δ = 10.99 (s, 1H), 8.44 (dt, J = 8.0, 1.1 Hz, 1H), 7.68–7.63 (m, 2H), 
7.42 (dt, J = 8.1, 4.1 Hz, 1H), 2.73–2.61 (m, 4H), 1.81–1.66 (m, 2H), 1.66–1.51 (m, 2H), 1.04 (t, 
J = 7.3 Hz, 3H), 1.03 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 163.8 (Cq), 138.6 (Cq), 138.2 (Cq), 132.4 (CH), 127.8 (CH), 125.4 
(CH), 125.3 (Cq), 123.2 (CH), 113.1 (Cq), 33.1 (CH2), 28.8 (CH2), 23.7 (CH2), 22.9 (CH2), 14.5 
(CH3), 14.1 (CH3).  
IR (neat): 3164, 3025, 2869, 1653, 1628, 1470, 1167, 774 cm-1.  
MS (EI) m/z (relative intensity): 229 ([M+] 30), 201 (20), 200 (100), 172 (12), 115 (10), 77 (6).  
HR-MS (EI) m/z calcd for C15H19NO
+ [M+] 229.1467, found 229.1462.  
The analytical data are in accordance with those reported in the literature.[109]   
Synthesis of 3,4-Di-(n-butyl)isoquinolin-1(2H)-one (41ah)  
 
9. Analytical Data 
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The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and dec-5-yne (38h) (104 mg, 0.75 mmol). After stirring at 100 °C for 18 h, purification by 
column chromatography on silica gel (CH2Cl2/Et2O: 4/1) yielded 41ah (101 mg, 78%) as a 
colorless solid. 
M.p. = 85–87 °C.  
1H-NMR (300 MHz, CDCl3): δ =
 11.24 (s, 1H), 8.43 (d, J = 8.0 Hz, 1H), 7.66 (m, 2H), 7.41 (dt, J = 
8.1, 4.0 Hz, 1H), 2.76–2.61 (m, 4H), 1.68 (tt, J = 7.9, 6.3 Hz, 2H), 1.60–1.38 (m, 6H), 0.96 (t, J = 
7.2 Hz, 6H).  
13C-NMR (75 MHz, CDCl3): δ =
 163.7 (Cq), 138.5 (Cq), 138.3 (Cq), 132.2 (CH), 127.6 (CH), 125.2 
(CH), 125.1 (Cq), 122.9 (CH), 112.9 (Cq), 32.6 (CH2), 31.6 (CH2), 30.8 (CH2), 26.2 (CH2), 
23.0(CH2), 22.7 (CH2), 14.0 (CH3), 13.8 (CH3).  
IR (neat): 3164, 2961, 2926, 2861, 1649, 1627, 1471, 769 cm-1.  
MS (EI) m/z (relative intensity): 257 ([M+] 58), 215 (23), 214 (100), 173 (22), 172 (83), 144 
(10), 115 (12), 77 (5).  
HR-MS (EI) m/z calcd for C17H23NO
+ [M+] 257.1780, found 257.1788. 
Synthesis of 6-Methoxy-3,4-di-(n-propyl)isoquinolin-1(2H)-one (41cg)  
 
The general procedure A was followed using N-hydroxy-4-methoxybenzamide (88c) (84 mg, 
0.50 mmol) and oct-4-yne (38g) (83 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 1/1) yielded 41cg 
(91 mg, 70%) as an off-white solid. 
M.p. = 158–160 °C.  
1H-NMR (300 MHz, CDCl3): δ = 10.97 (s, 1H), 8.38 (d, J = 9.6 Hz, 1H), 7.07–6.96 (m, 2H), 3.93 
(s, 3H), 2.68–2.57 (m, 4H), 1.80–1.54 (m, 4H), 1.05 (t, J = 7.3 Hz, 3H), 1.04 (t, J = 7.3 Hz, 3H).  
9. Analytical Data 
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13C-NMR (75 MHz, CDCl3): δ = 163.3 (Cq), 163.0 (Cq), 140.7 (Cq), 139.0 (Cq), 129.9 (CH), 119.2 
(Cq), 114.0 (CH), 112.6 (Cq), 105.4 (CH), 55.5 (CH3), 33.2 (CH2), 28.9 (CH2), 23.4 (CH2), 22.9 
(CH2), 14.5 (CH3), 14.1 (CH3).  
IR (neat): 3156, 2966, 2864, 1632, 1601, 1467, 1232, 833 cm-1.  
MS (EI) m/z (relative intensity): 259 ([M+] 40), 231 (32), 230 (100), 202 (14), 189 (8), 115 (6), 
77 (3).  
HR-MS (EI) m/z calcd for C16H21NO2
+ [M+] 259.1572, found 259.1574. 
Synthesis of 6-Fluoro-3,4-di-(n-propyl)isoquinolin-1(2H)-one (41dg) 
 
The general procedure A was followed using 4-fluoro-N-hydroxybenzamide (88d) (78 mg, 
0.50 mmol) and oct-4-yne (38g) (83 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41dg 
(94 mg, 76%) as a colorless solid. 
M.p. = 170–172 °C.  
1H-NMR (300 MHz CDCl3): δ = 11.24 (s, 1H), 8.45 (ddd, J = 8.9, 6.2, 2.9 Hz, 1H), 7.27 (dd, J = 
10.9, 2.7 Hz, 1H), 7.13 (td, J = 8.5, 2.5 Hz, 1H), 2.72–2.58 (m, 4H), 1.82–1.68 (m, 2H), 
1.66–1.51 (m, 2H), 1.06 (t, J = 7.3 Hz, 3H), 1.04 (t, J = 7.3 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 165.6 (d, JC-F = 251.3 Hz, Cq), 163.1 (Cq), 141.1 (d, JC-F = 9.7 Hz, 
Cq), 139.8 (Cq), 130.8 (d, JC-F = 10.2 Hz, CH), 121.8 (d, JC-F = 1.5 Hz, Cq), 114.0 (d, JC-F = 23.6 Hz, 
CH), 112.7 (d, JC-F = 3.5 Hz, Cq), 108.4 (d, JC-F = 22.6 Hz, CH), 33.2 (CH2), 28.9 (CH2), 23.6 (CH2), 
23.0 (CH2), 14.5 (CH3), 14.2 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -106.2 (ddd, J = 11.1, 8.1, 6.2 Hz).  
IR (neat): 3027, 2954, 2871, 1666, 1614, 1461, 1188, 863 cm-1.  
9. Analytical Data 
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MS (EI) m/z (relative intensity): 247 ([M+] 21), 219 (15), 218 (100), 202 (7), 190 (12), 133 (7), 
43 (13).  
HR-MS (EI) m/z calcd for C15H18FNO
+ [M+] 247.1372, found 247.1364.  
The analytical data are in accordance with those reported in the literature.[110]  
Synthesis of 6-Iodo-3,4-di-(n-propyl)isoquinolin-1(2H)-one (41gg) 
 
The general procedure A was followed using N-hydroxy-4-iodobenzamide (88g) (132 mg, 
0.50 mmol) and oct-4-yne (38g) (83 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41gg 
(122 mg, 69%) as an off-white solid.  
M.p. = 184–186 °C.  
1H-NMR (300 MHz, DMSO-d6): δ = 11.19 (s, 1H), 7.98 (s, 1H), 7.89 (d, J = 8.3 Hz, 1H), 7.71 (d, 
J = 8.3 Hz, 1H), 2.61–2.42 (m, 4H), 1.64–1.34 (m, 4H), 1.00–0.83 (m, 6H).  
13C-NMR (125 MHz, DMSO-d6): δ =
 161.3 (Cq), 140.3 (Cq), 139.4 (Cq), 133.7 (CH), 131.4 (CH), 
128.8 (CH), 124.1 (Cq), 109.7 (Cq), 101.0 (Cq), 31.7 (CH2), 27.4 (CH2), 23.0 (CH2), 22.4 (CH2), 
13.9 (CH3), 13.5 (CH3).  
IR (neat): 3169, 2953, 2867, 1666, 1625, 1589, 1455, 775 cm-1.  
MS (EI) m/z (relative intensity): 355 ([M+] 40), 327 (15), 326 (100), 298 (7), 199 (20), 184 (6), 
102 (5).  
HR-MS (EI) m/z calcd for C15H18INO
+ [M+] 355.0433, found 355.0433. 
Synthesis of 7-Methyl-3,4-di-(n-propyl)isoquinolin-1(2H)-one (41ig) 
9. Analytical Data 
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The general procedure A was followed using N-hydroxy-3-methylbenzamide (88i) (76 mg, 
0.50 mmol) and oct-4-yne (38g) (83 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41ig 
(85 mg, 70%) as a colorless solid. 
M.p. = 176–178 °C.  
1H-NMR (300 MHz, CDCl3): δ = 10.44 (s, 1H), 8.24 (s, 1H), 7.58 (dd, J = 8.4, 1.7 Hz, 1H), 7.49 
(dt, J = 8.4, 1.9 Hz, 1H), 2.72–2.60 (m, 4H), 2.48 (s, 3H), 1.82–1.51 (m, 4H), 1.08–1.00 (m, 6H).  
13C-NMR (125 MHz, CDCl3): δ =
 163.2 (Cq), 136.6 (Cq), 136.0 (Cq), 135.1 (Cq), 133.7 (CH), 127.1 
(CH), 125.0 (Cq), 123.0 (CH), 112.9 (Cq), 32.9 (CH2), 28.7 (CH2), 23.7 (CH2), 22.7 (CH2), 21.2 
(CH3), 14.4 (CH3), 14.0 (CH3).  
IR (neat): 2956, 2930, 2870, 1659, 1629, 1352, 900, 815 cm-1.  
MS (EI) m/z (relative intensity): 243 ([M+] 32), 215 (15), 214 (100), 186 (13), 115 (12), 77 (3).  
HR-MS (EI) m/z calcd for C16H21NO
+ [M+] 243.1623, found 243.1629. 
Synthesis of 4-(n-Butyl)-3-phenylisoquinolin-1(2H)-one (41ai) 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and hex-1-yn-1-ylbenzene (38i) (119 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41ai 
(110 mg, 79%) as a colorless solid. 
M.p. = 154–155 °C.  
9. Analytical Data 
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1H-NMR (300 MHz, CDCl3): δ = 8.86 (s, 1H), 8.43 (dt, J = 8.0, 1.1 Hz, 1H), 7.77–7.66 (m, 2H), 
7.53–7.37 (m, 6H), 2.68–2.56 (m, 2H), 1.61–1.47 (m, 2H), 1.27 (tt, J = 7.3, 7.3 Hz, 2H), 0.81 (t, 
J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 162.3 (Cq), 138.1 (Cq), 136.9 (Cq), 135.7 (Cq), 132.8 (CH), 129.3 
(CH), 129.1 (CH), 128.9 (CH), 128.1 (CH), 126.4 (CH), 126.0 (Cq), 123.9 (CH), 114.5 (Cq), 32.9 
(CH2), 27.1 (CH2), 22.9 (CH2), 13.9 (CH3).  
IR (neat): 3160, 2950, 2869, 1646, 1615, 1469, 1157, 761 cm-1.  
MS (EI) m/z (relative intensity): 277 ([M+] 35), 235 (15), 234 (100), 216 (19), 178 (6), 77 (11), 
43 (24).  
HR-MS (EI) m/z calcd for C19H19NO
+ [M+] 277.1467, found 277.1461. 
Synthesis of 4-(n-Butyl)-3-(4-methoxyphenyl)isoquinolin-1(2H)-one (41aj)  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 1-(hex-1-yn-1-yl)-4-methoxybenzene (38j) (141 mg, 0.75 mmol). After stirring at 100 °C 
for 18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1 → 1/1) 
yielded 41aj (100 mg, 65%) as an off-white solid. 
M.p. = 167–169 °C.  
1H-NMR (300 MHz, DMSO-d6): δ = 11.09 (s, 1H), 8.28 (dd, J = 7.9, 1.0 Hz, 1H), 7.83–7.71 (m, 
2H), 7.50 (dt, J = 8.1, 4.1 Hz, 1H), 7.39–7.32 (m, 2H), 7.08–7.01 (m, 2H), 3.83 (s, 3H), 
2.56–2.49 (m, 2H), 1.53–1.39 (m, 2H), 1.23 (tt, J = 7.3, 7.3 Hz, 2H), 0.77 (t, J = 7.3 Hz, 3H).  
13C-NMR (125 MHz, DMSO-d6): δ = 161.0 (Cq), 159.1 (Cq), 137.8 (Cq), 137.2 (Cq), 132.2 (CH), 
130.4 (CH), 127.1 (Cq), 126.9 (CH), 125.5 (CH), 125.5 (Cq), 123.4 (CH), 113.4 (CH), 112.0 (Cq), 
55.1 (CH3), 32.2 (CH2), 26.2 (CH2), 22.0 (CH2), 13.5 (CH3).  
IR (neat): 2955, 2932, 2869, 1634, 1604, 1245, 1023, 532 cm-1.  
9. Analytical Data 
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MS (EI) m/z (relative intensity): 307 ([M+] 50), 265 (20), 264 (100), 249 (12), 233 (18), 165 (6), 
102 (6), 43 (15).  
HR-MS (EI) m/z calcd for C20H21NO2
+ [M+] 307.1572, found 307.1580.  
The analytical data are in accordance with those reported in the literature.[110]  
Synthesis of 4-(n-Butyl)-3-(4-fluorophenyl)isoquinolin-1(2H)-one (41ak)  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 1-fluoro-4-(hex-1-yn-1-yl)benzene (38k) (132 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 3/1) yielded 
41ak (102 mg, 69%) as a colorless solid. 
M.p. = 182–184 °C.  
1H-NMR (300 MHz, CDCl3): δ = 9.44 (s, 1H), 8.39 (dt, J = 7.8, 1.0 Hz, 1H), 7.77–7.66 (m, 2H), 
7.54–7.37 (m, 3H), 7.22–7.13 (m, 2H), 2.65–2.54 (m, 2H), 1.52 (tt, J = 8.0, 6.3 Hz, 2H), 1.28 
(tt, J = 7.3, 7.3 Hz, 2H), 0.82 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 163.2 (d, JC-F = 249.2 Hz, Cq), 162.5 (Cq), 138.0 (Cq), 136.1 (Cq), 
132.8 (CH), 131.6 (d, JC-F = 3.5 Hz, Cq), 131.2 (d, JC-F = 8.4 Hz, CH), 128.1 (CH), 126.5 (CH), 
126.0 (Cq), 123.9 (CH), 116.0 (d, JC-F = 21.6 Hz, CH), 114.8 (Cq), 32.9 (CH2), 27.1 (CH2), 22.9 
(CH2), 13.9 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -111.6 (tt, J = 8.6, 5.3 Hz).  
IR (neat): 3163, 2929, 2860, 1644, 1602, 1221, 840 cm-1.  
MS (EI) m/z (relative intensity): 295 ([M+] 18), 253 (20), 252 (100), 234 (29), 196 (6), 77 (5).  
HR-MS (EI) m/z calcd for C19H18FNO
+ [M+] 295.1372, found 295.1368. 
Synthesis of 4-(Methoxymethyl)-3-phenylisoquinolin-1(2H)-one (41al)  
9. Analytical Data 
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The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and (3-methoxyprop-1-yn-1-yl)benzene (38l) (110 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 1/1 → 1/2) 
yielded 41al (97 mg, 73%) as an off-white solid. 
M.p. = 236–238 °C.  
1H-NMR (300 MHz, CDCl3): δ = 9.33 (s, 1H), 8.40 (dd, J = 8.1, 1.4 Hz, 1H), 7.91–7.82 (m, 1H), 
7.75 (ddd, J = 8.3, 7.0, 1.4 Hz, 1H), 7.61–7.45 (m, 6H), 4.42 (s, 2H), 3.40 (d, J = 1.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 162.9 (Cq), 140.6 (Cq), 138.2 (Cq), 134.5 (Cq), 133.2 (CH), 129.9 
(CH), 129.1 (CH), 129.0 (CH), 127.8 (CH), 126.8 (CH), 125.6 (Cq), 124.2 (CH), 110.4 (Cq), 68.4 
(CH2), 58.1 (CH3).  
IR (neat): 3171, 2971, 2886, 2807, 1653, 1608, 1090, 697 cm-1.  
MS (EI) m/z (relative intensity): 265 ([M+] 40), 235 (18), 234 (100), 216 (30), 178 (8), 102 (15), 
77 (22).  
HR-MS (EI) m/z calcd for C17H15NO2
+ [M+] 265.1103, found 265.1102. 
Synthesis of 4-(4-Hydroxy-n-butyl)-3-phenylisoquinolin-1(2H)-one (41am) 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 6-phenylhex-5-yn-1-ol (38m) (131 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 1/3) yielded 41am 
(103 mg, 70%) as a colorless solid. 
9. Analytical Data 
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M.p. = 113–115 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.95 (s, 1H), 8.41 (d, J = 7.7 Hz, 1H), 7.77–7.65 (m, 2H), 
7.52–7.34 (m, 6H), 3.51 (t, J = 6.4 Hz, 2H), 2.70–2.57 (m, 2H), 1.77 (s, 1H), 1.70–1.41 (m, 4H).  
13C-NMR (125 MHz, CDCl3): δ = 162.2 (Cq), 137.9 (Cq), 137.0 (Cq), 135.5 (Cq), 132.8 (CH), 129.3 
(CH), 129.0 (CH), 128.9 (CH), 128.1 (CH), 126.4 (CH), 125.9 (Cq), 123.8 (CH), 114.1 (Cq), 62.5 
(CH2), 32.6 (CH2), 27.1 (CH2), 26.9 (CH2).  
IR (neat): 3167, 2931, 2860, 1647, 1606, 1359, 1053, 764 cm-1.  
MS (EI) m/z (relative intensity): 293 ([M+] 35), 235 (17), 234 (100), 216 (25), 204 (10), 178 (8), 
77 (10).  
HR-MS (EI) m/z calcd for C19H19NO2
+ [M+] 293.1416, found 293.1423. 
Synthesis of 4-(n-Butyl)-3-(thiophen-2-yl)isoquinolin-1(2H)-one (41an) 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 2-(hex-1-yn-1-yl)thiophene (38n) (123 mg, 0.75 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded 41an 
(63 mg, 44%) as an off-white solid.  
M.p. = 164–166 °C.  
1H-NMR (300 MHz, DMSO-d6): δ = 11.18 (s, 1H), 8.28 (dd, J = 7.8, 1.1 Hz, 1H), 7.83–7.77 (m, 
2H), 7.75 (dd, J = 5.1, 1.2 Hz, 1H), 7.54 (ddd, J = 8.1, 5.1, 3.1 Hz, 1H), 7.31 (dd, J = 3.6, 1.2 Hz, 
1H), 7.19 (dd, J = 5.1, 3.6 Hz, 1H), 2.72–2.60 (m, 2H), 1.52 (tt, J = 7.9, 6.2 Hz, 2H), 1.32 (tt, J = 
7.3, 7.3 Hz, 2H), 0.84 (t, J = 7.3 Hz, 3H).  
13C-NMR (125 MHz, DMSO-d6): δ =
 160.9 (Cq), 136.7 (Cq), 134.6 (Cq), 132.4 (CH), 130.6 (Cq), 
129.0 (CH), 127.6 (CH), 126.9 (CH), 126.9 (CH), 126.2 (CH), 125.8 (Cq), 123.7 (CH), 114.4 (Cq), 
32.5 (CH2), 26.7 (CH2), 22.1 (CH2), 13.5 (CH3).  
9. Analytical Data 
- 114 - 
 
IR (neat): 3067, 2952, 2849, 1641, 1600, 1156, 764 cm-1.  
MS (EI) m/z (relative intensity): 283 ([M+] 35), 241 (18), 240 (100), 222 (13), 184 (6), 128 (5), 
77 (3).  
HR-MS (EI) m/z calcd for C17H17NOS
+ [M+] 283.1031, found 283.1027. 
Synthesis of 4-(n-Butyl)-3-(cyclohex-1-en-1-yl)isoquinolin-1(2H)-one (41ao)  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 1-(hex-1-yn-1-yl)cyclohex-1-ene (38o) (122 mg, 0.75 mmol). After stirring at 100 °C for 
18 h, purification by column chromatography on silica gel (CH2Cl2/Et2O: 5/1) yielded 41ao 
(69 mg, 49%) as a colorless solid. 
M.p. = 152–154 °C.  
1H-NMR (300 MHz, CDCl3): δ = 9.05 (s, 1H), 8.43 (d, J = 8.0 Hz, 1H), 7.74–7.62 (m, 2H), 7.45 
(dt, J = 8.2, 4.1 Hz, 1H), 5.91 (dd, J = 3.8, 2.1 Hz, 1H), 2.66 (dd, J = 9.9, 6.0 Hz, 2H), 2.31–2.14 
(m, 4H), 1.87–1.65 (m, 4H), 1.63–1.35 (m, 4H), 0.96 (t, J = 7.2 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 162.6 (Cq), 139.2 (Cq), 138.3 (Cq), 133.3 (Cq), 132.3 (CH), 130.9 
(CH), 127.8 (CH), 125.7 (CH), 125.5 (Cq), 123.6 (CH), 112.9 (Cq), 33.0 (CH2), 28.9 (CH2), 27.1 
(CH2), 25.2 (CH2), 23.0 (CH2), 22.7 (CH2), 21.8 (CH2), 13.9 (CH3).  
IR (neat): 2958, 2922, 2856, 1650, 1622, 1460, 764 cm-1.  
MS (EI) m/z (relative intensity): 281 ([M+] 40), 239 (20), 238 (100), 196 (23), 178 (11), 115 (9), 
77 (6).  
HR-MS (EI) m/z calcd for C19H23NO
+ [M+] 281.1780, found 281.1770. 
Synthesis of Ethyl (E)-3-(2-carbamoylphenyl)acrylate (44aa) 
9. Analytical Data 
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The general procedure B was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and ethyl acrylate (37a) (75 mg, 0.75 mmol). After stirring at 60 °C for 18 h, purification by 
column chromatography on silica gel (CH2Cl2/EtOAc: 2/1) yielded 44aa (90 mg, 82%) as a 
colorless solid. 
M.p. = 161–163 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.10 (d, J = 16.0 Hz, 1H), 7.65–7.56 (m, 2H), 7.50–7.39 (m, 2H), 
6.39 (d, J = 16.0 Hz, 1H), 6.12 (br s, 1H), 5.91 (br s, 1H), 4.25 (q, J = 7.1 Hz, 2H), 1.32 (t, J = 
7.1 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ =
 170.5 (Cq), 166.4 (Cq), 141.8 (CH), 135.8 (Cq), 133.1 (Cq), 130.8 
(CH), 129.7 (CH), 127.7 (CH), 127.3 (CH), 121.1 (CH), 60.6 (CH2), 14.3 (CH3).  
IR (neat): 3378, 3180, 2980, 1716, 1637, 1315, 1182, 634 cm-1.  
MS (EI) m/z (relative intensity): 219 ([M+] 5), 190 (14), 174 (15), 146 (100), 131 (25), 117 (12), 
103 (14), 77 (11).  
HR-MS (EI) m/z calcd for C12H13NO3
+ [M+] 219.0895, found 219.0894.  
The analytical data are in accordance with those reported in the literature.[113]  
Synthesis of Ethyl (E)-3-(2-carbamoyl-5-methylphenyl)acrylate (44ba)  
 
The general procedure B was followed using 4-methyl-N-hydroxybenzamide (88b) (76 mg, 
0.5 mmol) and ethyl acrylate (37a) (75 mg, 0.75 mmol). After stirring at 60 °C for 18 h, 
purification by column chromatography on silica gel (CH2Cl2/EtOAc: 2/1) yielded 44ba 
(93 mg, 80%) as a colorless solid. 
9. Analytical Data 
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M.p. = 172–174 °C.  
1H-NMR (300 MHz, acetone-d6): δ = 8.22 (d, J = 16.0 Hz, 1H), 7.67 (s, 1H), 7.50 (d, J = 7.8 Hz, 
1H), 7.32–7.21 (m, 2H), 6.81 (br s, 1H), 6.46 (d, J = 16.0 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 2.40 
(s, 3H), 1.28 (t, J = 7.1 Hz, 3H).  
13C-NMR (125 MHz, acetone-d6): δ = 170.8 (Cq), 166.9 (Cq), 143.5 (CH), 141.0 (Cq), 135.6 (Cq), 
133.7 (Cq), 131.1 (CH), 128.6 (CH), 128.2 (CH), 120.3 (CH), 60.7 (CH2), 21.1 (CH3), 14.6 (CH3).  
IR (neat): 3375, 3198, 1690, 1656, 1294, 1040, 643 cm-1.  
MS (EI) m/z (relative intensity): 233 ([M+] 3), 204 (9), 188 (10), 160 (100), 145 (22), 115 (28), 
77 (5).  
HR-MS (EI) m/z calcd for C13H15NO3
+ [M+] 233.1052, found 233.1058. 
Synthesis of Ethyl (E)-3-(2-carbamoyl-5-fluorophenyl)acrylate (44da) 
 
The general procedure B was followed using 4-fluoro-N-hydroxybenzamide (88d) (78 mg, 
0.5 mmol) and ethyl acrylate (37a) (75 mg, 0.75 mmol). After stirring at 60 °C for 18 h, 
purification by column chromatography on silica gel (CH2Cl2/EtOAc: 2/1) yielded 44da 
(80 mg, 67%) as an off-white solid. 
M.p. = 162–164 °C.  
1H-NMR (300 MHz, acetone-d6): δ = 8.17 (dd, J = 16.0, 1.7 Hz, 1H), 7.70–7.59 (m, 2H), 7.38 
(br s, 1H), 7.23 (td, J = 8.4, 2.6 Hz, 1H), 6.93 (br s, 1H), 6.56 (d, J = 16.0 Hz, 1H), 4.22 (q, J = 
7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H).  
13C-NMR (125 MHz, acetone-d6): δ = 169.9 (Cq), 166.6 (Cq), 164.1 (d, JC-F = 247.4 Hz), 141.9 (d, 
JC-F = 2.2 Hz), 136.5 (d, JC-F = 8.2 Hz), 134.9 (d, JC-F = 3.3 Hz), 131.0 (d, JC-F = 8.8 Hz), 122.0 (CH), 
117.1 (d, JC-F = 22.0 Hz), 114.2 (d, JC-F = 22.9 Hz), 60.9 (CH2), 14.6 (CH3).  
19F-NMR (283 MHz, acetone-d6): δ = -107.1 (dddd, J = 9.7, 7.7, 5.7, 1.7 Hz).  
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IR (neat): 3389, 3203, 3004, 1688, 1650, 1388, 1215, 978 cm-1.  
MS (EI) m/z (relative intensity): 237 ([M+] 1), 208 (5), 192 (6), 164 (100), 149 (15), 135 (9), 
120 (9).  
HR-MS (EI) m/z calcd for C12H13FNO3
+ [M+H+] 238.0879, found 238.0876. 
Synthesis of n-Butyl (E)-3-(2-carbamoylphenyl)acrylate (44ab) 
 
The general procedure B was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and butyl acrylate (37b) (96 mg, 0.75 mmol). After stirring at 60 °C for 18 h, purification by 
column chromatography on silica gel (CH2Cl2/EtOAc: 2/1) yielded 44ab (90 mg, 73%) as a 
colorless solid. 
M.p. = 140–141 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.10 (d, J = 16.0 Hz, 1H), 7.68–7.54 (m, 2H), 7.52–7.37 (m, 2H), 
6.40 (d, J = 16.0 Hz, 1H), 6.03 (br s, 1H), 5.87 (br s, 1H), 4.19 (t, J = 6.7 Hz, 2H), 1.73–1.63 (m, 
2H), 1.50–1.35 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ =
 170.4 (Cq), 166.5 (Cq), 141.8 (CH), 135.7 (Cq), 133.1 (Cq), 130.8 
(CH), 129.7 (CH), 127.8 (CH), 127.3 (CH), 121.2 (CH), 64.6 (CH2), 30.7 (CH2), 19.2 (CH2), 13.7 
(CH3).  
IR (neat): 3356, 3167, 2952, 1707, 1626, 1276, 974, 766 cm-1.  
MS (EI) m/z (relative intensity): 247 ([M+] 6), 190 (15), 174 (12), 146 (100), 131 (25), 117 (11), 
77 (8).  
HR-MS (EI) m/z calcd for C14H18NO3
+ [M+H+] 248.1287, found 248.1282.  
The analytical data are in accordance with those reported in the literature.[194]  
Synthesis of Benzyl (E)-3-(2-carbamoylphenyl)acrylate (44ac)  
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The general procedure B was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and benzyl acrylate (37c) (122 mg, 0.75 mmol). After stirring at 60 °C for 18 h, purification by 
column chromatography on silica gel (CH2Cl2/EtOAc: 2/1) yielded 44ac (115 mg, 82%) as a 
colorless solid. 
M.p. = 149–151 °C.  
1H-NMR (300 MHz, acetone-d6): δ = 8.26 (d, J = 16.1 Hz, 1H), 7.90–7.83 (m, 1H), 7.59 (dd, J = 
7.1, 1.9 Hz, 1H), 7.55–7.28 (m, 8H), 6.91 (br s, 1H), 6.56 (d, J = 16.1 Hz, 1H), 5.25 (s, 2H).  
13C-NMR (125 MHz, acetone-d6): δ = 170.8 (Cq), 166.8 (Cq), 143.8 (CH), 138.6 (Cq), 137.5 (Cq), 
133.5 (Cq), 130.8 (CH), 130.6 (CH), 129.3 (CH), 129.0 (CH), 128.8 (CH), 128.5 (CH), 127.7 (CH), 
120.2 (CH), 66.5 (CH2).  
IR (neat): 3377, 3181, 1709, 1639, 1276, 1162, 765 cm-1.  
MS (EI) m/z (relative intensity): 281 ([M+] 7), 237 (3), 190 (19), 146 (100), 131 (30), 91 (72), 
77 (17).  
HR-MS (EI) m/z calcd for C17H15NO3
+ [M+] 281.1052, found 281.1051.  
The analytical data are in accordance with those reported in the literature.[113]   
Synthesis of (E)-2-(3-Oxobut-1-en-1-yl)benzamide (44ad) 
 
The general procedure B was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and but-3-en-2-one (37d) (105 mg, 1.50 mmol). After stirring at 60 °C for 18 h, purification by 
column chromatography on silica gel (CH2Cl2/acetone: 2/1) yielded 44ad (49 mg, 52%) as an 
off-white solid. 
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M.p. = 148–150 °C.  
1H-NMR (300 MHz, acetone-d6): δ = 8.10 (d, J = 16.3 Hz, 1H), 7.83 (dd, J = 7.4, 1.7 Hz, 1H), 
7.62 (dd, J = 7.3, 1.7 Hz, 1H), 7.54–7.43 (m, 2H), 7.36 (br s, 1H), 6.91 (br s, 1H), 6.70 (d, J = 
16.3 Hz, 1H), 2.31 (s, 3H).  
13C-NMR (125 MHz, acetone-d6): δ = 197.9 (Cq), 170.8 (Cq), 141.7 (CH), 138.5 (Cq), 134.0 (Cq), 
130.9 (CH), 130.5 (CH), 129.4 (CH), 128.7 (CH), 127.6 (CH), 27.4 (CH3).  
IR (neat): 3354, 3173, 1644, 1616, 1247, 971, 625 cm-1.  
MS (EI) m/z (relative intensity): 189 ([M+] 5), 174 (3), 146 (100), 132 (24), 118 (12), 103 (16), 
77 (15).  
HR-MS (EI) m/z calcd for C11H11NO2
+ [M+] 189.0790, found 189.0796. 
 
Competition Experiments 
Intermolecular Competition Experiment between Alkynes 38a and 38g 
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol), and oct-4-yne (38g) (110 mg, 1.00 mmol). 
After stirring at 100 °C for 18 h, purification by column chromatography on silica gel 
(n-pentane/EtOAc: 2/1) yielded a mixture of 41aa and 41ag (94 mg), the ratio of 3a and 5b 
was determined to be 45/55 by 1H-NMR. 
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Intermolecular Competition Experiments between Alkynes 38b and 38c  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol), 
1,2-bis(4-methoxyphenyl)ethyne (38b) (238 mg, 1.0 mmol) and 
1,2-bis(4-fluorophenyl)ethyne (38c)  (214 mg, 1.0 mmol). After stirring at 100 °C for 18 h, 
purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1 → 1/1) yielded 
41ab (36 mg, 20%) and 41ac (86 mg, 52%). 
Intermolecular Competition Experiment between N-hydroxybenzamides 88b and 88d 
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The general procedure A was followed using 4-methyl-N-hydroxybenzamide (88b) (151 mg, 
1.0 mmol), 4-fluoro-N-hydroxybenzamide (88d) (155 mg, 1.0 mmol), and diphenylethyne 
(38a) (89 mg, 0.5 mmol). After stirring at 100 °C for 18 h, purification by column 
chromatography on silica gel (CH2Cl2/Et2O: 3/1) yielded a mixture of 41ba and 41da (42 mg), 
the ratio of 41ba and 41da was determined to be 39/61 by 1H-NMR spectroscopy. 
 
Intramolecular Competition Experiment with Alkyne 38p 
The general procedure A was followed using N-hydroxybenzamide (88a) (69 mg, 0.50 mmol) 
and 1-methoxy-4-(phenylethynyl)benzene (38p)  (156 mg, 0.75 mmol). After stirring at 
100 °C for 18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) 
yielded 41ap (65 mg, 40%) and 41ap' (65 mg, 40%) both as colorless solids. 
4-(4-methoxyphenyl)-3-phenylisoquinolin-1(2H)-one (41ap) 
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M. p. = 257–259 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.41 (s, 1H), 8.29 (d, J = 7.9 Hz, 1H), 7.61 (ddd, J = 8.3, 
7.1, 1.5 Hz, 1H), 7.48 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.22 (s, 5H), 7.18 – 7.13 (m, 1H), 7.04 (d, 
J = 8.5 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 3.71 (s, 3H). 
13C-NMR (75 MHz, DMSO-d6): δ = 161.6 (Cq), 158.0 (Cq), 138.5 (Cq), 138.4 (Cq), 134.7 (Cq), 
132.7 (CH), 132.3 (CH), 129.7 (CH), 128.0 (CH), 127.7 (Cq), 127.6 (CH), 126.7 (CH), 126.0 (CH), 
125.0(Cq), 124.9 (CH), 115.0 (Cq), 113.6 (CH), 54.9 (CH3). 
IR (neat): 3048, 3004, 2957, 1646, 1605, 1244, 1029, 695 cm-1. 
MS (EI) m/z (relative intensity): 327 ([M+] 100), 326 (30), 284 (12), 254 (10), 152 (12), 98 (12), 
77 (13). 
HR-MS (EI) m/z calcd for C22H17NO2
+ [M+] 327.1259, found 327.1262. 
3-(4-methoxyphenyl)-4-phenylisoquinolin-1(2H)-one (41ap') 
 
M. p. = 250–252 °C. 
1H-NMR (300 MHz, DMSO-d6): δ = 11.37 (s, 1H), 8.29 (dd, J = 8.0, 1.5 Hz, 1H), 7.60 (ddd, J = 
8.4, 7.1, 1.6 Hz, 1H), 7.47 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.35 – 7.21 (m, 3H), 7.18 – 7.08 (m, 
5H), 6.80 – 6.71 (m, 2H), 3.69 (s, 3H). 
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13C-NMR (75 MHz, DMSO-d6): δ = 161.7 (Cq), 158.9 (Cq), 138.3 (Cq), 138.1 (Cq), 136.0 (Cq), 
132.3 (CH), 131.6 (CH), 131.1 (CH), 128.2 (CH), 126.9 (CH), 126.7 (Cq), 126.7 (CH), 125.9 (CH), 
124.8 (Cq), 124.7 (CH), 115.1 (Cq), 113.0(CH), 55.0 (CH3). 
IR (neat): 3164, 3022, 2963, 1645, 1601, 1247, 1023, 775 cm-1. 
MS (EI) m/z (relative intensity): 327 ([M+] 100), 326 (35), 283 (9), 254 (7), 165 (9), 77 (3). 
HR-MS (EI) m/z calcd for C22H17NO2
+ [M+] 327.1259, found 327.1246. 
Relative Reactivities of N-Methoxybenzamides 40 and N-Hydroxybenzamides 88  
 
The general procedure A was followed using 4-methyl-N-methoxybenzamide (40b) (165 mg, 
1.0 mmol), 4-ethyl-N-hydroxybenzamide (88m) (165 mg, 1.0 mmol) and diphenylethyne 
(38a) (89 mg, 0.5 mmol). After stirring at 100 °C for 18 h, purification by column 
chromatography on silica gel (CH2Cl2/Et2O: 3/1) yielded a mixture of 41ba and 41ma (19 mg), 
the ratio of 41ba and 41ma was determined to be 10/90 by 1H-NMR spectroscopy. 
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The general procedure A was followed using 4-methyl-N-hydroxybenzamide (88b) (151 mg, 
1.0 mmol), 4-ethyl-N-methoxybenzamide (40m) (179 mg, 1.0 mmol) and diphenylethyne 
(38a) (89 mg, 0.5 mmol). After stirring at 100 °C for 18 h, purification by column 
chromatography on silica gel (CH2Cl2/Et2O: 3/1) yielded a mixture of 41ba and 41ma (41 mg), 
the ratio of 41ba and 41ma was determined to be 77/23 by 1H-NMR spectroscopy. 
 
6-Ethyl-3,4-diphenylisoquinolin-1(2H)-one (41ma):  
 
Off-white solid.  
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M.p. = 256–258 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.94 (s, 1H), 8.41 (d, J = 8.2 Hz, 1H), 7.48–7.06 (m, 12H), 2.66 
(q, J = 7.6 Hz, 2H), 1.19 (t, J = 7.6 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 162.4 (Cq), 149.4 (Cq), 138.7 (Cq), 136.9 (Cq), 135.7 (Cq), 135.2 
(Cq), 131.7 (CH), 129.0 (CH), 128.5 (CH), 128.3 (CH), 128.2 (CH), 127.5 (CH), 127.1 (CH), 127.0 
(CH), 124.2 (CH), 123.1 (Cq), 117.1 (Cq), 29.4 (CH2), 15.4 (CH3).  
IR (neat): 3118, 3022, 2885, 1640, 1611, 1442, 1151, 695 cm-1.  
MS (EI) m/z (relative intensity): 325 ([M+] 100), 324 (45), 295 (12), 178 (10), 104 (8), 77 (13).  
HR-MS (EI) m/z calcd for C23H19NO
+ [M+] 325.1467, found 325.1465. 
 
Experiments with Isotopically Labeled Compounds 
C–H/N–O Functionalizations with Isotopically Labeled Solvent  
 
A mixture of N-hydroxybenzamide (88a) (69 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 
5.0 mol %) and potassium 3-(trifluoromethyl)benzoate (34 mg, 30.0 mol%) in D2O (2 mL) was 
stirred at 100 °C under N2 atmosphere for 18 h. D2O was removed under reduced pressure. 
Purification by column chromatography on silica gel (CH2Cl2/acetone: 2/1) recovered [Dn]-88a 
(62 mg, 87%) with approximately 8% hydrogen incorporation at each ortho-position as 
estimated by 1H-NMR spectroscopy. 
C–H/N–OH Functionalizations with Isotopically Labeled Substrate [D5]-88a 
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The general procedure A was followed using [D5]-88a (71 mg, 0.50 mmol) and 
diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 100 °C for 18 h, purification by 
column chromatography on silica gel (n-pentane/EtOAc: 2/1) yielded [D4]-41aa (101 mg, 
67%) with approximately 15% deuterium incorporation at the ortho-position as estimated by 
1H-NMR spectroscopy. 
 
3,4-Diphenylisoquinolin-1(2H)-one-5,6,7,8-d4 ([D4]-41aa):  
 
Colorless solid.  
M.p. = 254–256 °C.  
1H-NMR (300 MHz, DMSO-d6): δ =
 11.53 (s, 1H), 7.35–7.07 (m, 10H).  
13C-NMR (125 MHz, DMSO-d6): δ =
 161.4 (Cq), 138.3 (Cq), 137.8 (Cq), 135.6 (Cq), 134.4 (Cq), 
131.7 (t, J = 22.7 Hz, CD), 131.5 (CH), 129.6 (CH), 128.0 (CH), 127.9 (CH), 127.4 (CH), 126.8 
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(CH), 126.5 (t, J = 22.7 Hz, CD), 124.8 (t, J = 22.7 Hz, CD), 124.7 (Cq), 124.3 (t, J = 22.7 Hz, CD), 
115.2 (Cq).  
IR (neat): 3149, 3017, 2886, 1642, 1327, 902, 697 cm-1.  
MS (EI) m/z (relative intensity): 301 ([M+] 100), 300 (80), 282 (14), 271 (9), 169 (12), 104 (5), 
77 (11).  
HR-MS (EI) m/z calcd for C21H11D4NO
+ [M+] 301.1405, found 301.1408.  
The analytical data are in accordance with those reported in the literature.[110]   
 
Kinetic Isotope Effect Studies with 88a and [D5]-88a  
 
The general procedure A was followed using N-hydroxybenzamide (88a) (137 mg, 1.0 mmol), 
N-hydroxybenzamide-d5 ([D5]-88a) (142 mg, 1.0 mmol) and diphenylethyne (38a) (89 mg, 
0.5 mmol). After stirring at 100 °C for 18 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 2/1) yielded a mixture of [Dn]-41aa (15 mg), the kinetic isotope effect 
of this reaction was thus determined to be 2.6 as estimated by 1H-NMR spectroscopy. 
 
Crossover Experiment with 95 and 88c 
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The general procedure A was followed using 2-methoxy-6-methyl-3,4- 
diphenylisoquinolin-1(2H)-one (95) (171 mg, 0.50 mmol), N-hydroxy-4-methoxybenzamide 
(88c) (84 mg, 0.50 mmol) and diphenylacetylene (38a) (134 mg, 0.75 mmol). After stirring at 
100 °C for 18 h, purification by column chromatography on silica gel (n-pentane/EtOAc: 2/1) 
yielded 41ca (108 mg, 66%) and reisolated 95 (157 mg, 92%). 
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9.2 Analytical Data for Ruthenium(II)-Catalyzed C–H Oxygenation on Weinreb Amides 
Synthesis of 2-Hydroxy-N-methoxy-N-methylbenzamide (90a) 
 
The general procedure C was followed using N-methoxy-N-methylbenzamide (89a) (83 mg, 
0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 5/1) yielded 90a (76 mg, 84%) as a pale green liquid. 
1H-NMR (300 MHz, CDCl3) δ = 11.17 (s, 1H), 7.95 (dd, J = 8.1, 1.6 Hz, 1H), 7.36 (ddd, J = 8.8, 
7.2, 1.7 Hz, 1H), 6.98 (dd, J = 8.4, 1.2 Hz, 1H), 6.84 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 3.64 (s, 3H), 
3.40 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.9 (Cq), 161.0 (Cq), 133.9 (CH), 129.6 (CH), 118.7 (CH), 118.1 
(CH), 114.5 (Cq), 61.3 (CH3), 34.2 (CH3).  
IR (neat): 2935, 1625, 1589, 1452, 755 cm-1.  
MS (EI) m/z (relative intensity): 181 ([M+] 27), 121 (100), 93 (30), 65 (30).  
HR-MS (EI) m/z calcd for C9H11NO3
+ [M+] 181.0739, found 181.0737. 
The spectral data are in accordance with those reported in the literature.[195]  
Synthesis of N-Ethyl-2-hydroxy-N-methoxybenzamide (90b) 
 
The general procedure C was followed using N-ethyl-N-methoxybenzamide (89b) (90 mg, 
0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 5/1) yielded 90b (77 mg, 78%) as a colorless liquid.  
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1H-NMR (300 MHz, CDCl3) δ = 11.10 (s, 1H), 7.91 (dd, J = 7.9, 1.5 Hz, 1H), 7.37 (ddd, J = 8.3, 
7.3, 1.7 Hz, 1H), 7.01–6.96 (m, 1H), 6.88–6.81 (m, 1H), 3.84 (q, J = 7.1 Hz, 2H), 3.64 (s, 3H), 
1.33 (t, J = 7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.7 (Cq), 160.9 (Cq), 133.7 (CH), 129.3 (CH), 118.6 (CH), 118.0 
(CH), 114.8 (Cq), 61.8 (CH3), 42.0 (CH2), 12.4 (CH3).  
IR (neat): 2933, 1626, 1582, 1452, 1010, 756 cm-1.  
MS (EI) m/z (relative intensity): 195([M+] 25), 121 (100), 93 (28), 65 (28).  
HR-MS (EI) m/z calcd for C10H13NO3
+ [M+] 195.0895, found 195.0900. 
Synthesis of N-Ethyl-2-hydroxy-N-methoxy-4-methylbenzamide (90c) 
 
The general procedure C was followed using N-ethyl-N-methoxy-4-methylbenzamide (89c) 
(97 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography 
on silica gel (n-pentane/EtOAc: 10/1) yielded 90c (81 mg, 77%) as a colorless liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.29 (s, 1H), 7.82 (d, J = 8.3 Hz, 1H), 6.81–6.78 (m, 1H), 6.65 
(ddd, J = 8.3, 1.8, 0.5 Hz, 1H), 3.82 (q, J = 7.1 Hz, 2H), 3.64 (s, 3H), 2.32 (s, 3H), 1.32 (t, J = 
7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.8 (Cq), 161.2 (Cq), 144.8 (Cq), 129.2 (CH), 119.7 (CH), 118.2 
(CH), 111.9 (Cq), 61.7 (CH3), 42.0 (CH2), 21.6 (CH3), 12.4 (CH3).  
IR (neat): 2936, 1633, 1582, 1447, 1253, 807 cm-1.  
MS (EI) m/z (relative intensity): 209 ([M+] 9), 135 (100), 107 (12), 77 (27).  
HR-MS (EI) m/z calcd for C11H15NO3
+ [M+] 209.1052, found 209.1052. 
Synthesis of N-Ethyl-4-fluoro-2-hydroxy-N-methoxybenzamide (90d) 
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The general procedure C was followed using N-ethyl-4-fluoro-N-methoxybenzamide (89d) 
(99 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography 
on silica gel (n-pentane/EtOAc: 10/1) yielded 90d (80 mg, 75%) as a colorless liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.78 (s, 1H), 8.02 (dd, J = 9.1, 6.7 Hz, 1H), 6.67 (dd, J = 10.4, 
2.7 Hz, 1H), 6.55 (ddd, J = 9.1, 8.0, 2.7 Hz, 1H), 3.83 (q, J = 7.1 Hz, 2H), 3.64 (s, 3H), 1.33 (t, J = 
7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 168.8 (Cq), 165.7 (Cq, JC-F = 253.1 Hz), 163.8 (Cq, JC-F = 13.6 Hz), 
131.6 (CH, JC-F = 10.9 Hz), 111.0 (Cq, JC-F = 2.9 Hz), 106.3 (CH, JC-F = 22.1 Hz), 104.7 (CH, JC-F = 
23.7 Hz), 61.7 (CH3), 41.6 (CH2), 12.3 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -104.1 (ddd, J = 10.4, 8.0, 6.8 Hz).  
IR (neat): 2938, 1598, 1451, 1262, 977 cm-1.  
MS (EI) m/z (relative intensity): 213 ([M+] 7), 139 (100), 111 (8), 83 (12).  
HR-MS (EI) m/z calcd for C10H12FNO3
+ [M+] 213.0801, found 213.0804. 
Synthesis of 2-Hydroxy-N-methoxy-N-n-propylbenzamide (90e) 
 
The general procedure C was followed using N-methoxy-N-n-propylbenzamide (89e) (97 mg, 
0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 10/1) yielded 90e (77 mg, 74%) as a colorless liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.09 (s, 1H), 7.95 (dd, J = 8.1, 1.6 Hz, 1H), 7.37 (ddd, J = 8.4, 
7.2, 1.7 Hz, 1H), 6.98 (dd, J = 8.4, 1.2 Hz, 1H), 6.84 (ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 3.81–3.72 
(m, 2H), 3.61 (s, 3H), 1.88–1.68 (m, 2H), 0.99 (t, J = 7.4 Hz, 3H).  
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13C-NMR (75 MHz, CDCl3) δ = 169.7 (Cq), 160.8 (Cq), 133.6 (CH), 129.4 (CH), 118.5 (CH), 118.0 
(CH), 114.8 (Cq), 61.6 (CH3), 48.1 (CH2), 20.5 (CH2), 11.2 (CH3).  
IR (neat): 2965, 2934, 1626, 1583, 1452, 756 cm-1.  
MS (EI) m/z (relative intensity): 209 ([M+] 25), 121 (100), 93 (22), 65 (27).  
HR-MS (EI) m/z calcd for C11H15NO3
+ [M+] 209.1052, found 209.1042. 
Synthesis of N-n-Butyl-2-hydroxy-N-methoxybenzamide (90f) 
 
The general procedure C was followed using N-n-butyl-N-methoxybenzamide (89f) (104 mg, 
0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 10/1) yielded 90f (84 mg, 75%) as a pale yellow liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.10 (s, 1H), 7.94 (dd, J = 8.1, 1.6 Hz, 1H), 7.37 (ddd, J = 8.3, 
7.2, 1.7 Hz, 1H), 6.98 (dd, J = 8.4, 1.2 Hz, 1H), 6.84 (ddd, J = 8.5, 7.3, 1.3 Hz, 1H), 3.79 (t, J = 
7.3 Hz, 2H), 3.61 (s, 3H), 1.81–1.66 (m, 2H), 1.48–1.33 (m, 2H), 0.96 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.6 (Cq), 160.9 (Cq), 133.6 (CH), 129.4 (CH), 118.5 (CH), 118.0 
(CH), 114.8 (Cq), 61.6 (CH3), 46.2 (CH2), 29.1 (CH2), 19.9 (CH2), 13.7 (CH3).  
IR (neat): 2958, 2933, 1627, 1584, 1454, 756 cm-1.  
MS (EI) m/z (relative intensity): 223 ([M+] 10), 121 (100), 93 (12), 65 (11).  
HR-MS (EI) m/z calcd for C12H17NO3
+ [M+] 223.1208, found 223.1211. 
Synthesis of N-Benzyl-2-hydroxy-N-methoxybenzamide (90g) 
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The general procedure C was followed using N-benzyl-N-methoxybenzamide (89g) (121 mg, 
0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 10/1) yielded 90g (83 mg, 64%) as a colorless liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.14 (s, 1H), 8.01 (dd, J = 8.1, 1.6 Hz, 1H), 7.47–7.30 (m, 6H), 
7.05–6.97 (m, 1H), 6.84 (ddd, J = 8.2, 7.3, 1.3 Hz, 1H), 4.99 (s, 2H), 3.58 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.7 (Cq), 161.1 (Cq), 135.8 (Cq), 133.9 (CH), 129.4 (CH), 128.7 
(CH), 128.2 (CH), 127.9 (CH), 118.7 (CH), 118.0 (CH), 114.5 (Cq), 62.2 (CH3), 50.5 (CH2).  
IR (neat): 2926, 1626, 1582, 1447, 1249, 756 cm-1.  
MS (EI) m/z (relative intensity): 257 ([M+] 13), 226 (15), 121 (100), 91 (48), 65 (35).  
HR-MS (EI) m/z calcd for C15H15NO3
+ [M+] 257.1052, found 257.1061. 
Synthesis of N-Ethoxy-N-ethyl-2-hydroxybenzamide (90h) 
 
The general procedure C was followed using N-ethoxy-N-ethylbenzamide (89h) (97 mg, 
0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 10/1) yielded 90h (80 mg, 76%) as a colorless liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.03 (s, 1H), 7.96 (dd, J = 8.1, 1.7 Hz, 1H), 7.36 (ddd, J = 8.4, 
7.2, 1.7 Hz, 1H), 7.03–6.92 (m, 1H), 6.83 (ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 3.82 (q, J = 7.1 Hz, 2H), 
3.82 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H), 1.19 (t, J = 7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.7 (Cq), 160.7 (Cq), 133.5 (CH), 129.4 (CH), 118.3 (CH), 117.9 
(CH), 115.1 (Cq), 70.2 (CH2), 42.3 (CH2), 13.3 (CH3), 12.5 (CH3).  
IR (neat): 2980, 2925, 1627, 1582, 1451, 1251, 1019, 756 cm-1.  
MS (EI) m/z (relative intensity): 209 ([M+] 18), 121 (100), 93 (22), 65 (30).   
HR-MS (EI) m/z calcd for C11H15NO3
+ [M+] 209.1052, found 209.1051. 
Synthesis of 2-Hydroxy-N-methoxy-N,4-dimethylbenzamide (90i) 
9. Analytical Data 
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The general procedure C was followed using N-methoxy-N,4-dimethylbenzamide (89i) 
(90 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography 
on silica gel (n-pentane/EtOAc: 10/1) yielded 90i (74 mg, 76%) as a pale yellow liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.36 (s, 1H), 7.86 (d, J = 8.3 Hz, 1H), 6.79 (d, J = 0.7 Hz, 1H), 
6.69–6.59 (m, 1H), 3.64 (s, 3H), 3.39 (s, 3H), 2.32 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 170.1 (Cq), 161.4 (Cq), 145.0 (Cq), 129.5 (CH), 119.9 (CH), 118.3 
(CH), 111.6 (Cq), 61.2 (CH3), 34.2 (CH3), 21.8 (CH3).  
IR (neat): 2922, 1633, 1583, 1430, 808 cm-1.  
MS (EI) m/z (relative intensity): 195 ([M+] 23), 169 (20), 135 (100), 107 (26), 77 (30).  
HR-MS (EI) m/z calcd for C10H13NO3
+ [M+] 195.0895, found 195.0892. 
Synthesis of 4-Ethyl-2-hydroxy-N-methoxy-N-methylbenzamide (90j) 
 
The general procedure C was followed using 4-ethyl-N-methoxy-N-methylbenzamide (89j) 
(97 mg, 0.50 mmol).  After stirring at 50 °C for 16 h, purification by column chromatography 
on silica gel (n-pentane/EtOAc: 6/1) yielded 90j (81 mg, 78%) as a pale yellow liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.39 (s, 1H), 7.89 (d, J = 8.3 Hz, 1H), 6.82 (d, J = 1.5 Hz, 1H), 
6.68 (dd, J = 8.3, 1.5 Hz, 1H), 3.65 (s, 3H), 3.39 (s, 3H), 2.62 (q, J = 7.6 Hz, 2H), 1.23 (t, J = 
7.6 Hz, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 170.0 (Cq), 161.4 (Cq), 151.0 (Cq), 129.4 (CH), 118.5 (CH), 116.9 
(CH), 111.7 (Cq), 61.1 (CH3), 34.1 (CH3), 28.8 (CH2), 14.7 (CH3).  
IR (neat): 2966, 2932, 1631, 1583, 973cm-1.  
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MS (EI) m/z (relative intensity): 209 ([M+] 6), 149 (100), 91 (8), 77 (9).  
HR-MS (EI) m/z calcd for C11H15NO3
+ [M+] 209.1052, found 209.1044. 
Synthesis of 4-(Trifluoromethyl)-2-hydroxy-N-methoxy-N-methylbenzamide (90k) 
 
The general procedure C was followed using 4-(trifluoromethyl)-N-methoxy-N- 
methylbenzamide (89k) (117 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by 
column chromatography on silica gel (n-pentane/EtOAc: 4/1) yielded 90k (91 mg, 73%) as a 
green solid.  
M. p. = 72–73 °C.  
1H-NMR (300 MHz, CDCl3) δ = 11.29 (s, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.25–7.24 (m, 1H), 
7.13–7.03 (m, 1H), 3.65 (s, 3H), 3.43 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 168.5 (Cq), 161.0 (Cq), 135.1 (Cq, JC-F = 32.8 Hz), 130.3 (CH), 
123.3 (Cq, JC-F = 272.8 Hz), 117.1 (Cq), 115.3 (CH, JC-F = 3.9 Hz), 114.9 (CH, JC-F = 3.6 Hz), 61.5 
(CH3), 33.7 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -63.8 (s).  
IR (neat): 2923, 1593, 1425, 1329, 925 cm-1.  
MS (EI) m/z (relative intensity): 249 ([M+] 27), 189 (100), 161 (40), 113 (19), 61 (19).  
HR-MS (EI) m/z calcd for C10H10F3NO3
+ [M+] 249.0613, found 249.0612. 
Synthesis of 4-Fluoro-2-hydroxy-N-methoxy-N-methylbenzamide (90l) 
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- 136 - 
 
The general procedure C was followed using 4-fluoro-N-methoxy-N-methylbenzamide (89l) 
(92 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography 
on silica gel (n-pentane/EtOAc: 5/1) yielded 90l (79 mg, 79%) as a pale green solid. 
M. p. = 60–61 °C.  
1H-NMR (300 MHz, CDCl3) δ = 11.81 (s, 1H), 8.05 (dd, J = 9.1, 6.7 Hz, 1H), 6.67 (dd, J = 10.4, 
2.7 Hz, 1H), 6.55 (ddd, J = 9.1, 8.1, 2.7 Hz, 1H), 3.65 (s, 3H), 3.40 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.0 (Cq), 165.7 (Cq, JC-F = 253.3 Hz), 163.8 (Cq, JC-F = 13.8 Hz), 
131.7 (CH, JC-F = 11.0 Hz), 110.6 (Cq, JC-F = 2.8 Hz), 106.3 (CH, JC-F = 22.1 Hz), 104.7 (CH, JC-F = 
23.8 Hz), 61.1 (CH3), 33.8 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -(103.9–104.0) (m).  
IR (neat): 2938, 1622, 1597, 1265, 967 cm-1.  
MS (EI) m/z (relative intensity): 199 ([M+] 22), 139 (100), 111 (27), 83 (30), 57 (20).  
HR-MS (EI) m/z calcd for C9H10FNO3
+ [M+] 199.0645, found 199.0645. 
Synthesis of 4-Chloro-2-hydroxy-N-methoxy-N-methylbenzamide (90m) 
 
The general procedure C was followed using 4-chloro-N-methoxy-N-methylbenzamide (89m) 
(100 mg, 0.50 mmol).  After stirring at 50 °C for 16 h, purification by column 
chromatography on silica gel (n-pentane/EtOAc: 5/1) yielded 90m (92 mg, 85%) as an 
off-white solid.  
M. p. = 94–96 °C.  
1H-NMR (300 MHz, CDCl3) δ = 11.57 (s, 1H), 7.95 (d, J = 8.7 Hz, 1H), 7.00 (d, J = 2.2 Hz, 1H), 
6.82 (dd, J = 8.7, 2.2 Hz, 1H), 3.64 (s, 3H), 3.40 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.2 (Cq), 162.3 (Cq), 139.5 (Cq), 130.8 (CH), 119.2 (CH), 118.3 
(CH), 112.8 (Cq), 61.4 (CH3), 34.0 (CH3). 
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IR (neat): 2934, 1621, 1572, 1458, 915 cm-1.  
MS (EI) m/z (relative intensity): 215 ([M+] 10), 155 (100), 127 (12), 99 (15).  
HR-MS (EI) m/z calcd for C9H10ClNO3
+ [M+] 215.0349, found 215.0352. 
Synthesis of 2-Hydroxy-4-iodo-N-methoxy-N-methylbenzamide (90n) 
 
The general procedure C was followed using 4-iodo-N-methoxy-N-methylbenzamide (89n) 
(146 mg, 0.50 mmol).  After stirring at 50 °C for 16 h, purification by column 
chromatography on silica gel (n-pentane/EtOAc: 5/1) yielded 90n (123 mg, 80%) as a pale 
yellow liquid.  
1H-NMR (300 MHz, CDCl3) δ = 11.40 (s, 1H), 7.69 (d, J = 8.6 Hz, 1H), 7.40 (d, J = 1.8 Hz, 1H), 
7.19 (dd, J = 8.6, 1.8 Hz, 1H), 3.64 (s, 3H), 3.39 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.2 (Cq), 161.4 (Cq), 130.4 (CH), 127.8 (CH), 127.3 (CH), 113.6 
(Cq), 100.3 (Cq), 61.3 (CH3), 33.8 (CH3).  
IR (neat): 2925, 1617, 1570, 853 cm-1.  
MS (EI) m/z (relative intensity): 307 ([M+] 26), 247 (100), 120 (30), 63 (21).  
HR-MS (EI) m/z calcd for C9H10INO3
+ [M+] 306.9705, found 306.9700. 
Synthesis of 4-(Chloromethyl)-2-hydroxy-N-methoxy-N-methylbenzamide (90o) 
 
The general procedure C was followed using 4-(chloromethyl)-N-methoxy-N- 
methylbenzamide (89o) (107 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by 
column chromatography on silica gel (n-pentane/EtOAc: 4/1) yielded 90o (70 mg, 61%) as a 
pale green liquid.  
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1H-NMR (300 MHz, CDCl3) δ = 11.35 (s, 1H), 7.98 (d, J = 8.3 Hz, 1H), 7.01 (s, 1H), 6.93–6.83 
(m, 1H), 4.52 (s, 2H), 3.65 (s, 3H), 3.41 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.3 (Cq), 161.3 (Cq), 143.1 (Cq), 130.0 (CH), 118.5 (CH), 117.8 
(CH), 114.0 (Cq), 61.3 (CH3), 45.3 (CH2), 33.9 (CH3).  
IR (neat): 2936, 1632, 1584, 1425, 714 cm-1.  
MS (EI) m/z (relative intensity): 229 ([M+] 20), 169 (100), 134 (38), 105 (30), 77 (28).  
HR-MS (EI) m/z calcd for C10H12ClNO3
+ [M+] 229.0506, found 229.0505. 
Competition Experiments 
Intramolecular Competition Experiment with meta-Substituted Weinreb Amides 89p 
 
The general procedure C was followed using N-methoxy-N,3-dimethylbenzamide (89p) 
(90 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography 




1H-NMR (300 MHz, CDCl3) δ = 10.79 (s, 1H), 7.71 (s, 1H), 7.18 (dd, J = 8.4, 2.1 Hz, 1H), 6.89 (d, 
J = 8.4 Hz, 1H), 3.65 (s, 3H), 3.40 (s, 3H), 2.28 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 170.2 (Cq), 158.7 (Cq), 134.7 (CH), 129.5 (CH), 127.7 (Cq), 117.8 
(CH), 114.4 (Cq), 61.3 (CH3), 34.3 (CH3), 20.8 (CH3).  
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IR (neat): 2928, 1632, 1579, 1485, 1247, 822 cm-1.  
MS (EI) m/z (relative intensity): 195 ([M+] 29), 135 (100), 107 (30), 77 (31).  
HR-MS (EI) m/z calcd for C10H13NO3
+ [M+] 195.0895, found 195.0893. 
2-Hydroxy-N-methoxy-N,3-dimethylbenzamide (90p') 
 
1H-NMR (300 MHz, CDCl3) δ = 11.30 (s, 1H), 7.78 (dd, J = 8.2, 1.1 Hz, 1H), 7.26–7.21 (m, 1H), 
6.78–6.70 (m, 1H), 3.64 (s, 3H), 3.41 (s, 3H), 2.26 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 170.4 (Cq), 159.2 (Cq), 134.6 (CH), 127.0 (CH), 126.8 (Cq), 117.8 
(CH), 113.6 (Cq), 61.2 (CH3), 34.3 (CH3), 16.0 (CH3).  
IR (neat): 2921, 1603, 1425, 1253, 1014, 802 cm-1.  
MS (EI) m/z (relative intensity): 195 ([M+] 9), 135 (100), 77 (14).  
HR-MS (EI) m/z calcd for C10H13NO3
+ [M+] 195.0895, found 195.0898. 
Intramolecular Competition Experiment with meta-Substituted Weinreb Amide 89q 
 
The general procedure C was followed using 3-fluoro-N-methoxy-N-methylbenzamide (89q) 
(92 mg, 0.50 mmol). After stirring at 50 °C for 16 h, purification by column chromatography 
on silica gel (n-pentane/EtOAc: 5/1) yielded 90q (51 mg, 51%) and 90q' (24 mg, 24%) both as 
colorless liquids. 
5-Fluoro-2-hydroxy-N-methoxy-N-methylbenzamide (90q) 
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1H-NMR (300 MHz, CDCl3) δ = 11.05 (s, 1H), 7.72 (dd, J = 10.1, 3.1 Hz, 1H), 7.12 (ddd, J = 9.1, 
7.7, 3.1 Hz, 1H), 6.94 (dd, J = 9.1, 4.9 Hz, 1H), 3.66 (s, 3H), 3.40 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 168.7 (Cq, JC-F = 2.5 Hz), 157.5 (Cq, JC-F = 1.7 Hz), 154.9 (Cq, JC-F = 
236.3 Hz), 121.3 (CH, JC-F = 23.4 Hz), 119.1 (CH, JC-F = 7.7 Hz), 115.4 (CH, JC-F = 25.6 Hz), 114.1 
(Cq, JC-F = 7.7 Hz), 61.5 (CH3), 33.9 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -124.7 (ddd, J = 10.0, 7.7, 4.9 Hz).  
IR (neat): 2938, 1631, 1582, 1480, 1180, 789 cm-1.  
MS (EI) m/z (relative intensity): 199 ([M+] 30), 139 (100), 111 (34), 83 (31), 57 (22).  
HR-MS (EI) m/z calcd for C9H10FNO3
+ [M+] 199.0645, found 199.0639. 
3-Fluoro-2-hydroxy-N-methoxy-N-methylbenzamide (90q') 
 
1H-NMR (300 MHz, CDCl3) δ = 11.29 (s, 1H), 7.76 (dd, J = 8.3, 1.3 Hz, 1H), 7.24–7.16 (m, 1H), 
6.83–6.74 (m, 1H), 3.65 (s, 3H), 3.41 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 168.9 (Cq, JC-F = 3.2 Hz), 151.9 (Cq, JC-F = 244.9 Hz), 149.8 (Cq, 
JC-F = 12.9 Hz), 124.6 (CH, JC-F = 3.9 Hz), 119.6 (CH, JC-F = 17.4 Hz), 117.8 (CH, JC-F = 6.8 Hz), 
116.4 (Cq, JC-F = 3.0 Hz), 61.4 (CH3), 33.9 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -136.0 (ddd, J = 10.5, 4.9, 1.4 Hz).  
IR (neat): 2929, 1638, 1580, 1447, 1235, 743 cm-1.  
MS (EI) m/z (relative intensity): 199 ([M+] 9), 139 (100), 111 (10), 83 (13), 57 (7).  
HR-MS (EI) m/z calcd for C9H10FNO3
+ [M+] 199.0645, found 199.0646. 
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Intermolecular Competition Experiment between Weinreb Amides 89i and 89l 
 
The general procedure C was followed using N-methoxy-N,4-dimethylbenzamide (89i) 
(179 mg, 1.00 mmol) and 4-fluoro-N-methoxy-N-methylbenzamide (89l) (183 mg, 
1.00 mmol). After stirring at 50 °C for 16 h, purification by column chromatography on silica 
gel (n-pentane/EtOAc: 5/1) yielded a mixture of 90i and 90l as a pale green liquid (90 mg), 
the ratio of which was found to be 84/16 by 1H-NMR spectroscopy. 
 
 
Experiments with Isotopically Labeled Compounds  
Ruthenium(II)-Catalyzed Reaction with Labeled Substrate [D5]-89a 
9. Analytical Data 
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The general procedure C was followed using [D5]-N-methoxy-N-methylbenzamide ([D5]-89a) 
(85 mg, 0.50 mmol). After stirring at 50 °C for 3 h, purification by column chromatography on 
silica gel (n-pentane/EtOAc: 5/1) yielded [D4]-90a as a colorless liquid (19 mg, 20%) as a 
colorless liquid and reisolated [D5]-89a (46 mg, 54%). The hydrogen incorporation at ortho 
position of [D4]-90a or reisolated [D5]-89a was less than 1% as estimated by 
1H-NMR 
spectroscopy. 
An additional reaction was performed at 50 °C for 16 h and yielded [D4]-90a (66 mg, 71%). 





1H-NMR (300 MHz, CDCl3) δ = 11.19 (s, 1H), 3.64 (s, 3H), 3.40 (s, 3H).  
13C-NMR (75 MHz, CDCl3) δ = 169.8 (Cq), 160.9 (Cq), 133.3 (t, J = 24.2 Hz, CD), 129.1 (t, J = 
25.0 Hz, CD), 118.0 (t, J = 25.0 Hz, CD), 117.6 (t, J = 24.6 Hz, CD), 114.2 (Cq), 61.2 (CH3), 34.0 
(CH3).  
IR (neat): 2935, 1617, 1567, 1390, 770 cm-1.  
MS (EI) m/z (relative intensity): 185 ([M+] 10), 125 (100), 97 (16), 69 (20), 43(18).  
HR-MS (EI) m/z calcd for C9H7D4NO3
+ [M+] 185.0990, found 185.0990. 
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Kinetic Isotope Effect Studies with 89a and [D5]-89a 
 
The general procedure C was followed using N-methoxy-N-methylbenzamide (89a) (165 mg, 
1.00 mmol) and [D5]-N-methoxy-N-methylbenzamide ([D5]-89a) (170 mg, 1.00 mmol). After 
stirring at 50 °C for 16 h, purification by column chromatography on silica gel 
(n-pentane/EtOAc: 5/1) yielded a mixture of 90a and [D4]-90a as a pale green liquid (81 mg, 
22%). The kinetic isotope effect of this reaction was determined to be kH/kD ≈ 3.0 as 
estimated by 1H-NMR spectroscopy. 
 
 
Diversification of Products 
Synthesis of ortho-Hydroxybenzaldehyde (92a) 
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To a 100 mL flame dried Schlenk flask were added 90a (181 mg, 1.0 mmol) and THF (30 mL) 
under N2. At -78 °C, LiAlH4 (38 mg, 1.0 mmol, 1 M in Et2O) was added dropwise. The mixture 
was stirred for 15 min at -78 °C. Then, another portion of LiAlH4 (114 mg, 3.0 mmol, 1 M in 
Et2O) was added. The reaction mixture was afterwards allowed to warm to 0 °C in 2 h. 
Aqueous NaHSO4 (2 mL, 10%) was carefully added, followed by HCl (20 mL, 1N). The reaction 
mixture was extracted with Et2O (50 mL) and n-pentane (50 mL). The organic phase was 
washed with brine (50 mL), dried over Na2SO4, and evaporated under reduced pressure at 
ambient temperature. The crude product was purified by Kugelrohr distillation (80 ± 5 °C, 10 
mbar) to yield 92a (100 mg, 82%) as a colorless liquid. 
2-Hydroxybenzaldehyde (92a)  
 
1H-NMR (300 MHz, CDCl3) δ = 11.02 (s, 1H), 9.90 (s, 1H), 7.58–7.50 (m, 2H), 7.05–6.97 (m, 
2H).  
13C-NMR (75 MHz, CDCl3) δ =196.6 (CH), 161.6 (Cq), 137.0 (CH), 133.7 (CH), 120.6 (Cq), 119.8 
(CH), 117.6 (CH).  
IR (neat): 3059, 2846, 2750, 1661, 1644, 1275, 759 cm-1.  
MS (EI) m/z (relative intensity): 122 ([M+] 100), 121 (97), 93 (30), 65 (42).  
HR-MS (EI) m/z calcd for C7H6O2
+ [M+] 122.0368, found 122.0365. 
The spectral data are in accordance with those reported in the literature.[196]   
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9.3 Analytical Data for Ruthenium(II)-Catalyzed C–H Oxygenation on Aldehydes 
Synthesis of 2-Hydroxy-4-methoxybenzaldehyde (92b) 
 
The general procedure D was followed using 4-methoxybenzaldehyde (91b) (68 mg, 
0.5 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 6/1) yielded 92b (55 mg, 72%) as a colorless solid. 
M. p. = 40–41 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.49 (s, 1H), 9.72 (s, 1H), 7.43 (d, J = 8.7 Hz, 1H), 6.54 (dd, J = 
8.7, 2.4 Hz, 1H), 6.43 (d, J = 2.4 Hz, 1H), 3.86 (s, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 194.4 (CH), 166.8 (Cq), 164.5 (Cq), 135.2 (CH), 115.1 (Cq), 108.4 
(CH), 100.6 (CH), 55.7 (CH3).  
IR (neat): 3019, 2923, 2844, 1628, 1574, 1217, 797 cm-1.  
MS (EI) m/z (relative intensity): 152 ([M+] 64), 151 (100), 125 (11), 111 (23), 97 (35), 71 (45).  
HR-MS (ESI) m/z calcd for C8H7O3
+ [M-H+] 151.0395, found 151.0397.  
The analytical data are in accordance with those reported in the literature.[197]  
Synthesis of 2-Hydroxy-4-methylbenzaldehyde (92a) 
 
The general procedure D was followed using benzaldehyde (91a) (53 mg, 0.5 mmol) and 
[bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 50/1) yielded 92a 
(29 mg, 48%) as a colorless solid. 
9. Analytical Data 
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Synthesis of 2-Hydroxy-4-methylbenzaldehyde (92c) 
 
The general procedure D was followed using 4-methylbenzaldehyde (91c) (60 mg, 0.50 
mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 100 °C 
for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 50/1) yielded 
92c (41 mg, 61%) as a colorless solid. 
M. p. = 59–60 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.02 (s, 1H), 9.81 (s, 1H), 7.41 (d, J = 7.8 Hz, 1H), 6.80 (d, J = 
7.8 Hz, 1H), 6.78 (s, 1H), 2.36 (s, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 195.8 (CH), 161.7 (Cq), 148.9 (Cq), 133.5 (CH), 121.1 (CH), 118.6 
(Cq), 117.6 (CH), 22.2 (CH3).  
IR (neat): 3040, 2866, 2762, 1624, 1570, 1200, 715 cm-1.  
MS (EI) m/z (relative intensity): 136 ([M+] 76), 135 (100), 118 (7), 107 (15), 90 (12), 77 (33).  
HR-MS (ESI) m/z calcd for C8H7O2
+ [M-H+] 135.0446, found 135.0450.  
The analytical data are in accordance with those reported in the literature.[198]   
Synthesis of 4-Ethyl-2-hydroxybenzaldehyde (92d) 
 
The general procedure D was followed using 4-ethylbenzaldehyde (91d) (67 mg, 0.50 mmol) 
and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 80/1) yielded 92d 
(43 mg, 57%) as a colorless liquid. 
9. Analytical Data 
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1H-NMR (300 MHz, CDCl3): δ = 11.05 (s, 1H), 9.83 (s, 1H), 7.45 (d, J = 7.9 Hz, 1H), 6.87–6.82 
(m, 2H), 2.67 (q, J = 7.6 Hz, 2H), 1.25 (t, J = 7.6 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 195.8 (CH), 161.9 (Cq), 155.0 (Cq), 133.7 (CH), 120.0 (CH), 118.8 
(Cq), 116.7 (CH), 29.4 (CH2), 14.7 (CH3).  
IR (neat): 2969, 2933, 2841, 1651, 1626, 1202, 809 cm-1.  
MS (EI) m/z (relative intensity): 150 ([M+] 76), 149 (100), 121 (12), 107 (25), 91 (15), 77 (36).  
HR-MS (ESI) m/z calcd for C9H9O2
+ [M-H+] 149.0603, found 149.0606.  
The analytical data are in accordance with those reported in the literature.[199]  
Synthesis of 2-Hydroxy-4-isopropylbenzaldehyde (92e) 
 
The general procedure D was followed using 4-isopropylbenzaldehyde (91e) (74 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 80/1) 
yielded 92e (45 mg, 55%) as a colorless liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.02 (s, 1H), 9.81 (s, 1H), 7.45 (d, J = 7.8 Hz, 1H), 6.87 (dd, J = 
7.8, 1.6 Hz, 1H), 6.83 (d, J = 1.6 Hz, 1H), 2.90 (hept, J = 6.9 Hz, 1H), 1.24 (d, J = 6.9 Hz, 6H).  
13C-NMR (125 MHz, CDCl3): δ = 195.8 (CH), 161.9 (Cq), 159.6 (Cq), 133.7 (CH), 119.0 (Cq), 
118.7 (CH), 115.1 (CH), 34.7 (CH), 23.3 (CH3).  
IR (neat): 2963, 2870, 2743, 1651, 1626, 1204, 720 cm-1.  
MS (EI) m/z (relative intensity): 164 ([M+] 98), 163 (26), 149 (100), 135 (22), 121 (45), 103 
(33), 91 (33).  
HR-MS (EI) m/z calcd for C10H12O2
+ [M+] 164.0837, found 164.0841.  
The analytical data are in accordance with those reported in the literature.[200]  
9. Analytical Data 
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Synthesis of 4-(tertButyl)-2-hydroxybenzaldehyde (92f) 
 
The general procedure D was followed using 4-(tert-butyl)benzaldehyde (91f) (81 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 80/1) 
yielded 92f (55 mg, 61%) as an off-white liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.00 (s, 1H), 9.84 (s, 1H), 7.48 (d, J = 8.2 Hz, 1H), 7.05 (dd, J = 
8.2, 1.7 Hz, 1H), 7.00 (d, J = 1.7 Hz, 1H), 1.32 (s, 9H).  
13C-NMR (125 MHz, CDCl3): δ = 195.8 (CH), 161.8 (Cq), 161.6 (Cq), 133.3 (CH), 118.5 (Cq), 
117.6 (CH), 114.4 (CH), 35.5 (Cq), 30.8 (CH3).  
IR (neat): 2964, 2907, 2869, 1652, 1628, 1196, 705 cm-1.  
MS (EI) m/z (relative intensity): 178 ([M+] 46), 163 (100), 135 (36), 107 (45), 95 (16), 77 (18).  
HR-MS (EI) m/z calcd for C11H14O2
+ [M+] 178.0994, found 178.0990.  
The analytical data are in accordance with those reported in the literature.[201]   
Synthesis of 3-Hydroxy-[1,1'-biphenyl]-4-carbaldehyde (92g) 
 
The general procedure D was followed using [1,1'-biphenyl]-4-carbaldehyde (91g) (91 mg, 
0.50 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 40/1) yielded 92g (57 mg, 57%) as a colorless solid. 
M. p. = 78–79 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.10 (s, 1H), 9.90 (s, 1H), 7.64–7.57 (m, 3H), 7.50–7.39 (m, 
3H), 7.25–7.19 (m, 2H).  
9. Analytical Data 
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13C-NMR (75 MHz, CDCl3): δ = 196.0 (CH), 161.9 (Cq), 149.8 (Cq), 139.3 (Cq), 134.1 (CH), 129.0 
(CH), 128.8 (CH), 127.3 (CH), 119.5 (Cq), 118.9 (CH), 115.8 (CH).  
IR (neat): 3037, 2868, 1657, 1555, 1198, 694 cm-1.  
MS (EI) m/z (relative intensity): 198 ([M+] 90), 197 (100), 152 (10), 141 (15), 139 (11), 115 
(22).  
HR-MS (EI) m/z calcd for C13H10O2
+ [M+] 198.0681, found 198.0679.  
The analytical data are in accordance with those reported in the literature.[202]  
Synthesis of 3-Hydroxy-4'-(trifluoromethyl)-[1,1'-biphenyl]-4-carbaldehyde (92h) 
 
The general procedure D was followed using 4'-(trifluoromethyl)-[1,1'-biphenyl]-4- 
carbaldehyde (91h) (125 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), and 
[bis(trifluoroacetoxy)iodo]benzene (538 mg, 1.25 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 15/1) yielded 92h 
(78 mg, 59%) as colorless solid. 
M. p. = 86–88 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.12 (s, 1H), 9.95 (s, 1H), 7.76–7.71 (m, 4H), 7.66 (d, J = 7.9 
Hz, 1H), 7.30–7.18 (m, 2H).  
13C-NMR (125 MHz, CDCl3): δ =
 195.9 (CH), 161.8 (Cq), 148.0 (Cq), 142.8 (Cq), 134.2 (CH), 
130.7 (Cq, q, JC-F = 33 Hz), 127.6 (CH), 125.9 (CH, q, JC-F = 4 Hz), 123.9 (Cq, d, JC-F = 273 Hz), 
120.0 (Cq), 118.9 (CH), 116.2 (CH).  
19F-NMR (283 MHz, CDCl3) δ = - 62.7 (s).  
IR (neat): 3180, 2928, 2865, 1652, 1616, 1320, 1109 cm-1.  
MS (EI) m/z (relative intensity): 266 ([M+] 83), 265 (100), 247 (9), 220 (14), 168 (11), 139 (12).  
9. Analytical Data 
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HR-MS (EI) m/z calcd for C14H9F3O2
+ [M+] 266.0555, found 266.0549. 
Synthesis of 2-Hydroxy-4-ethoxybenzaldehyde (92i) 
 
The general procedure D was followed using 4-ethoxybenzaldehyde (91i) (75 mg, 
0.50 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 10/1) yielded 92i (57 mg, 69%) as a colorless liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.46 (s, 1H), 9.68 (s, 1H), 7.39 (d, J = 8.7 Hz, 1H), 6.50 (dd, J = 
8.7, 2.4 Hz, 1H), 6.39 (d, J = 2.4 Hz, 1H), 4.06 (q, J = 7.0 Hz, 2H), 1.42 (t, J = 7.0 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 194.3 (CH), 166.2 (Cq), 164.5 (Cq), 135.2 (CH), 115.0 (Cq), 
108.7 (CH), 101.0 (CH), 64.1 (CH2), 14.5 (CH3).  
IR (neat): 2984, 2940, 2869, 1626, 1570, 1218, 1107 cm-1.  
MS (EI) m/z (relative intensity): 166 ([M+] 45), 165 (7), 138 (25), 137 (100), 81 (14), 69 (12).  
HR-MS (EI) m/z calcd for C9H10O3
+ [M+] 166.0630, found 166.0636.  
The analytical data are in accordance with those reported in the literature.[203]  
Synthesis of 4-Hexanoxy-2-hydroxybenzaldehyde (92j) 
 
The general procedure D was followed using 4-hexanoxybenzaldehyde (91j) (103 mg, 
0.50 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 20/1) yielded 92j (61 mg, 55%) as an off-white liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.45 (s, 1H), 9.68 (s, 1H), 7.39 (d, J = 8.7 Hz, 1H), 6.50 (dd, J = 
8.7, 2.3 Hz, 1H), 6.39 (d, J = 2.3 Hz, 1H), 3.98 (t, J = 6.6 Hz, 2H), 1.83–1.70 (m, 2H), 1.50–1.25 
(m, 6H), 0.93–0.85 (m, 3H).  
9. Analytical Data 
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13C-NMR (75 MHz, CDCl3): δ = 194.3 (CH), 166.4 (Cq), 164.5 (Cq), 135.2 (CH), 115.0 (Cq), 108.8 
(CH), 101.0 (CH), 68.6 (CH2), 31.5 (CH2), 28.9 (CH2), 25.6 (CH2), 22.5 (CH2), 14.0 (CH3).  
IR (neat): 2859, 2748, 1627, 1506, 1335, 1217, 1115, 803, 635 cm-1.  
MS (EI) m/z (relative intensity): 222 ([M+] 52), 139 (22), 138 (100), 137 (85), 110 (10), 81 (10), 
65 (12), 55 (15), 43 (49).  
HR-MS (EI) m/z calcd for C13H18O3
+ [M+] 222.1256, found 222.1259.  
The analytical data are in accordance with those reported in the literature.[204]   
Synthesis of 2-Hydroxy-4-phenoxybenzaldehyde (92k) 
 
The general procedure D was followed using 4-phenoxybenzaldehyde (91k) (99 mg, 
0.50 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 15/1) yielded 92k (71 mg, 66%) as an off-white liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.35 (s, 1H), 9.74 (s, 1H), 7.49–7.36 (m, 3H), 7.27–7.18 (m, 
1H), 7.11–7.04 (m, 2H), 6.59 (dd, J = 8.6, 2.3 Hz, 1H), 6.39 (d, J = 2.3 Hz, 1H).  
13C-NMR (75 MHz, CDCl3): δ = 194.6 (CH), 165.6 (Cq), 164.1 (Cq), 154.3 (Cq), 135.6 (CH), 130.1 
(CH), 125.4 (CH), 120.9 (CH), 116.2 (Cq), 109.7 (CH), 104.4 (CH).  
IR (neat): 3190, 2848, 1636, 1482, 1294, 1212, 979, 499 cm-1.  
MS (EI) m/z (relative intensity): 214 ([M+] 99), 213 (100), 185 (6), 128 (13), 98 (7), 77 (16), 63 
(10), 57 (16), 51 (10), 43 (14).  
HR-MS (EI) m/z calcd for C13H10O3
+ [M+] 214.0630, found 214.0619. 
Synthesis of 2-Hydroxy-4-[(triisopropylsilyl)oxy]benzaldehyde (92l) 
9. Analytical Data 
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The general procedure D was followed using 4-[(triisopropylsilyl)oxy]benzaldehyde (91l) 
(139 mg, 0.50 mmol), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mol). After 
stirring at 100 °C for 8 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 60/1) yielded 92l (61 mg, 41%) as a colorless liquid. 
1H-NMR (400 MHz, CDCl3): δ = 11.32 (s, 1H), 9.70 (s, 1H), 7.37 (d, J = 8.5 Hz, 1H), 6.48 (dd, J = 
8.5, 2.2 Hz, 1H), 6.40 (dd, J = 2.2, 0.6 Hz, 1H), 1.33–1.21 (m, 3H), 1.09 (d, J = 7.2 Hz, 18H).  
13C-NMR (100 MHz, CDCl3): δ = 194.4 (CH), 164.2 (Cq), 164.2 (Cq), 135.4 (CH), 115.7 (Cq), 
113.0 (CH), 107.5 (CH), 17.8 (CH3), 12.7 (CH).  
IR (neat): 2954, 2868, 1642, 1623, 1218, 683 cm-1.  
MS (EI) m/z (relative intensity): 294 ([M+] 20), 251 (93), 223 (83), 195 (100), 181 (62), 75 (32).  
HR-MS (EI) m/z calcd for C16H26O3Si
+ [M+] 294.1651, found 294.1659.  
The analytical data are in accordance with those reported in the literature.[205]   
Synthesis of 4-Fluoro-2-hydroxybenzaldehyde (92m)  
 
The general procedure D was followed using 4-fluorobenzaldehyde (91m) (62 mg, 
0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5 mol %), and [bis(trifluoroacetoxy)iodo]benzene 
(538 mg, 1.25 mmol). After stirring at 100 °C for 8 h, purification by column chromatography 
on silica gel (n-pentane/Et2O: 80/1 → 50/1) yielded 92m (31 mg, 44%) as a colorless solid. 
M. p. = 69–70 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.37 (s, 1H), 9.83 (s, 1H), 7.56 (dd, J = 8.6, 6.4 Hz, 1H), 
6.79–6.63 (m, 2H).  
9. Analytical Data 
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13C-NMR (125 MHz, CDCl3): δ = 195.0 (CH), 167.9 (Cq, JC-F = 258 Hz), 164.0 (Cq, JC-F = 15 Hz), 
136.0 (CH, JC-F = 12 Hz), 117.8 (Cq, JC-F = 2 Hz), 108.2 (CH, JC-F = 23 Hz), 104.6 (CH, JC-F = 25 Hz).  
19F-NMR (283 MHz, CDCl3) δ = -97.5 (dddd, J = 10, 8, 7, 2 Hz).  
IR (neat): 3102, 2928, 2869, 1655, 1590, 1201, 802 cm-1.  
MS (EI) m/z (relative intensity): 140 ([M+] 87), 139 (100), 122 (9), 111 (22), 94 (18).  
HR-MS (EI) m/z calcd for C7H5FO2
+ [M+] 140.0274, found 140.0269.  
The analytical data are in accordance with those reported in the literature.[206]   
Synthesis of 4-Chloro-2-hydroxybenzaldehyde (92n) 
 
The general procedure D was followed using 4-chlorobenzaldehyde (91n) (70 mg, 
0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5 mol %), and [bis(trifluoroacetoxy)iodo]benzene 
(538 mg, 1.25 mmol). After stirring at 100 °C for 8 h, purification by column chromatography 
on silica gel (n-pentane/Et2O: 80/1) yielded 92n (34 mg, 43%) as a colorless solid. 
M. p. = 48–49 °C. 
1H-NMR (300 MHz, CDCl3): δ = 11.16 (s, 1H), 9.86 (s, 1H), 7.49 (d, J = 8.8 Hz, 1H), 7.04–6.98 
(m, 2H). 
13C-NMR (75 MHz, CDCl3): δ = 195.3 (CH), 162.1 (Cq), 143.2 (Cq), 134.5 (CH), 120.6 (CH), 119.2 
(Cq), 117.9 (CH). 
IR (neat): 3152, 2925, 2885, 1652, 1563, 1184, 712 cm-1. 
MS (EI) m/z (relative intensity): 156 ([M+] 75), 155 (100), 138 (10), 127 (12), 111 (17), 97 (20). 
HR-MS (EI) m/z calcd for C7H5ClO2
+ [M+] 155.9978, found 155.9978. 
Synthesis of 2-Hydroxy-5-methoxybenzaldehyde (92o) and 2-Hydroxy-3- 
methoxybenzaldehyde (92o') 
9. Analytical Data 
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The general procedure D was followed using 3-methoxybenzaldehyde (91o) (68 mg, 
0.50 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 10/1 → 3/1) yielded 92o (37 mg, 49%) and 92o' (14 mg, 19%). 
2-Hydroxy-5-methoxybenzaldehyde (92o)  
 
Yellow liquid. 
1H-NMR (300 MHz, CDCl3): δ = 10.63 (s, 1H), 9.84 (s, 1H), 7.13 (dd, J = 9.0, 3.1 Hz, 1H), 6.98 
(d, J = 3.1 Hz, 1H), 6.92 (d, J = 9.0 Hz, 1H), 3.80 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ = 196.1 (CH), 156.1 (Cq), 152.7 (Cq), 125.2 (CH), 120.0 (Cq), 118.7 
(CH), 115.2 (CH), 55.9 (CH). 
IR (neat): 2939, 2837, 2738, 1655, 1483, 1266, 1149 cm-1. 
MS (EI) m/z (relative intensity): 152 ([M+] 100), 151 (18), 137 (65), 109 (23), 81 (20), 53 (18). 
HR-MS (EI) m/z calcd for C8H8O3




1H-NMR (300 MHz, CDCl3): δ = 11.12 (s, 1H), 9.92 (s, 1H), 7.18 (dd, J = 7.8, 1.5 Hz, 1H), 7.12 
(dd, J = 8.0, 1.5 Hz, 1H), 6.97 (dt, J = 8.1, 7.8 Hz, 1H), 3.92 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ = 196.6 (CH), 151.6 (Cq), 148.3 (Cq), 124.5 (CH), 120.7 (Cq), 119.6 
(CH), 117.9 (CH), 56.3 (CH). 
IR (neat): 2939, 2843, 2751, 1654, 1457, 1254, 719 cm-1. 
9. Analytical Data 
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MS (EI) m/z (relative intensity): 152 ([M+] 100), 151 (14), 121 (12), 109 (30), 106 (47), 81 (28).  
HR-MS (EI) m/z calcd for C8H8O3
+ [M+] 152.0473, found 152.0473. 
Synthesis of 2-Hydroxy-5-phenoxybenzaldehyde (92p) 
 
The general procedure D was followed using 3-phenoxybenzaldehyde (91p) (99 mg, 
0.50 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 80/1) yielded 92p (65 mg, 60%) as a yellow solid. 
M. p. = 56–57 °C.  
1H-NMR (300 MHz, CDCl3): δ = 10.82 (s, 1H), 9.82 (s, 1H), 7.38–7.25 (m, 3H), 7.20 (d, J = 
2.9 Hz, 1H), 7.14–7.08 (m, 1H), 7.02–6.95 (m, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 195.9 (CH), 157.8 (Cq), 157.6 (Cq), 149.4 (Cq), 129.9 (CH), 
129.3 (CH), 123.3 (CH), 122.7 (CH), 120.5 (Cq), 119.1 (CH), 118.0 (CH).  
IR (neat): 3056, 2923, 2875, 1648, 1478, 1244, 686 cm-1.  
MS (EI) m/z (relative intensity): 214 ([M+] 100), 213 (25) 168 (23), 137 (9), 128 (11), 77 (17).  
HR-MS (EI) m/z calcd for C13H10O3
+ [M+] 214.0630, found 214.0636. 
Synthesis of 2-Hydroxy-6-methylbenzaldehyde (92q) 
 
The general procedure D was followed using 2-methylbenzaldehyde (91q) (60 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 80/1) 
yielded 92q (36 mg, 53%) as an off-white liquid. 
9. Analytical Data 
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1H-NMR (300 MHz, CDCl3): δ = 11.89 (s, 1H), 10.31 (s, 1H), 7.36 (dd, J = 8.4, 7.5 Hz, 1H), 6.80 
(dd, J = 8.4, 1.2 Hz, 1H), 6.69 (dd, J = 7.5, 1.2 Hz, 1H), 2.59 (s, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 195.3 (CH), 163.2 (Cq), 142.1 (Cq), 137.4 (CH), 121.8 (CH), 118.5 
(Cq), 116.1 (CH), 18.1 (CH3).  
IR (neat): 3049, 2928, 2887, 1637, 1616, 718 cm-1.  
MS (EI) m/z (relative intensity): 136 ([M+] 96), 135 (100), 118 (11), 107 (14), 77 (23).  
HR-MS (EI) m/z calcd for C8H8O2
+ [M+] 136.0524, found 136.0518.  
The analytical data are in accordance with those reported in the literature.[207]  
Synthesis of 2-Ethoxy-6-hydroxybenzaldehyde (92r) 
 
The general procedure D was followed using 2-ethoxybenzaldehyde (91r) (75 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 20/1) 
yielded 92r (54 mg, 65%) as an off-white liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.95 (s, 1H), 10.35 (s, 1H), 7.36 (dd, J = 8.4, 8.1 Hz, 1H), 6.48 
(dd, J = 8.4, 0.8 Hz, 1H), 6.33 (dd, J = 8.1, 0.8 Hz, 1H), 4.09 (q, J = 7.0 Hz, 2H), 1.44 (t, J = 
7.0 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 194.5 (CH), 163.6 (Cq), 161.9 (Cq), 138.4 (CH), 110.8 (Cq), 109.6 
(CH), 101.7 (CH), 64.3 (CH2), 14.5 (CH3).  
IR (neat): 2983, 2938, 2890, 1636, 1617, 1232, 1077 cm-1.  
MS (EI) m/z (relative intensity): 166 ([M+] 50), 148 (42), 138 (30), 137 (100), 120 (24), 92 (20).  
HR-MS (EI) m/z calcd for C9H10O3
+ [M+] 166.0630, found 166.0629. 
Synthesis of 2-Hydroxy-6-phenoxybenzaldehyde (92s) 
9. Analytical Data 
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The general procedure D was followed using 2-phenoxybenzaldehyde (91s) (99 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 30/1) 
yielded 92s (67 mg, 63%) as a yellow liquid. 
1H-NMR (300 MHz, CDCl3): δ = 11.85 (s, 1H), 10.42 (s, 1H), 7.44–7.28 (m, 3H), 7.25–7.17 (m, 
1H), 7.12–7.05 (m, 2H), 6.63 (dt, J = 8.5, 0.7 Hz, 1H), 6.22 (dd, J = 8.3, 0.9 Hz, 1H).  
13C-NMR (75 MHz, CDCl3): δ = 194.2 (CH), 163.4 (Cq), 160.8 (Cq), 155.4 (Cq), 138.0 (CH), 130.1 
(CH), 124.8 (CH), 120.0 (CH), 112.2 (Cq), 111.7 (CH), 106.9 (CH).  
IR (neat): 3057, 2888, 1578, 1453, 1224, 1033, 756, 691 cm-1.  
MS (EI) m/z (relative intensity): 214 ([M+] 79), 213 (100), 139 (17), 137 (32), 136 (53), 128 
(10), 108 (38), 77 (17), 65 (12), 51 (19).  
HR-MS (EI) m/z calcd for C13H10O3
+ [M+] 214.0630, found 214.0620. 
Synthesis of 2-Chloro-6-hydroxybenzaldehyde (92t) 
 
The general procedure D was followed using 2-chlorobenzaldehyde (91t) (70 mg, 0.50 mmol) 
and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 200/1) yielded 92t 
(39 mg, 50%) as a colorless solid. 
M. p. = 51–52 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.89 (s, 1H), 10.40 (s, 1H), 7.39 (dd, J = 8.5, 8.0 Hz, 1H), 6.94 
(dd, J = 8.0, 1.0 Hz, 1H), 6.88 (dd, J = 8.5, 1.0 Hz, 1H).  
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13C-NMR (125 MHz, CDCl3): δ = 195.4 (CH), 163.9 (Cq), 138.1 (Cq), 137.4 (CH), 121.0 (CH), 
117.1 (CH), 117.0 (Cq).  
IR (neat): 3074, 2916, 1646, 1442, 1164, 698 cm-1.  
MS (EI) m/z (relative intensity): 156([M+] 82), 155 (100), 138 (15), 110 (14), 99 (21), 63 (43).  
HR-MS (ESI) m/z calcd for C7H4ClO2
+ [M-H+] 154.9900, found 154.9903. 
Synthesis of 2-Bromo-6-hydroxybenzaldehyde (92u) 
 
The general procedure D was followed using 2-bromobenzaldehyde (91u) (93 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 100/1) 
yielded 92u (57 mg, 57%) as a colorless solid. 
M. p. = 55–57 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.96 (s, 1H), 10.31 (d, J = 0.6 Hz, 1H), 7.31 (dd, J = 8.5, 7.8 Hz, 
1H), 7.14 (dd, J = 7.8, 1.0 Hz, 1H), 6.92 (ddd, J = 8.4, 1.0, 0.6 Hz, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 197.6 (CH), 163.8 (Cq), 137.4 (CH), 127.3 (Cq), 124.4 (CH), 
117.8 (CH), 117.7 (Cq).  
IR (neat): 3064, 2868, 1695, 1652, 1441, 1169, 1135, 901, 753 cm-1.  
MS (EI) m/z (relative intensity): 200 ([M+] 61), 199 (56), 183 (47), 155 (18), 144 (12), 104 (11), 
92 (21), 86 (66), 84 (100), 76 (30), 71 (19), 63 (29).  
HR-MS (ESI) m/z calcd for C7H5BrO2
+ [M+] 199.9473, found 199.9476.  
The analytical data are in accordance with those reported in the literature.[208]  
Synthesis of 3-Hydroxy-[1,1'-biphenyl]-2-carbaldehyde (92v) 
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The general procedure D was followed using [1,1'-biphenyl]-2-carbaldehyde (91v) (91 mg, 
0.50 mmol) and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-Pentane/Et2O: 40/1) 
yielded 92v (69 mg, 70%) as a colorless liquid. 
1H-NMR (300 MHz, CDCl3):
 δ = 11.90 (s, 1H), 9.82 (s, 1H), 7.56–7.40 (m, 4H), 7.38–7.32 (m, 
2H), 6.98 (dd, J = 8.4, 0.9 Hz, 1H), 6.87 (dd, J = 7.5, 1.1 Hz, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 196.9 (CH), 162.7 (Cq), 147.4 (Cq), 137.3 (Cq), 136.5 (CH), 
129.9 (CH), 128.3 (CH), 128.2 (CH), 121.4 (CH), 117.9 (Cq), 116.9 (CH).  
IR (neat): 3058, 2881, 1649, 1452, 1251, 1166, 700 cm-1.  
MS (EI) m/z (relative intensity): 198 ([M+] 97), 197 (100), 180 (8), 169 (15), 152 (19), 141 (22), 
115 (22).  
HR-MS (EI) m/z calcd for C13H10O2
+ [M+] 198.0681, found 198.0673.  
The analytical data are in accordance with those reported in the literature.[209]  
Synthesis of 3-Hydroxy-2-naphthaldehyde (92w) 
 
The general procedure D was followed using 2-naphthaldehyde (91w) (78 mg, 0.50 mmol) 
and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 70/1 → 50/1) yielded 
92w (45 mg, 52%) as a yellow solid. 
M. p. = 95–96°C.  
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1H-NMR (300 MHz, CDCl3): δ = 10.30 (s, 1H), 10.07 (s, 1H), 8.13 (s, 1H), 7.85 (dd, J = 8.3, 0.8 
Hz, 1H), 7.70 (dd, J = 8.4, 0.6 Hz, 1H), 7.55 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H), 7.36 (ddd, J = 8.1, 
6.8, 1.2 Hz, 1H), 7.27 (s, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 196.7 (CH), 155.8 (Cq), 138.2 (Cq), 137.8 (CH), 130.3 (CH), 
129.4 (CH), 127.4 (Cq), 126.7 (CH), 124.4 (CH), 122.3 (Cq), 111.9 (CH).  
IR (neat): 3287, 3051, 2873, 1659, 1267, 742 cm-1.  
MS (EI) m/z (relative intensity): 172 ([M+] 99), 171 (58), 126 (20), 115 (100), 89 (12), 63 (17).  
HR-MS (ESI) m/z calcd for C11H7O2
+ [M-H+] 171.0446, found 171.0448.  
The analytical data are in accordance with those reported in the literature.[210]  
Synthesis of 4-Fluoro-2-hydroxy-5-methoxybenzaldehyde (92x) 
 
The general procedure D was followed using 4-fluoro-3-methoxybenzaldehyde (91x) (77 mg, 
0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), and 
[bis(trifluoroacetoxy)iodo]benzene (538 mg, 1.25 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 10/1) yielded 92x 
(51 mg, 60%) as an off-white solid. 
M. p. = 85–87 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.06 (s, 1H), 9.78 (s, 1H), 7.06 (d, J = 9.0 Hz, 1H), 6.72 (d, J = 
12.1 Hz, 1H), 3.87 (s, 3H).  
13C-NMR (125 MHz, CDCl3): δ =194.6 (CH), 158.4 (Cq, JC-F = 260 Hz), 157.8 (Cq, JC-F = 13 Hz), 
141.8 (Cq, JC-F = 12 Hz), 116.6 (CH, JC-F = 5 Hz), 116.3 (Cq, JC-F = 3 Hz), 106.0 (CH, JC-F = 22 Hz), 
57.0 (CH3).  
19F-NMR (283 MHz, CDCl3) δ = -117.9 (ddd, J = 12, 9, 2 Hz).  
IR (neat): 3052, 2969, 2848, 1652, 1504, 1139, 695 cm-1.  
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MS (EI) m/z (relative intensity): 170 ([M+] 100), 169 (23), 155 (75), 127 (15), 99 (22), 71 (17).  
HR-MS (EI) m/z calcd for C8H7FO3
+ [M+] 170.0379, found 170.0378. 
Synthesis of 5-Bromo-2-hydroxy-4-methoxybenzaldehyde (92y) 
 
The general procedure D was followed using 3-bromo-4-methoxybenzaldehyde (91y) 
(108 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), and 
[bis(trifluoroacetoxy)iodo]benzene (538 mg, 1.25 mmol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 20/1) yielded 92y 
(61 mg, 53%) as a colorless solid. 
M. p. = 118–120 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.43 (s, 1H), 9.68 (s, 1H), 7.67 (s, 1H), 6.48 (s, 1H), 3.95 (s, 
3H).  
13C-NMR (125 MHz, CDCl3): δ = 193.4 (CH), 163.6 (Cq), 162.4 (Cq), 137.1 (CH), 115.7 (Cq), 
102.1 (Cq), 100.4 (CH), 56.8 (CH3).  
IR (neat): 2962, 2925, 2882, 1636, 1618, 1196, 687 cm-1.  
MS (EI) m/z (relative intensity): 230 ([M+] 100), 229 (96), 186 (7), 159 (10), 111 (18), 97 (20).  
HR-MS (EI) m/z calcd for C8H7BrO3
+ [M+] 229.9579, found 229.9579.  
The analytical data are in accordance with those reported in the literature.[211]  
 
Competition Experiments 
Competition Experiments between Aldehydes 91 
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The representative procedure was followed using 4-methoxybenzaldehyde (91b) (68 mg, 
0.50 mmol), 4-fluorobenzaldehyde (91m) (62 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 
5.0 mol %), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.0 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 80/1 → 
5/1) yielded 92b (49 mg, 64%) and 92m (9 mg, 13%). 
 
The representative procedure was followed using 3-isopropoxybenzaldehyde (91z) (82 mg, 
0.50 mmol), 3-(trifluoromethyl)benzaldehyde (91aa) (87 mg, 0.50 mmol), and 
[bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 50/1 → 30/1) yielded 
92z (45 mg, 50%) and 92aa (< 1 mg, < 1%). 
2-Hydroxy-5-isopropoxybenzaldehyde (92z) 
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1H-NMR (300 MHz, CD3OD): δ = 10.07 (s, 1H), 7.12 (d, J = 3.2 Hz, 1H), 7.05 (dd, J = 9.0, 3.2 Hz, 
1H), 6.78 (d, J = 9.0 Hz, 1H), 4.44 (hept, J = 6.0 Hz, 1H), 1.27 (d, J = 6.0 Hz, 6H). 
13C-NMR (125 MHz, CD3OD): δ = 195.3 (CH), 161.9 (Cq), 150.5 (Cq), 128.8 (CH), 123.2 (Cq), 
121.3 (CH), 116.5 (CH), 72.3 (CH), 22.4 (CH3).  
IR (neat): 3282, 2976, 2465, 1583, 1486, 1372, 1193, 1105, 826, 768 cm-1.  
MS (EI) m/z (relative intensity): 180 ([M+] 14), 139 (10), 138 (100), 137 (57), 120 (11), 92 (12), 
58 (16), 41 (68).  
HR-MS (ESI) m/z calcd for C10H12O3Na
+ [M+Na+] 203.0679, found 203.0675. 
Comparison between Aldehyde and Amide as Directing Groups 
 
The representative procedure was followed using benzaldehyde (91a) (53 mg, 0.50 mmol), 
N,N-diisopropylbenzamide (56a) (103 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 
5.0 mol %), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.0 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 60/1 → 
1/2) yielded 92a (3 mg, 5%) and 57a (91 mg, 82%). 
2-Hydroxy-N,N-diisopropylbenzamide (57a) 
 
Colorless solid.  
M. p. = 155–157 °C.  
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1H-NMR (300 MHz, CDCl3): δ = 7.26 (ddd, J = 8.3, 6.6, 1.7 Hz, 1H), 7.15 (dd, J = 7.7, 1.7 Hz, 
1H), 6.97 (dd, J = 8.3, 1.2 Hz, 1H), 6.81 (ddd, J = 7.7, 6.6, 1.2 Hz, 1H), 4.01–3.81 (m, 2H), 1.37 
(d, J = 6.7 Hz, 12H).  
13C-NMR (125 MHz, CDCl3): δ = 170.9 (Cq), 157.9 (Cq), 131.5 (CH), 126.6 (CH), 120.2 (Cq), 
118.4 (CH), 117.9 (CH), 49.0 (CH), 21.1 (CH3).  
IR (neat): 3066, 2968, 2934, 1582, 1445, 1348, 750 cm-1.  
MS (EI) m/z (relative intensity): 221 ([M+] 20), 178 (37), 121 (92), 86 (100), 58 (40).  
HR-MS (EI) m/z calcd for C13H19NO2
+ [M+] 221.1416, found 221.1411.  
The analytical data are in accordance with those reported in the literature.[129]    
Comparison between Aldehyde and Weinreb Amide as Directing Groups 
 
The representative procedure was followed using benzaldehyde (91a) (53 mg, 0.50 mmol), 
N-methoxy-N-methylbenzamide (89a) (83 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 
5.0 mol %), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.0 mmol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 60/1 → 
3/1) yielded 92a (< 1 mg, < 2%) and 90a (32 mg, 35%). 
Comparison between Aldehyde and Ketone as Directing Groups 
 
The representative procedure was followed using benzaldehyde (91a) (53 mg, 0.50 mmol), 
2,2-dimethyl-1-phenylpropan-1-one (60a) (81 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 
5.0 mol %), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.0 mmol). After stirring at 
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100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 60/1 → 
30/1) yielded 92a (9 mg, 15%) and 61a (88 mg, 99%). 
1-(2-Hydroxyphenyl)-2,2-dimethylpropan-1-one (61a) 
 
Colorless liquid.  
1H-NMR (300 MHz, CDCl3): δ = 12.71 (s, 1H), 8.02 (dd, J = 8.3, 1.6 Hz, 1H), 7.42 (ddd, J = 8.5, 
7.1, 1.6 Hz, 1H), 7.01 (dd, J = 8.5, 1.4 Hz, 1H), 6.85 (ddd, J = 8.3, 7.1, 1.4 Hz, 1H), 1.46 (s, 9H).  
13C-NMR (125 MHz, CDCl3): δ = 212.3 (Cq), 163.8 (Cq), 135.4 (CH), 130.9 (CH), 119.4 (CH), 
117.8 (CH), 117.6 (Cq), 44.6 (Cq), 28.7 (CH3).  
IR (neat): 2976, 2934, 2875, 1628, 1149, 754 cm-1.  
MS (EI) m/z (relative intensity): 178 ([M+] 10), 155 (4), 135 (3), 122 (9), 121 (100), 93 (10), 65 
(14).  
HR-MS (ESI) m/z calcd for C11H14O2
+ [M+] 178.0994, found 178.1000.  
The analytical data are in accordance with those reported in the literature.[130]   
Intramolecular Competition with 103a 
 
The general procedure D was followed using 4-formyl-N,N-diisopropylbenzamide (103a) 
(117 mg, 0.50 mmol), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mol). After 
stirring at 100 °C for 8 h, purification by column chromatography on silica gel 
(n-pentane/EtOAc: 2/1 → 1/1) yielded 104a (87 mg, 70%) as a colorless solid. 
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4-Formyl-2-hydroxy-N,N-diisopropylbenzamide  (104a)  
 
M. p. = 228–230 °C.  
1H-NMR (400 MHz, DMSO-d6): δ = 10.15 (s, 1H), 9.91 (s, 1H), 7.39 (dd, J = 7.6, 1.4 Hz, 1H), 
7.32 (dd, J = 1.4, 0.4 Hz, 1H), 7.24 (d, J = 7.6 Hz, 1H), 3.55 (p, J = 6.7 Hz, 2H), 1.41 (br, 6H), 
1.06 (br, 6H).  
13C-NMR (100 MHz, DMSO-d6): δ = 192.5 (CH), 166.6 (Cq), 153.4 (Cq), 136.9 (Cq), 132.6 (Cq), 
127.3 (CH), 121.5 (CH), 114.7 (CH), 50.3 (CH), 20.2 (CH3).  
IR (neat): 2970, 2733, 1697, 1579, 1428, 1155, 817 cm-1.  
MS (EI) m/z (relative intensity): 249 ([M+] 23), 206 (58), 149 (85), 121 (21), 86 (100), 58 (48).  
HR-MS (ESI) m/z calcd for C14H19NO3
+ [M+] 249.1365, found 249.1366. 
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Intramoleculare Competition with 103b 
 
The general procedure D was followed using ethyl 4-formylbenzoate (103b) (89 mg, 
0.50 mmol), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 40/1 → 
20/1) yielded 104b (13 mg, 13%) as a pale yellow liquid and reisolated ethyl 
4-formylbenzoate (53 mg, 59%). 
Ethyl 4-formyl-2-hydroxybenzoate (104b) 
 
1H-NMR (400 MHz, CDCl3): δ = 10.92 (s, 1H), 9.99 (s, 1H), 7.99 (dt, J = 8.1, 0.5 Hz, 1H), 7.43 
(dd, J = 1.6, 0.5 Hz, 1H), 7.37 (dd, J = 8.1, 1.6 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H), 1.42 (t, J = 
7.1 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 191.3 (CH), 169.3 (Cq), 161.8 (Cq), 141.2 (Cq), 130.7 (CH), 
119.2 (CH), 118.6 (CH), 117.0 (Cq), 62.1 (CH2), 14.2 (CH3).  
IR (neat): 3169, 2984, 1704, 1681, 1294, 783 cm-1.  
MS (EI) m/z (relative intensity): 194 ([M+] 45), 149 (36), 148 (100), 119 (52), 65 (15).  
HR-MS (ESI) m/z calcd for C10H10O4
+ [M+] 194.0579, found 194.0573.  
The analytical data are in accordance with those reported in the literature.[212]   
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Intramoleculare Competition with 103c 
 
The general procedure D was followed using 4-pivaloylbenzaldehyde (103c) (95 mg, 
0.50 mmol), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mol). After stirring at 
100 °C for 8 h, purification by column chromatography on silica gel (n-pentane/Et2O: 20/1) 
yielded 104c (78 mg, 76%) as a colorless liquid. 
3-Hydroxy-4-pivaloylbenzaldehyde (104c) 
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1H-NMR (500 MHz, CDCl3): δ = 12.52 (s, 1H), 9.97 (s, 1H), 8.14 (dt, J = 8.4, 0.5 Hz, 1H), 7.46 
(dd, J = 1.7, 0.5 Hz, 1H), 7.34 (dd, J = 8.4, 1.7 Hz, 1H), 1.44 (s, 9H).  
13C-NMR (125 MHz, CDCl3): δ = 211.9 (Cq), 191.1 (CH), 163.6 (Cq), 140.4 (Cq), 131.3 (CH), 
121.3 (CH), 121.1 (Cq), 117.0 (CH), 45.0 (Cq), 28.6 (CH3).  
IR (neat): 2975, 2935, 1698, 1635, 1294, 1146, 784 cm-1.  
MS (EI) m/z (relative intensity): 206 ([M+] 15), 150 (60), 149 (100), 121 (24), 65 (24), 57 (45).  
HR-MS (ESI) m/z calcd for C12H14O3
+ [M+] 206.0943, found 206.0942. 
 
Experiments with Isotopically Labled Compounds 
Synthesis of Arene [D4]-91r 
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To a 50 mL Schlenk flask coated with aluminum foil were added [D4]-90a (0.95 g, 5.0 mmol), 
EtI (2.34 g, 15.0 mmol), K2CO3 (1.04 g, 7.5 mmol), and acetone (20 mL). The mixture was 
stirred at 50 °C for 3 d under N2. Acetone was removed under reduced pressure. The residue 
was extracted with EtOAc (50 mL), washed with brine (3 × 20 mL), and dried over Na2SO4. 
The crude product 122 was used in the next step without further purification. 
To a 100 mL flame-dried Schlenk flask were added 122 and THF (50 mL) under N2. The 
mixture was cooled to -78 °C. LiAlH4 (0.38 g, 11.0 mmol) suspended in Et2O (15 mL) was 
added dropwise. The mixture was stirred for 30 min at -78 °C, then quenched with 10% 
KHSO4 (10 mL) and warmed up to ambient temperature. The organic phase was washed with 
HCl (1N, 2 × 20 mL) and brine (2 × 20 mL), dried over Na2SO4 and removed by rotary 
evaporation at ambient temperature. Purification by column chromatography on silica gel 
(n-pentane/Et2O: 10/1) yielded [D4]-91r (0.54 g, 70%) as a colorless liquid. 
2-Ethoxy-3,4,5,6-d4-benzaldehyde ([D4]-91r) 
 
1H-NMR (300 MHz, CDCl3): δ = 10.49 (s, 1H), 4.13 (q, J = 7.0 Hz, 2H), 1.46 (t, J = 7.0 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 189.8 (CH), 161.2 (Cq), 135.3 (t, J = 23.8 Hz, CD), 127.8 (t, J = 
25.0 Hz, CD), 124.7 (Cq), 119.9 (t, J = 25.0 Hz, CD), 112.0 (t, J = 25.0 Hz, CD), 64.2 (CH2), 14.7 
(CH3).  
IR (neat): 2980, 2861, 1682, 1572, 1352, 1192, 1042 cm-1.  
MS (EI) m/z (relative intensity): 154 ([M+] 28), 136 (10), 125 (100), 108 (15), 97 (15), 69 (31).  
HR-MS (EI) m/z calcd for C9H6D4O2
+ [M+] 154.0932, found 154.0937. 
Synthesis of [D3]-92r 
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The representative procedure D was followed using [D4]-91r (77 mg, 0.50 mmol), 
[RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), and [bis(trifluoroacetoxy)iodo]benzene (430 mg, 
1.0 mmol). After stirring at 100 °C for 8 h, purification by column chromatography on silica 
gel (n-pentane/Et2O: 30/1) yielded [D3]-92r (49 mg, 58%) as a colorless liquid. 
2-Ethoxy-6-hydroxy-3,4,5-d3-benzaldehyde ([D3]-92r) 
 
1H-NMR (300 MHz, CDCl3): δ = 11.96 (s, 1H), 10.36 (s, 1H), 4.10 (q, J = 7.0 Hz, 2H), 1.45 (t, J = 
7.0 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 194.3 (CH), 163.4 (Cq), 161.7 (Cq), 137.8 (t, J = 24.3 Hz, CD), 
110.8 (Cq), 109.1 (t, J = 25.1 Hz, CD), 101.3 (t, J = 24.7 Hz, CD), 64.3 (CH2), 14.6 (CH3).  
IR (neat): 2983, 2936, 2889, 1636, 1610, 1280, 1114 cm-1.  
MS (EI) m/z (relative intensity): 169 ([M+] 45), 151 (43), 141 (25), 140 (100), 123 (20), 95 (18).  
HR-MS (EI) m/z calcd for C9H7D3O3
+ [M+] 169.0818, found 169.0821. 
Independent KIE studies with 91r and [D4]-91r 
 
To a 25 mL two-necked pear-shaped flask equipped with a condenser were added 
2-ethoxybenzaldehyde (91r) (150 mg, 1.0 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 2.5 mol %), 
1,3,5-tri-tertbutylbenzene (24.6 mg, 0.1 mmol), [bis(trifluoroacetoxy)iodo]benzene (860 mg, 
2.0 mmol), and DCE (4.0 mL). The mixture was stirred at 100 °C under N2. From the 
beginning to 2.5 h, an aliquot (0.1 mL) was taken out by syringe every 15 min and analyzed 
by 1H-NMR to provide the following conversions: 
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Time (min) 0 15 30 45 60 75 90 105 120 135 150 
91r (%) 100 94 88 75 70 63 56 50 46 41 39 
92r (%) 0 5 11 17 25 31 33 40 45 49 50 
 
 
The procedure above was followed using [D4]-91r (154 mg, 1.0 mmol) to provide the 
following conversions: 
Time (min) 0 15 30 45 60 75 90 105 120 135 150 
D4-91r (%) 100 98 96 87 87 84 81 77 76 74 74 
D3-92r (%) 0 2 4 5 8 8 11 12 15 16 18 
 
Data from independent kinetic isotope studies are collected in the scheme below and kH/kD 
was found to be 3.1. 
 
▲: 91r; ●: [D4]-91r; ×: 92r; ■: [D3]-92r. 
y = -0.1977x + 100 
R² = 0.9519 
y = 0.1197x 
R² = 0.9921 
y = -0.4497x + 100 
R² = 0.9763 
y = 0.3657x 












0 15 30 45 60 75 90 105 120 135 150
(%) 
(min) 
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Intramolecular KIE studies 
 
The general procedure D was followed using [D1]-91a (54 mg, 0.50 mmol), and 
[bis(trifluoroacetoxy)iodo]benzene (430 mg, 1.00 mol). After stirring at 100 °C for 8 h, 
purification by column chromatography on silica gel (n-pentane/Et2O: 80/1) yielded [Dx]-92a 
(19 mg, 31%) as a colorless liquid. The intramolecular KIE was determined to be 4.3 by 
1H-NMR. 
 
Diversification of Salicylaldehydes 92 
a) Synthesis of 2H-Chromen-2-one (107) 
 
A literature procedure was used for the synthesis of 105:[213] To a 25 mL flask were added 
NaH (0.12 g, 5.0 mmol), DMF (8.0 mL), and THF (2.0 mL), the mixture was cooled to 0 °C, 
followed by dropwise addition of 92a (0.61 g, 5.0 mmol) and MeI (2.13 g, 15.0 mmol) in THF 
(5.0 mL). The mixture was stirred for 2 h at 0 °C, and then raised to ambient temperature to 
stir for another 12 h. The reaction mixture was poured into H2O (25 mL) and extracted with 
Et2O (3 × 25 mL). The combined organic phase was washed with brine (3 × 25 mL), dried over 
Na2SO4 and removed under vacuum to get the crude product 105.  
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A literature procedure was used for the synthesis of 106:[214] The crude 105 was dissolved in 
CH2Cl2 (10.0 mL), Ph3P=CHCO2Et (1.92 g, 5.5 mmol) was added slowly. The mixture was 
stirred at 40 °C for 2 h. To the reaction was added H2O (50 mL) and extracted with CH2Cl2 
(3 × 50 mL). Purification by column chromatography on silica gel (n-pentane/EtOAc: 10/1) 
yielded 106 (0.85 g, 82%, E:Z ratio 6:1) as a colorless liquid. 
Ethyl (E)-3-(2-methoxyphenyl)acrylate (106) 
 
1H-NMR (300 MHz, CDCl3): δ = 7.99 (d, J = 16.2 Hz, 1H), 7.51 (dd, J = 7.7, 1.7 Hz, 1H), 
7.38–7.31 (m, 1H), 7.00–6.88 (m, 2H), 6.53 (d, J = 16.2 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 3.89 
(s, 3H), 1.34 (t, J = 7.1 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 167.5 (Cq), 158.3 (Cq), 140.0 (CH), 131.4 (CH), 128.9 (CH), 
123.4 (Cq), 120.7 (CH), 118.8 (CH), 111.1 (CH), 60.3 (CH2), 55.4 (CH3), 14.3 (CH3).  
IR (neat): 2939, 2839, 1703, 1630, 1157, 1025, 749 cm-1.  
MS (EI) m/z (relative intensity): 206 ([M+] 68), 175 (80), 161 (100), 147 (75), 131 (23), 118 
(33), 105 (31).  
HR-MS (ESI) m/z calcd for C12H14O3
+ [M+] 206.0943, found 206.0944.  
The analytical data are in accordance with those reported in the literature.[214]   
A literature procedure was used for the synthesis of 107:[215] To a 25 mL two-necked flask 
equipped with a condenser were added 106 (0.41 , 2.0 mmol) and CH2Cl2 (6.0 mL). The 
mixture was cooled to 0 °C. BBr3 (5.0 mmol, 1 M in CH2Cl2) was added dropwise. The mixture 
was stirred at 50 °C under N2 for 5 h. After cooling to ambient temperature, to the reaction 
was added H2O (25 mL), extracted with Et2O (3 × 25 mL), washed with brine (50 mL), and 
dried over Na2SO4. Purification by column chromatography on silica gel (n-pentane/EtOAc: 
5/1) yielded 107 (0.28 g, 96%) as a colorless solid. 
2H-Chromen-2-one (107) 
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M.p. = 75–78 °C.  
1H-NMR (400 MHz, CDCl3): δ = 7.71 (d, J = 9.6 Hz, 1H), 7.60–7.44 (m, 2H), 7.38–7.20 (m, 2H), 
6.42 (d, J = 9.6 Hz, 1H).  
13C-NMR (100 MHz, CDCl3): δ = 160.7 (Cq), 154.0 (Cq), 143.4 (CH), 131.8 (CH), 127.8 (CH), 
124.4 (CH), 118.8 (Cq), 116.9 (CH), 116.7 (CH).  
IR (neat): 3057, 1700, 1601, 1452, 1258, 1175, 753 cm-1.  
MS (EI) m/z (relative intensity): 146 ([M+] 98), 118 (100), 90 (67), 89 (54), 64 (14), 63 (43), 62 
(17), 51 (15).  
HR-MS (EI) m/z calcd for C9H6O2
+ [M+] 146.0368, found 146.0372.  
The analytical data are in accordance with those reported in the literature.[216]   
b) Synthesis of 2-n-Butyl-4H-chromen-4-one (110) 
 
A literature procedure was used for the synthesis of 108:[217] To a 25 mL Schlenk flask 
charged with N2 were added 1-hexyne (181 mg, 2.2 mmol) and THF (5.0 mL). The mixture 
was cooled to -78 °C. nBuLi (2.1 mmol, 2.5 M in hexane) was added dropwise. The mixture 
was stirred for another 1 h after the addition of nBuLi. 92a (122 mg, 1.0 mmol) dissolved in 
THF (3.0 mL) was added in dropwise, and the mixture was stirred at -78 °C for 1 h. To the 
reaction was added saturated aqueous NH4Cl solution (10 mL), extracted with Et2O (3 × 
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25 mL), washed with HCl (1N, 25 mL) and brine (50 mL). The organic phase was removed 
under vacuum to afford crude 108. 
A literature procedure was used for the synthesis of 109:[217] Crude 108 was dissolved in 
CH2Cl2 (10.0 mL), MnO2 (0.87 g, 10 mmol) was added portionwise. The mixture was stirred at 
23 °C for 1 h, then filtrated through a pad of silica gel. The organic phase was removed to 
afford crude 109. 
A literature procedure was used for the synthesis of 110:[218] To a 25 mL flask were added 
crude 109, K2CO3 (42 mg, 0.3 mmol), and acetone (10.0 mL). The mixture was heated at 
70 °C for 1 h. The organic phase was removed under vacuum. Purification by column 
chromatography on silica gel (n-pentane/EtOAc: 5/1) yielded 2-nbutyl-4H-chromen-4-one 
(110) (148 mg, 73%) as a colorless liquid. 
2-nButyl-4H-chromen-4-one (110)   
 
1H-NMR (300 MHz, CDCl3): δ = 8.16 (ddd, J = 8.0, 1.7, 0.5 Hz, 1H), 7.62 (ddd, J = 8.7, 7.1, 
1.7 Hz, 1H), 7.44–7.30 (m, 2H), 6.16 (s, 1H), 2.60 (t, J = 7.5 Hz, 2H), 1.71 (tt, J = 7.8, 7.5 Hz, 
2H), 1.42 (qt, J = 7.8, 7.3 Hz, 2H), 0.95 (t, J = 7.3 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 178.2 (Cq), 169.6 (Cq), 156.4 (Cq), 133.3 (CH), 125.6 (CH), 
124.8 (CH), 123.7 (Cq), 117.7 (CH), 109.7 (CH), 34.1 (CH2), 28.9 (CH2), 22.2 (CH2), 13.8 (CH3).  
IR (neat): 2958, 2931, 2872, 1647, 1464, 1380, 758 cm-1.  
MS (EI) m/z (relative intensity): 202 ([M+] 20), 173 (7), 160 (100), 131 (14), 120 (30), 92 (21).  
HR-MS (EI) m/z calcd for C13H14O2
+ [M+] 202.0994, found 202.1000.  
The analytical data are in accordance with those reported in the literature.[219]   
c) Synthesis of 2-Nitrobenzofuran (113) 
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A literature procedure was used for the synthesis of 111:[220] To a 25 mL flask were added 
nitromethane (5.0 mL), NH4OAc (77 mg, 1.0 mmol), and acetic acid (2.0 mL). The mixture 
was stirred at 90 °C for 15 min before addition of 92a (0.61 g, 5.0 mmol). The reaction 
mixture was heated at 135 °C for 3 h. After cooling to ambient temperature, to the reaction 
was added Et2O (50 mL) and brine (50 mL). The organic phase was separated, dried over 
Na2SO4, removed under reduced pressure. Purification by column chromatography on silica 
gel (n-pentane/EtOAc: 5/1) yielded 111 (0.62 g, 75%) as a yellow solid. 
(E)-2-(2-Nitrovinyl)phenol (111)  
 
M.p. = 134–136 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.14 (d, J = 13.6 Hz, 1H), 7.97 (d, J = 13.6 Hz, 1H), 7.44 (dd, J = 
7.7, 1.7 Hz, 1H), 7.40–7.31 (m, 1H), 7.01 (ddd, J = 7.7, 7.5, 1.0 Hz, 1H), 6.87 (dd, J = 8.2, 
1.0 Hz, 1H), 5.81 (s, 1H).   
13C-NMR (100 MHz, CDCl3): δ = 155.9 (Cq), 138.6 (CH), 135.5 (CH), 133.2 (CH), 132.6 (CH), 
121.6 (CH), 117.7 (Cq), 116.4 (CH).  
IR (neat): 3343, 1621, 1492, 1320, 1241, 758 cm-1.  
MS (EI) m/z (relative intensity): 165 ([M+] 20), 118 (100), 91 (28), 89 (20), 65 (25), 51 (12).  
HR-MS (EI) m/z calcd for C8H7NO3
+ [M+] 165.0426, found 165.0421.  
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The analytical data are in accordance with those reported in the literature.[221]   
A literature procedure was used for the synthesis of 112:[222] NaBH4 (45 mg, 1.2 mmol) was 
suspended in a mixture of 1,4-dioxane and EtOH (4.0 mL, 3:1).  111 (165 mg, 1 mmol) 
dissolved in 1,4-dioxane (3.0 mL) was added dropwise at 0 °C. The reaction mixture was 
stirred at 0 °C for 1 h, then was added saturated aqueous NH4Cl solution (10 mL) and 
extracted with Et2O (3 × 25 mL), washed with brine (50 mL), and dried over Na2SO4. The 
organic phase was removed under vacuum to afford the crude 112.  
A literature procedure was used for the synthesis of 113:[223] To a 25 mL flask were added 
crude 112, Bu4NI (923 mg, 2.5 mmol), NEt3 (202 mg, 2.0 mmol), PhI(OAc)2 (966 mg, 
3.0 mmol), and acetonitrile (10.0 mL). The mixture was stirred at 35 °C for 30 min, extracted 
with Et2O (50 mL) and brine (3 × 25 mL), dried over Na2SO4. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 20/1) yielded 2-nitrobenzofuran (113) 
(124 mg, 76%) as an off-white solid. 
2-Nitrobenzofuran (113)  
 
M.p. = 135–137 °C.  
1H-NMR (400 MHz, CDCl3): δ = 7.77 (d, J = 7.8 Hz, 1H), 7.68 (s, 1H), 7.65–7.56 (m, 2H), 7.43 
(ddd, J = 8.2, 6.0, 2.1 Hz, 1H).  
13C-NMR (100 MHz, CDCl3): δ = 153.3 (Cq), 129.9 (CH), 125.7 (Cq), 125.2 (CH), 123.9 (CH), 
112.6 (CH), 107.1 (CH).  
IR (neat): 3152, 2925, 1511, 1366, 1243, 751 cm-1.  
MS (EI) m/z (relative intensity):163 ([M+] 80), 133 (100), 105 (50), 89 (85), 77 (45), 63 (63), 51 
(25).  
HR-MS (EI) m/z calcd for C8H5NO3
+ [M+] 163.0269, found 163.0273.  
The analytical data are in accordance with those reported in the literature.[223]   
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d) Synthesis of 2-Phenylbenzofuran (115) 
 
A literature procedure was used for the synthesis of 114:[170] To a 250 mL flask were added 
PPh3 (15.7 g, 60 mmol) and CH2Cl2 (60 mL). The mixture was cooled to 0 °C, after which CBr4 
(9.95 g, 30 mmol) dissolved in CH2Cl2 (30 mL) was added and stirred for 10 min. NEt3 (6.07 g, 
60 mmol) was added dropwise and stirred for an additional 5 minutes, after which 92a 
(1.22 g, 10 mmol) in CH2Cl2 (10 mL) was added dropwise. The mixture was stirred for an 
additional 30 min at 0 °C, then warmed to 23 °C and stirred for 1 h. To the reaction was 
added saturated aqueous NH4Cl solution (50 mL). The phases were then separated, and the 
aqueous layer was extracted with CH2Cl2 (100 mL). The combined organic layers were 
concentrated to approximately 10% of the original volume. The residue was dissolved in 
Et2O (100 mL) and filtered over a pad of celite. The resulting solution was concentrated and 
purified by column chromatography on silica gel (n-pentane/EtOAc: 5/1) to yield 114 (2.39 g, 
86%) as an off-white solid. 
2-(2,2-Dibromovinyl)phenol (114)  
 
M.p. = 65–67 °C.  
1H-NMR (400 MHz, CDCl3): 7.59–7.51 (m, 2H), 7.22 (ddd, J = 7.6, 1.6, 0.5 Hz, 1H), 6.96 (ddd, 
J = 7.6, 1.2, 0.5 Hz, 1H), 6.82 (dd, J = 8.2, 1.2 Hz, 1H), 4.96 (s, 1H).  
13C-NMR (100 MHz, CDCl3): δ = 152.4 (Cq), 132.3 (CH), 130.1 (CH), 129.2 (CH), 122.8 (Cq), 
120.7 (CH), 115.7 (CH), 92.1 (Cq).  
IR (neat): 3394, 3031, 1601, 1453, 1247, 759 cm-1.  
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MS (EI) m/z (relative intensity): 276 ([M+] 12), 197 (13), 169 (16), 118 (100), 89 (32), 63 (17).  
HR-MS (EI) m/z calcd for C8H6Br2O
+ [M+] 275.8785, found 275.8790.  
The analytical data are in accordance with those reported in the literature.[224]   
To a 25 mL Schlenk tube were added 114 (139 mg, 0.5 mmol), PhB(OH)2 (152 mg, 
1.25 mmol), Pd(OAc)2 (5.6 mg, 5.0 mol %), CuI (4.8 mg, 5.0 mol %), PPh3 (20 mg, 15 mol %), 
K3PO4 (318 mg, 1.5 mmol), and 1,4-dioxane (5.0 mL) under N2. The mixture was stirred at 
100 °C for 24 h, extracted with Et2O (50 mL) and brine (3 × 25 mL), and dried over Na2SO4. 
Purification by column chromatography on silica gel (n-pentane/Et2O: 200/1) yielded 
2-phenylbenzofuran (115) (78 mg, 80%) as a colorless solid. 
2-Phenylbenzofuran (115)  
 
M.p. = 120–121 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.94–7.85 (m, 2H), 7.63–7.58 (m, 1H), 7.54 (d, J = 7.8 Hz, 1H), 
7.50–7.42 (m, 2H), 7.40–7.35 (m, 1H), 7.35–7.21 (m, 2H), 7.04 (s, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 155.8 (Cq), 154.8 (Cq), 130.4 (Cq), 129.1 (Cq), 128.7 (CH), 128.4 
(CH), 124.8 (CH), 124.2 (CH), 122.8 (CH), 120.8 (CH), 111.1 (CH), 101.2 (CH).  
IR (neat): 3052, 3036, 1455, 1260, 1021, 742 cm-1.  
MS (EI) m/z (relative intensity): 194 ([M+] 100), 165 (58), 139 (8), 115 (4), 97 (5).  
HR-MS (EI) m/z calcd for C14H10O
+ [M+] 194.0732, found 194.0735.  
The analytical data are in accordance with those reported in the literature.[225]   
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9.4 Analytical Data for Photo-Induced Copper(I)-Catalyzed C(sp2)–H Arylations 
Synthesis of 2-(m-Tolyl)benzo[d]thiazole (94ab) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
30/1 → 20/1) yielded 94ab (41 mg, 73%) as a pale yellow liquid. 
The general procedure F was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 35 °C under 
450-500 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 30/1 → 20/1) yielded 94ab (28 mg, 50%) as a pale yellow liquid. 
1H-NMR (500 MHz, CDCl3): δ = 8.09 (dd, J = 8.2, 1.1 Hz, 1H), 7.95 (s, 1H), 7.92–7.86 (m, 2H), 
7.50 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.38 (ddd, J = 8.1, 7.2, 1.0 Hz, 2H), 7.31 (dd, J = 7.6, 1.8 Hz, 
1H), 2.45 (s, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 168.3 (Cq), 154.1 (Cq), 138.8 (Cq), 135.0 (Cq), 133.5 (Cq), 131.8 
(CH), 128.9 (CH), 127.9 (CH), 126.2 (CH), 125.1 (CH), 124.8 (CH), 123.1 (CH), 121.6 (CH), 21.3 
(CH3).  
IR (neat): 3058, 2919, 2862, 1509, 1435, 1313, 1172, 757 cm-1.   
MS (EI) m/z (relative intensity): 225 ([M+] 100), 210 (3), 197 (3), 165 (4), 108 (12), 82 (7), 69 
(15).  
HR-MS (EI) m/z calcd for C14H11NS
+ [M+] 225.0612, found 225.0609.  
The analytical data are in accordance with those reported in the literature.[226] 
Synthesis of 2-Phenylbenzo[d]thiazole (94aa) 
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The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
iodobenzene (19a) (255 mg, 1.25 mmol). After stirring at 28 °C under 254 nm irradiation for 
16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 30/1 → 20/1) 
yielded 94aa (37 mg, 70%) as a pale yellow solid. 
M. p. = 112–113 °C.  
1H-NMR (500 MHz, CDCl3): δ = 8.14–8.07 (m, 3H), 7.91 (ddd, J = 8.0, 1.2, 0.6 Hz, 1H), 
7.53–7.47 (m, 4H), 7.39 (ddd, J = 8.2, 7.2, 1.2 Hz, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 168.0 (Cq), 154.1 (Cq), 135.1 (Cq), 133.6 (Cq), 130.9 (CH), 129.0 
(CH), 127.5 (CH), 126.3 (CH), 125.2 (CH), 123.2 (CH), 121.6 (CH).  
IR (neat): 3065, 3020, 1556, 1478, 1434, 1226, 963, 765 cm-1.   
MS (EI) m/z (relative intensity): 211 ([M+] 100), 184 (8), 167 (3), 134 (5), 108 (30), 84 (25).  
HR-MS (EI) m/z calcd for C13H9NS
+ [M+] 211.0456, found 211.0461.  
The analytical data are in accordance with those reported in the literature.[171] 
Synthesis of 2-(4-Methoxyphenyl)benzo[d]thiazole (94ac) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-4-methoxybenzene (19c) (293 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
15/1 → 10/1) yielded 94ac (38 mg, 63%) as a colorless solid. 
M. p. = 118–120 °C.  
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1H-NMR (500 MHz, CDCl3): δ = 8.07–8.00 (m, 3H), 7.88 (ddd, J = 8.0, 1.2, 0.6 Hz, 1H), 7.47 
(ddd, J = 8.1, 7.2, 1.2 Hz, 1H), 7.35 (ddd, J = 7.9, 7.2, 1.2 Hz, 1H), 7.02–6.99 (m, 2H), 3.88 (s, 
3H).  
13C-NMR (125 MHz, CDCl3): δ = 167.8 (Cq), 161.9 (Cq), 154.2 (Cq), 134.9 (Cq), 129.1 (CH), 126.5 
(Cq), 126.2 (CH), 124.8 (CH), 122.8 (CH), 121.5 (CH), 114.4 (CH), 55.5 (CH3).  
IR (neat): 3063, 2995, 2837, 1605, 1485, 1259, 832, 757 cm-1.   
MS (EI) m/z (relative intensity): 241 ([M+] 100), 226 (35), 198 (33), 154 (8), 108 (6), 84 (8).  
HR-MS (EI) m/z calcd for C14H11NOS
+ [M+] 241.0561, found 241.0566.  
The analytical data are in accordance with those reported in the literature.[227] 
Synthesis of 2-{4-(Trifluoromethyl)phenyl}benzo[d]thiazole (94ad) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-4-(trifluoromethyl)benzene (19d) (340 mg, 1.25 mmol). After stirring at 28 °C under 
254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 40/1 → 30/1) yielded 94ad (49 mg, 70%) as a colorless solid. 
M. p. = 158–159 °C.  
1H-NMR (400 MHz, CDCl3): δ = 8.24–8.18 (m, 2H), 8.11 (ddd, J = 8.2, 1.2, 0.7 Hz, 1H), 7.94 
(ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.77–7.74 (m, 2H), 7.53 (ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 7.44 
(ddd, J = 8.0, 7.2, 1.2 Hz, 1H). 
13C-NMR (125 MHz, CDCl3): δ =
 166.0 (Cq), 154.1 (Cq), 136.8 (d, JC-F = 2 Hz, Cq), 135.2 (Cq), 
132.5 (q, JC-F = 33 Hz, Cq), 127.8 (CH), 126.6 (CH), 126.0 (q, JC-F = 4 Hz, CH), 125.8 (CH), 123.8 
(d, JC-F = 272 Hz, Cq), 123.6 (CH), 121.7 (CH).  
19F-NMR (376 MHz, CDCl3): δ = -62.9 (s).  
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IR (neat): 3059, 1617, 1484, 1324, 1110, 1067, 759 cm-1.  
MS (EI) m/z (relative intensity): 279 ([M+] 100), 260 (10), 210 (5), 170 (3), 140 (5), 108 (28), 
82 (10).  
HR-MS (EI) m/z calcd for C14H8F3NS
+ [M+] 279.0330, found 279.0321.  
The analytical data are in accordance with those reported in the literature.[227] 
Synthesis of 2-(4-Chlorophenyl)benzo[d]thiazole (94ae) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-chloro-4-iodobenzene (19e) (298 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
40/1 → 30/1) yielded 94ae (39 mg, 63%) as a colorless solid. 
M. p. = 113–114 °C.  
1H-NMR (500 MHz, CDCl3): δ = 8.05 (ddd, J = 8.2, 1.2, 0.6 Hz, 1H), 8.03–7.99 (m, 2H), 7.89 
(ddd, J = 8.0, 1.3, 0.6 Hz, 1H), 7.51–7.43 (m, 3H), 7.38 (ddd, J = 8.0, 7.2, 1.2 Hz, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 166.6 (Cq), 154.1 (Cq), 137.0 (Cq), 135.1 (Cq), 132.1 (Cq), 129.3 
(CH), 128.7 (CH), 126.5 (CH), 125.4 (CH), 123.3 (CH), 121.6 (CH).  
IR (neat): 3056, 3032, 1597, 1507, 1475, 1091, 829, 756 cm-1.   
MS (EI) m/z (relative intensity): 245 ([M+] 100), 210 (12), 183 (5), 137 (5), 108 (25), 69 (20).  
HR-MS (EI) m/z calcd for C13H8ClNS
+ [M+] 245.0066, found 245.0064.  
The analytical data are in accordance with those reported in the literature.[228] 
Synthesis of tert-Butyl 4-(benzo[d]thiazol-2-yl)benzoate (94af) 
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The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
tert-butyl 4-iodobenzoate (19f) (380 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/CH2Cl2/Et2O: 1/1/0 → 1/2/0 → 10/0/1) yielded 94af (36 mg, 46%) as a colorless 
solid. 
M. p. = 111–112 °C.  
1H-NMR (400 MHz, CDCl3): δ = 8.17–8.07 (m, 5H), 7.93 (ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.52 
(ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 7.42 (ddd, J = 8.0, 7.2, 1.2 Hz, 1H), 1.63 (s, 9H).  
13C-NMR (100 MHz, CDCl3): δ = 166.8 (Cq), 165.0 (Cq), 154.1 (Cq), 137.0 (Cq), 135.2 (Cq), 134.0 
(Cq), 130.1 (CH), 127.3 (CH), 126.5 (CH), 125.6 (CH), 123.5 (CH), 121.7 (CH), 81.5 (Cq), 28.2 
(CH3).  
IR (neat): 3059, 2976, 2931, 1706, 1482, 1292, 1165, 1108, 755 cm-1.  
MS (EI) m/z (relative intensity): 311 ([M+] 28), 255 (100), 238 (20), 210 (16), 183 (5), 139 (6), 
108 (6), 57 (10).  
HR-MS (EI) m/z calcd for C18H17NO2S
+ [M+] 311.0980, found 311.0977.  
The analytical data are in accordance with those reported in the literature.[229] 
Synthesis of 2-{3-(Trifluoromethyl)phenyl}benzo[d]thiazole (94ag) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-3-(trifluoromethyl)benzene (19g) (340 mg, 1.25 mmol). After stirring at 28 °C under 
254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 40/1 → 30/1) yielded 94ag (42 mg, 60%) as a pale yellow solid. 
M. p. = 91–93 °C.  
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1H-NMR (300 MHz, CDCl3): δ =
 8.42–8.36 (m, 1H), 8.27–8.23 (m, 1H), 8.15–8.07 (m, 1H), 7.94 
(ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.77–7.73 (m, 1H), 7.68–7.59 (m, 1H), 7.53 (ddd, J = 8.3, 7.3, 
1.3 Hz, 1H), 7.43 (ddd, J = 8.2, 7.3, 1.3 Hz, 1H).  
13C-NMR (75 MHz, CDCl3): δ = 166.1 (Cq), 154.0 (Cq), 135.1 (Cq), 134.4 (Cq), 131.6 (d, JC-F = 
33 Hz, Cq), 130.7 (CH), 129.6 (CH), 127.3 (q, JC-F = 4 Hz, CH), 126.6 (CH), 125.7 (CH), 124.2 (q, 
JC-F = 4 Hz, CH), 123.8 (d, JC-F = 273 Hz, Cq), 123.5 (CH), 121.7 (CH).  
19F-NMR (283 MHz, CDCl3): δ = -62.8 (s).  
IR (neat): 3064, 2925, 2854, 1613, 1420, 1330, 1168, 1114, 757 cm-1.  
MS (EI) m/z (relative intensity): 279 ([M+] 100), 258 (5), 210 (4), 159 (5), 108 (28), 69 (23).  
HR-MS (ESI) m/z calcd for C14H9F3NS
+ [M+H+] 208.0408, found 208.0405.  
The analytical data are in accordance with those reported in the literature.[230] 
Synthesis of 2-(3-Methoxyphenyl)benzo[d]thiazole (94ah) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-3-methoxybenzene (19h) (293 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
10/1) yielded 94ah (42 mg, 70%) as a pale yellow solid. 
The general procedure F was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-iodo-3-methoxybenzene (19h) (293 mg, 1.25 mmol). After stirring at 35 °C under 
450-500 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 10/1) yielded 94ah (29 mg, 48%) as a pale yellow liquid. 
M. p. = 82–83 °C. 
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1H-NMR (400 MHz, CDCl3): δ = 8.08 (ddd, J = 8.2, 1.2, 0.6 Hz, 1H), 7.91 (ddd, J = 8.0, 1.3, 
0.6 Hz, 1H), 7.70–7.62 (m, 2H), 7.50 (ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 7.43–7.36 (m, 2H), 7.05 
(ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 3.92 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 167.9 (Cq), 160.1 (Cq), 154.1 (Cq), 135.1 (Cq), 134.9 (Cq), 130.0 
(CH), 126.3 (CH), 125.2 (CH), 123.2 (CH), 121.6 (CH), 120.2 (CH), 117.3 (CH), 112.0 (CH), 55.5 
(CH3).  
IR (neat): 3066, 2998, 2959, 2833, 1597, 1433, 1265, 1048, 758 cm-1.  
MS (EI) m/z (relative intensity): 241 ([M+] 100), 211 (45), 198 (10), 154 (8), 108 (22), 69 (25).  
HR-MS (ESI) m/z calcd for C14H12NOS
+ [M+H+] 242.0640, found 242.0636.  
The analytical data are in accordance with those reported in the literature.[231] 
Synthesis of 2-(3-Fluorophenyl)benzo[d]thiazole (94ai) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-fluoro-3-iodobenzene (19i) (278 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
30/1) yielded 94ai (45 mg, 79%) as a pale yellow solid. 
M. p. = 86–87 °C.  
1H-NMR (300 MHz, CDCl3): δ =
 8.09 (d, J = 8.3 Hz, 1H), 7.96–7.89 (m, 1H), 7.87–7.82 (m, 2H), 
7.57–7.36 (m, 3H), 7.19 (ddd, J = 8.4, 8.4, 2.5 Hz, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 166.4 (d, JC-F = 3 Hz, Cq), 163.0 (d, JC-F = 248 Hz, Cq), 154.0 (Cq), 
135.7 (d, JC-F = 8 Hz, Cq), 135.1 (Cq), 130.6 (d, JC-F = 8 Hz, CH), 126.5 (CH), 125.5 (CH), 123.5 
(CH), 123.3 (d, JC-F = 3 Hz, CH), 121.7 (CH), 117.8 (d, JC-F = 22 Hz, CH), 114.3 (d, JC-F = 24 Hz, 
CH).  
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19F-NMR (283 MHz, CDCl3): δ = -112.1 (ddd, J = 9.8, 8.5, 5.7 Hz).  
IR (neat): 3055, 3029, 1614, 1587, 1445, 1268, 755 cm-1.  
MS (EI) m/z (relative intensity): 229 ([M+] 100), 202 (6), 185 (4), 108 (27), 82 (9), 69 (16).  
HR-MS (EI) m/z calcd for C13H8FNS
+ [M+] 229.0361, found 229.0360.  
The analytical data are in accordance with those reported in the literature.[227] 
Synthesis of 2-(3-Chlorophenyl)benzo[d]thiazole (94aj) 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-chloro-3-iodobenzene (19j) (298 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
30/1) yielded 94aj (49 mg, 80%) as a pale yellow solid. 
The general procedure F was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol) and 
1-chloro-3-iodobenzene (19j) (298 mg, 1.25 mmol). After stirring at 35 °C under 450-500 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
30/1) yielded 94aj (26 mg, 42%) as a pale yellow liquid. 
M. p. = 95–96 °C. 
1H-NMR (500 MHz, CDCl3): δ = 8.14–8.12 (m, 1H), 8.09 (ddd, J = 8.2, 1.2, 0.7 Hz, 1H), 
7.97–7.90 (m, 2H), 7.52 (ddd, J = 8.3, 7.2, 1.2 Hz, 1H), 7.48–7.39 (m, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 166.3 (Cq), 154.0 (Cq), 135.3 (Cq), 135.2 (Cq), 135.1 (Cq), 130.8 
(CH), 130.2 (CH), 127.4 (CH), 126.5 (CH), 125.7 (CH), 125.6 (CH), 123.5 (CH), 121.7 (CH).  
IR (neat): 3054, 1590, 1571, 1424, 1232, 759, 733 cm-1.  
MS (EI) m/z (relative intensity): 245 ([M+] 100), 210 (16), 183 (5), 137 (6), 108 (25), 82 (12).  
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HR-MS (EI) m/z calcd for C13H8ClNS
+ [M+] 245.0066, found 245.0060.  
The analytical data are in accordance with those reported in the literature.[232] 
Synthesis of 2-Phenylbenzo[d]oxazole (94ba) 
 
The general procedure E was followed using benzo[d]oxazole (93b) (30 mg, 0.25 mmol) and 
iodobenzene (19a) (255 mg, 1.25 mmol). After stirring at 28 °C under 254 nm irradiation for 
16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 15/1 → 10/1) 
yielded 94ba (31 mg, 64%) as a pale yellow solid. 
M. p. = 101–102 °C.  
1H-NMR (400 MHz, CDCl3): δ = 8.30–8.24 (m, 2H), 7.82–7.76 (m, 1H), 7.62–7.56 (m, 1H), 
7.56–7.49 (m, 3H), 7.39–7.33 (m, 2H).  
13C-NMR (100 MHz, CDCl3): δ = 163.0 (Cq), 150.8 (Cq), 142.1 (Cq), 131.5 (CH), 128.9 (CH), 
127.6 (CH), 127.2 (Cq), 125.1 (CH), 124.6 (CH), 120.0 (CH), 110.6 (CH).  
IR (neat): 3062, 3051, 2922, 1618, 1553, 1448, 1242, 1054, 743 cm-1.  
MS (EI) m/z (relative intensity): 195 ([M+] 100), 167 (30), 139 (6), 92 (10), 77 (13), 63 (22).  
HR-MS (EI) m/z calcd for C13H9NO
+ [M+] 195.0684, found 195.0679.  
The analytical data are in accordance with those reported in the literature.[233] 
Synthesis of 2-(m-Tolyl)benzo[d]oxazole (94bb) 
 
The general procedure E was followed using benzo[d]oxazole (93b) (30 mg, 0.25 mmol) and 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
9. Analytical Data 
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irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
20/1 → 15/1) yielded 94bb (31 mg, 59%) as a pale yellow solid. 
M. p. = 80–82 °C.  
1H-NMR (400 MHz, CDCl3): δ = 8.11–8.10 (m, 1H), 8.06 (ddd, J = 7.6, 1.8, 1.3 Hz, 1H), 
7.81–7.75 (m, 1H), 7.62–7.55 (m, 1H), 7.45–7.39 (m, 1H), 7.38–7.32 (m, 3H), 2.46 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 163.2 (Cq), 150.7 (Cq), 142.1 (Cq), 138.7 (Cq), 132.3 (CH), 128.8 
(CH), 128.2 (CH), 127.0 (Cq), 125.0 (CH), 124.8 (CH), 124.5 (CH), 120.0 (CH), 110.5 (CH), 21.3 
(CH3).  
IR (neat): 3056, 2956, 2921, 1616, 1552, 1453, 1244, 744 cm-1.  
MS (EI) m/z (relative intensity): 209 ([M+] 100), 180 (15), 152 (5), 116 (7), 91 (15), 63 (20).  
HR-MS (EI) m/z calcd for C14H11NO
+ [M+] 209.0841, found 209.0837.  
The analytical data are in accordance with those reported in the literature.[171] 
Synthesis of 5-Methyl-2-(m-tolyl)benzo[d]oxazole (94cb) 
 
The general procedure E was followed using 5-methylbenzo[d]oxazole (93c) (33 mg, 0.25 
mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C under 
254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 20/1 → 15/1) yielded 94cb (40 mg, 72%) as a yellow solid. 
The general procedure F was followed using 5-methylbenzo[d]oxazole (93c) (33 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 35 °C 
under 450-500 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 20/1 → 15/1) yielded 94cb (12 mg, 21%) as a pale yellow liquid. 
M. p. = 85–86 °C. 
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1H-NMR (400 MHz, CDCl3): δ =
 8.09–8.08 (m, 1H), 8.05–8.02 (m, 1H), 7.56–7.55 (m, 1H), 7.45 
(ddd, J = 8.3, 0.3 Hz, 1H), 7.43–7.38 (m, 1H), 7.34 (ddd, J = 7.6, 1.9, 1.3 Hz, 1H), 7.17–7.14 (m, 
1H), 2.49 (s, 3H), 2.46 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 163.3 (Cq), 149.0 (Cq), 142.3 (Cq), 138.7 (Cq), 134.3 (Cq), 132.2 
(CH), 128.8 (CH), 128.1 (CH), 127.2 (Cq), 126.1 (CH), 124.7 (CH), 119.9 (CH), 109.9 (CH), 21.5 
(CH3), 21.3 (CH3).  
IR (neat): 3020, 2921, 2862, 1552, 1474, 1263, 1181, 1057, 791 cm-1.  
MS (EI) m/z (relative intensity): 223 ([M+] 100), 194 (5), 106 (5), 91 (4), 78 (21), 51 (7).  
HR-MS (ESI) m/z calcd for C15H14NO
+ [M+H+] 224.1075, found 224.1072.  
The analytical data are in accordance with those reported in the literature.[234] 
Synthesis of 5-Chloro-2-(m-tolyl)benzo[d]oxazole (94db) 
 
The general procedure E was followed using 5-chlorobenzo[d]oxazole (93d) (38 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 40/1 → 30/1) yielded 94db (20 mg, 33%) as a pale yellow solid. 
M. p. = 114–115 °C.  
1H-NMR (400 MHz, CDCl3): δ =
 8.08–8.06 (m, 1H), 8.04–8.01 (m, 1H), 7.73 (dd, J = 2.1, 0.5 Hz, 
1H), 7.49 (dd, J = 8.6, 0.5 Hz, 1H), 7.44–7.39 (m, 1H), 7.39–7.35 (m, 1H), 7.31 (dd, J = 8.6, 
2.1 Hz, 1H), 2.46 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 164.6 (Cq), 149.3 (Cq), 143.3 (Cq), 138.8 (Cq), 132.8 (CH), 130.0 
(Cq), 128.9 (CH), 128.3 (CH), 126.6 (Cq), 125.3 (CH), 124.9 (CH), 119.9 (CH), 111.2 (CH), 21.3 
(CH3).  
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IR (neat): 3090, 2923, 2856, 1552, 1447, 1265, 1056, 804, 718 cm-1.  
MS (EI) m/z (relative intensity): 243 (M+ 100), 215 (3), 180 (5), 152 (3), 121 (6), 91 (18), 63 
(25).  
HR-MS (ESI) m/z calcd for C14H11ClNO
+ [M+H+] 244.0529, found 244.0519.  
Synthesis of 2-(m-Tolyl)thiazole (94eb) 
 
The general procedure E was followed using thiazole (93e) (21 mg, 0.25 mmol) and 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
20/1) yielded 94eb (22 mg, 50%) as a yellow oil. 
1H-NMR (500 MHz, CDCl3): δ = 7.86 (d, J = 3.3 Hz, 1H), 7.82–7.81 (m, 1H), 7.75 (ddd, J = 7.7, 
1.8, 1.2 Hz, 1H), 7.35–7.31 (m, 2H), 7.24 (ddd, J = 7.6, 1.8, 1.1 Hz, 1H), 2.42 (s, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 168.6 (Cq), 143.6 (CH), 138.7 (Cq), 133.5 (Cq), 130.8 (CH), 
128.8 (CH), 127.1 (CH), 123.8 (CH), 118.7 (CH), 21.3 (CH3).  
IR (neat): 3080, 2921, 2861, 1606, 1485, 1264, 1140, 785, 692 cm-1.  
MS (EI) m/z (relative intensity): 175 ([M+] 32), 131 (5), 116 (5), 104 (10), 91 (100), 58 (54).  
HR-MS (ESI) m/z calcd for C10H10NS
+ [M+H+] 176.0534, found 176.0528. 
Synthesis of 5-Phenyl-2-{4-(trifluoromethyl)phenyl}thiazole (94fd) 
 
The general procedure E was followed using 5-phenylthiazole (93f) (40 mg, 0.25 mmol) and 
1-iodo-4-(trifluoromethyl)benzene (19d) (340 mg, 1.25 mmol). After stirring at 28 °C under 
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254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 15/1) yielded 94fd (49 mg, 64%) as a pale yellow solid. 
M. p. = 155–157 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.10 (s, 1H), 8.08–8.06 (m, 2H), 7.75–7.69 (m, 2H), 7.66–7.59 
(m, 2H), 7.48–7.41 (m, 2H), 7.40–7.34 (m, 1H).  
13C-NMR (75 MHz, CDCl3): δ = 165.1 (Cq), 140.6 (Cq), 139.6 (CH), 136.8 (Cq), 131.5 (d, JC-F = 
33 Hz, Cq), 131.0 (Cq), 129.2 (CH), 128.7 (CH), 126.8 (CH), 126.5 (CH), 126.0 (q, JC-F = 4 Hz, CH), 
123.9 (d, JC-F = 272 Hz, Cq).  
19F-NMR (283 MHz, CDCl3): δ = -62.8 (s).  
IR (neat): 3093, 3006, 2930, 1613, 1450, 1326, 1107, 757 cm-1.  
MS (EI) m/z (relative intensity): 305 ([M+] 100), 286 (6), 171 (5), 134 (85), 90 (15), 77 (8).  
HR-MS (ESI) m/z calcd for C16H11F3NS
+ [M+H+] 306.0564, found 306.0553.  
The analytical data are in accordance with those reported in the literature.[46] 
Synthesis of 5-Phenyl-2-(m-tolyl)thiazole (94fb) 
 
The general procedure E was followed using 5-phenylthiazole (93f) (40 mg, 0.25 mmol) and 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
10/1) yielded 94fb (49 mg, 78%) as a yellow solid. 
M. p. = 104–106 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.02 (s, 1H), 7.83–7.81 (m, 1H), 7.76 (ddd, J = 7.7, 1.8, 1.2 Hz, 
1H), 7.64–7.58 (m, 2H), 7.46–7.39 (m, 2H), 7.38–7.31 (m, 2H), 7.27–7.23 (m, 1H), 2.44 (s, 3H).  
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13C-NMR (75 MHz, CDCl3): δ = 167.4 (Cq), 139.1 (Cq), 139.1 (CH), 138.8 (Cq), 133.6 (Cq), 131.4 
(Cq), 130.8 (CH), 129.1 (CH), 128.9 (CH), 128.3 (CH), 126.9 (CH), 126.6 (CH), 123.6 (CH), 21.4 
(CH3).  
IR (neat): 3065, 3029, 2916, 1599, 1447, 1143, 754, 683 cm-1.  
MS (EI) m/z (relative intensity): 251 ([M+] 93), 134 (100), 108 (7), 90 (20), 77 (8).  
HR-MS (EI) m/z calcd for C16H13NS
+ [M+] 251.0769, found 251.0762.  
Synthesis of 2-(4-Chlorophenyl)-4,5-dimethylthiazole (94ge) 
 
The general procedure E was followed using 4,5-dimethylthiazole (93g) (28 mg, 0.25 mmol) 
and 1-chloro-4-iodobenzene (19e) (298 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
20/1) yielded 94ge (35 mg, 63%) as a pale yellow solid. 
M. p. = 92–93 °C.  
1H-NMR (500 MHz, CDCl3): δ = 7.82–7.78 (m, 2H), 7.39–7.35 (m, 2H), 2.39 (s, 3H), 2.38 (s, 
3H).  
13C-NMR (125 MHz, CDCl3): δ = 161.9 (Cq), 149.5 (Cq), 135.2 (Cq), 132.5 (Cq), 129.0 (CH), 127.3 
(CH), 127.0 (Cq), 14.8 (CH3), 11.5 (CH3).  
IR (neat): 2955, 2911, 2855, 1592, 1543, 1496, 1244, 1086, 839 cm-1.  
MS (EI) m/z (relative intensity): 223 ([M+] 100), 190 (5), 155 (7), 137 (9), 86 (75), 71 (55).  
HR-MS (EI) m/z calcd for C11H10ClNS
+ [M+] 223.0222, found 223.0216.  
Synthesis of 2,5-Diphenyloxazole (94ha) 
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The general procedure E was followed using 5-phenyloxazole (93h) (36 mg, 0.25 mmol) and 
iodobenzene (19a) (255 mg, 1.25 mmol). After stirring at 28 °C under 254 nm irradiation for 
16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 10/1 → 6/1) 
yielded 94ha (41 mg, 74%) as a pale yellow solid. 
M. p. = 70–71 °C.  
1H-NMR (500 MHz, CDCl3): δ =
 8.14–8.10 (m, 2H), 7.76–7.72 (m, 2H), 7.52–7.43 (m, 6H), 
7.38–7.33 (m, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 161.1 (Cq), 151.3 (Cq), 130.3 (CH), 128.9 (CH), 128.8 (CH), 
128.4 (CH), 128.0 (Cq), 127.5 (Cq), 126.3 (CH), 124.2 (CH), 123.5 (CH).  
IR (neat): 3082, 3058, 3039, 588, 1480, 1134, 705, 685 cm-1.  
MS (EI) m/z (relative intensity): 221 ([M+] 100), 193 (20), 165 (50), 116 (12), 105 (10), 77 (25).  
HR-MS (EI) m/z calcd for C15H11NO
+ [M+] 221.0841, found 221.0840.  
The analytical data are in accordance with those reported in the literature.[235] 
Synthesis of 2-(4-Chlorophenyl)-5-phenyloxazole (94he) 
 
The general procedure E was followed using 5-phenyloxazole (93h) (36 mg, 0.25 mmol) and 
1-chloro-4-iodobenzene (19e) (298 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
8/1 → 6/1) yielded 94he (45 mg, 70%) as an off-white solid. 
M. p. = 114–116 °C.  
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1H-NMR (300 MHz, CDCl3): δ =
 8.08–8.01 (m, 2H), 7.76–7.69 (m, 2H), 7.50–7.42 (m, 5H), 
7.39–7.32 (m, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 160.2 (Cq), 151.5 (Cq), 136.4 (Cq), 129.1 (CH), 129.0 (CH), 
128.6 (CH), 127.8 (Cq), 127.5 (CH), 125.9 (Cq), 124.2 (CH), 123.5 (CH).  
IR (neat): 3084, 3066, 3040, 1730, 1603, 1477, 1243, 1090, 833 cm-1.  
MS (EI) m/z (relative intensity): 255 ([M+] 100), 227 (9), 200 (17), 165 (65), 123 (17), 105 (25), 
77 (37).  
HR-MS (ESI) m/z calcd for C15H11ClNO
+ [M+H+] 256.0529, found 256.0526.  
The analytical data are in accordance with those reported in the literature.[190] 
Synthesis of 5-Phenyl-2-(m-tolyl)oxazole (94hb) 
 
The general procedure E was followed using 5-phenyloxazole (93h) (36 mg, 0.25 mmol) and 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
10/1 → 7/1) yielded 94hb (46 mg, 78%) as a pale yellow solid. 
M. p. = 88–90 °C.  
1H-NMR (500 MHz, CDCl3): δ = 7.95
 –7.94 (m, 1H), 7.93–7.91 (m, 1H), 7.75–7.72 (m, 2H), 
7.48–7.43 (m, 3H), 7.40–7.32 (m, 2H), 7.28 (ddd, J = 7.6, 1.8, 1.2 Hz, 1H), 2.45 (s, 3H).  
13C-NMR (125 MHz, CDCl3): δ = 161.3 (Cq), 151.1 (Cq), 138.6 (Cq), 131.1 (CH), 128.9 (CH), 
128.7 (CH), 128.4 (CH), 128.1 (Cq), 127.3 (Cq), 126.8 (CH), 124.2 (CH), 123.4 (CH), 123.4 (CH), 
21.4 (CH3).  
IR (neat): 3059, 3038, 2919, 1611, 1542, 1132, 725 cm-1.  
MS (EI) m/z (relative intensity): 235 ([M+] 100), 207 (15), 179 (13), 165 (35), 130 (10), 77 (22).  
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HR-MS (ESI) m/z calcd for C16H13NO
+ [M-H+] 235.0997, found 235.0995.  
The analytical data are in accordance with those reported in the literature.[236] 
Synthesis of 2-(3-Fluorophenyl)-5-phenyloxazole (94hi) 
 
The general procedure E was followed using 5-phenyloxazole (93h) (36 mg, 0.25 mmol) and 
1-fluoro-3-iodobenzene (19i) (278 mg, 1.25 mmol). After stirring at 28 °C under 254 nm 
irradiation for 16 h, purification by column chromatography on silica gel (n-pentane/Et2O: 
15/1 → 10/1) yielded 94hi (42 mg, 70%) as a pale yellow solid. 
M. p. = 68–70 °C.  
1H-NMR (300 MHz, CDCl3): δ =
 7.90 (ddd, J = 7.8, 1.5, 1.0 Hz, 1H), 7.80 (dddd, J = 9.6, 2.6, 1.5, 
0.4 Hz, 1H), 7.75–7.70 (m, 2H), 7.50–7.42 (m, 4H), 7.40–7.32 (m, 1H), 7.16 (ddd, J = 8.4, 2.6, 
1.0 Hz, 1H).  
13C-NMR (125 MHz, CDCl3): δ = 162.9 (d, JC-F = 246 Hz, Cq), 160.0 (d, JC-F = 3 Hz, Cq), 151.7 (Cq), 
130.5 (d, JC-F = 8 Hz, CH), 129.4 (d, JC-F = 9 Hz, Cq), 129.0 (CH), 128.7 (CH), 127.8 (Cq), 124.3 
(CH), 123.6 (CH), 122.0 (d, JC-F = 3 Hz, CH), 117.2 (d, JC-F = 21 Hz, CH), 113.2 (d, JC-F = 24 Hz, 
CH).  
19F-NMR (283 MHz, CDCl3): δ = -(112.1–112.2) (m).  
IR (neat): 3121, 3072, 3041, 1731, 1687, 1592, 1486, 1195, 728 cm-1.  
MS (EI) m/z (relative intensity): 239 ([M+] 100), 211 (20), 183 (55), 134 (10), 105 (20), 77 (27).  
HR-MS (EI) m/z calcd for C15H10FNO
+ [M+] 239.0746, found 239.0739.  
The analytical data are in accordance with those reported in the literature.[237] 
Synthesis of 5-(3-Methoxyphenyl)-2-phenyloxazole (94ia) 
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The general procedure E was followed using 5-(3-methoxyphenyl)oxazole (93i) (44 mg, 
0.25 mmol) and iodobenzene (19a) (255 mg, 1.25 mmol). After stirring at 28 °C under 
254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 4/1 → 3/1) yielded 94ia (43 mg, 68%) as a colorless solid. 
M. p. = 91–92 °C.  
1H-NMR (400 MHz, CDCl3): δ = 8.15–8.09 (m, 2H), 7.53–7.45 (m, 3H), 7.44 (s, 1H), 7.37 (ddd, 
J = 7.8, 7.8, 0.5 Hz, 1H), 7.32 (ddd, J = 7.7, 1.4, 1.4 Hz, 1H), 7.26–7.25 (m, 1H), 6.90 (ddd, J = 
7.9, 2.6, 1.3 Hz, 1H), 3.89 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 161.1 (Cq), 160.0 (Cq), 151.1 (Cq), 130.3 (CH), 130.1 (CH), 
129.2 (Cq), 128.8 (CH), 127.4 (Cq), 126.3 (CH), 123.8 (CH), 116.7 (CH), 114.0 (CH), 109.7 (CH), 
55.4 (CH3).  
IR (neat): 3115, 3060, 3001, 2835, 1594, 1487, 1221, 1043, 711 cm-1.  
MS (EI) m/z (relative intensity): 251 ([M+] 100), 208 (12), 181 (20), 165 (12), 153 (10), 116 
(13), 77 (22).  
HR-MS (EI) m/z calcd for C16H13NO2
+ [M+] 251.0946, found 251.0945.  
The analytical data are in accordance with those reported in the literature.[238] 
Synthesis of 5-(4-Fluorophenyl)-2-phenyloxazole (94ja) 
 
The general procedure E was followed using 5-(4-fluorophenyl)oxazole (93j) (41 mg, 
0.25 mmol) and iodobenzene (19a) (255 mg, 1.25 mmol). After stirring at 28 °C under 
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254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1 → 5/1) yielded 94ja (37 mg, 62%) as a colorless solid. 
M. p. = 92–93 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.14–8.07 (m, 2H), 7.75–7.66 (m, 2H), 7.54–7.43 (m, 3H), 7.39 
(s, 1H), 7.20–7.10 (m, 2H).  
13C-NMR (100 MHz, CDCl3): δ = 162.7 (d, JC-F = 249 Hz, Cq), 161.1 (Cq), 150.4 (Cq), 130.4 (CH), 
128.8 (CH), 127.4 (Cq), 126.3 (CH), 126.1 (d, JC-F = 8 Hz, CH), 124.4 (d, JC-F = 3 Hz, Cq), 123.1 (d, 
JC-F = 2 Hz, CH), 116.1 (d, JC-F = 22 Hz, CH).  
19F-NMR (283 MHz, CDCl3): δ = -112.2 (tt, J = 8.5, 5.2 Hz).  
IR (neat): 3130, 3083, 3055, 1499, 1231, 1132, 952, 823 cm-1.  
MS (EI) m/z (relative intensity): 239 ([M+] 100), 211 (12), 183 (50), 123 (10), 116 (11), 107 
(15), 89 (16).  
HR-MS (EI) m/z calcd for C15H10FNO
+ [M+] 239.0746, found 239.0743.  
The analytical data are in accordance with those reported in the literature.[238] 
Synthesis of 5-(3,4-Dimethoxyphenyl)-2-phenyloxazole (94ka) 
 
The general procedure E was followed using 5-(3,4-dimethoxyphenyl)oxazole (93k) (51 mg, 
0.25 mmol) and iodobenzene (19a) (255 mg, 1.25 mmol). After stirring at 28 °C under 
254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 2/1 → 1/1) yielded 94ka (37 mg, 53%) as a yellow solid. 
M. p. = 95–96 °C.  
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1H-NMR (400 MHz, CDCl3): δ = 8.13–8.07 (m, 2H), 7.52–7.42 (m, 3H), 7.34 (s, 1H), 7.31 (dd, 
J = 8.3, 2.0 Hz, 1H), 7.20 (d, J = 2.0 Hz, 1H), 6.94 (d, J = 8.4 Hz, 1H), 3.98 (s, 3H), 3.93 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 160.6 (Cq), 151.3 (Cq), 149.5 (Cq), 149.4 (Cq), 130.2 (CH), 128.8 
(CH), 127.5 (Cq), 126.2 (CH), 122.3 (CH), 121.1 (Cq), 117.3 (CH), 111.5 (CH), 107.5 (CH), 56.1 
(CH3), 56.0 (CH3).  
IR (neat): 3000, 2957, 2935, 2835, 1595, 1504, 1251, 1024, 710 cm-1.  
MS (EI) m/z (relative intensity): 281 ([M+] 100), 266 (35), 238 (15), 195 (5), 165 (6), 107 (14), 
77 (12).  
HR-MS (EI) m/z calcd for C17H15NO3
+ [M+] 281.1052, found 281.1050.  
The analytical data are in accordance with those reported in the literature.[176] 
Synthesis of 2-Phenyl-5-(m-tolyl)-1,3,4-oxadiazole (94lb) 
 
The general procedure E was followed using 2-phenyl-1,3,4-oxadiazole (93l) (37 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1 → 5/1) yielded 94lb (32 mg, 54%) as a pale yellow solid. 
M. p. = 112–113 °C. 
1H-NMR (400 MHz, CDCl3): δ =
 8.18–8.12 (m, 2H), 7.98–7.97 (m, 1H), 7.95–7.92 (m, 1H), 
7.59–7.50 (m, 3H), 7.45–7.40 (m, 1H), 7.38–7.35 (m, 1H), 2.46 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 164.7 (Cq), 164.5 (Cq), 138.9 (Cq), 132.5 (CH), 131.6 (CH), 
129.0 (CH), 128.9 (CH), 127.4 (CH), 126.9 (CH), 124.1 (CH), 124.0 (Cq), 123.8 (Cq), 21.3 (CH3).  
IR (neat): 3057, 2922, 2858, 1548, 1474, 1274, 1068, 724 cm-1.  
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MS (EI) m/z (relative intensity): 236 ([M+] 90), 178 (31), 165 (100), 119 (59), 105 (46), 91 (45), 
77 (48).  
HR-MS (ESI) m/z calcd for C15H13N2O
+ [M+H+] 237.1028, found 237.1023.  
The analytical data are in accordance with those reported in the literature.[239] 
Synthesis of 2-(3-Chlorophenyl)-5-phenyl-1,3,4-oxadiazole (94lj) 
 
The general procedure E was followed using 2-phenyl-1,3,4-oxadiazole (93l) (37 mg, 
0.25 mmol) and 1-chloro-3-iodobenzene (19j) (298 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1 → 5/1) yielded 94lj (33 mg, 51%) as a pale yellow solid. 
M. p. = 119–121 °C.  
1H-NMR (400 MHz, CDCl3): δ =
 8.17–8.11 (m, 3H), 8.07–8.02 (m, 1H), 7.60–7.51 (m, 4H), 7.48 
(ddd, J = 8.1, 7.5, 0.5 Hz, 1H).  
13C-NMR (100 MHz, CDCl3): δ =
 164.9 (Cq), 163.4 (Cq), 135.2 (Cq), 131.9 (CH), 131.7 (CH), 
130.4 (CH), 129.1 (CH), 127.0 (CH), 126.9 (CH), 125.6 (Cq), 125.0 (CH), 123.7 (Cq).  
IR (neat): 3068, 3040, 1542, 1475, 1263, 1067, 773, 723 cm-1.  
MS (EI) m/z (relative intensity): 256 ([M+] 60), 200 (5), 165 (100), 139 (33), 111 (28), 105 (63), 
77 (43).   
HR-MS (EI) m/z calcd for C14H9ClN2O
+ [M+] 256.0403, found 256.0414.  
Synthesis of 2-(4-Methoxyphenyl)-4,4-dimethyl-4,5-dihydrooxazole (117ac) 
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The general procedure E was followed using 4,4-dimethyl-4,5-dihydrooxazole (116a) (25 mg, 
0.25 mmol) and 1-iodo-4-methoxybenzene (19c) (293 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1 → 2/1) yielded 117ac (26 mg, 51%) as a pale yellow liquid. 
1H-NMR (400 MHz, CDCl3): δ = 7.90–7.85 (m, 2H), 6.92–6.87 (m, 2H), 4.07 (s, 2H), 3.83 (s, 
3H), 1.36 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 161.9 (Cq), 161.8 (Cq), 129.9 (CH), 120.6 (Cq), 113.6 (CH), 79.0 
(CH2), 67.4 (Cq), 55.3 (CH3), 28.4 (CH3).  
IR (neat): 2965, 2932, 2894, 2839, 1646, 1512, 1252, 1169, 840 cm-1.  
MS (EI) m/z (relative intensity): 205 ([M+] 12), 190 (100), 175 (10), 162 (40), 134 (45), 119 (8), 
103 (8), 77 (10).  
HR-MS (EI) m/z calcd for C12H15NO2
+ [M+] 205.1103, found 205.1106.  
The analytical data are in accordance with those reported in the literature.[240] 
Synthesis of 4,4-Dimethyl-2-(m-tolyl)-4,5-dihydrooxazole (117ab) 
 
The general procedure E was followed using 4,4-dimethyl-4,5-dihydrooxazole (116a) (25 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1 → 6/1) yielded 117ab (35 mg, 74%) as a yellow liquid. 
The general procedure F was followed using 4,4-dimethyl-4,5-dihydrooxazole (116a) (25 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 35 °C 
under 450-500 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1→6/1) yielded 117ab (5 mg, 11%) as a pale yellow liquid. 
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1H-NMR (400 MHz, CDCl3): δ = 7.80 (s, 1H), 7.73–7.69 (m, 1H), 7.31–7.27 (m, 2H), 4.10 (s, 
2H), 2.37 (s, 3H), 1.38 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 162.2 (Cq), 138.0 (Cq), 131.9 (CH), 128.8 (CH), 128.2 (CH), 
127.9 (Cq), 125.2 (CH), 79.1 (CH2), 67.5 (Cq), 28.4 (CH3), 21.2 (CH3).  
IR (neat): 2966, 2926, 2892, 1649, 1462, 1311, 1062, 716 cm-1.  
MS (EI) m/z (relative intensity): 189 ([M+] 10), 174 (100), 159 (16), 146 (32), 118 (50), 101 (4), 
91 (17), 77 (3).  
HR-MS (EI) m/z calcd for C12H15NO
+ [M+] 189.1154, found 189.1151.  
The analytical data are in accordance with those reported in the literature.[241] 
Synthesis of 2-(3-Chlorophenyl)-4,4-dimethyl-4,5-dihydrooxazole (117aj) 
 
The general procedure E was followed using 4,4-dimethyl-4,5-dihydrooxazole (116a) (25 mg, 
0.25 mmol) and 1-chloro-3-iodobenzene (19j) (298 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1 → 6/1) yielded 117aj (36 mg, 69%) as a colorless liquid. 
1H-NMR (400 MHz, CDCl3): δ = 7.95 (ddd, J = 2.1, 1.6, 0.5 Hz, 1H), 7.81 (ddd, J = 7.7, 1.6, 
1.1 Hz, 1H), 7.43 (ddd, J = 8.0, 2.2, 1.1 Hz, 1H), 7.33 (ddd, J = 7.9, 7.9, 0.5 Hz, 1H), 4.11 (s, 2H), 
1.38 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 160.9 (Cq), 134.4 (Cq), 131.2 (CH), 129.8 (Cq), 129.6 (CH), 
128.3 (CH), 126.3 (CH), 79.3 (CH2), 67.8 (Cq), 28.4 (CH3).  
IR (neat): 3071, 2967, 2929, 2893, 1650, 1571, 1306, 1059, 715 cm-1.  
MS (EI) m/z (relative intensity): 209 ([M+] 10), 194 (100), 179 (25), 166 (30), 138 (60), 111 
(20), 84 (12).  
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HR-MS (EI) m/z calcd for C11H12ClNO
+ [M +] 209.0607, found 209.0610.  
The analytical data are in accordance with those reported in the literature.[242] 
Synthesis of 4-Benzyl-2-(m-tolyl)-4,5-dihydrooxazole (117bb) 
 
The general procedure E was followed using 4-benzyl-4,5-dihydrooxazole (116b) (40 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 4/1) yielded 117bb (45 mg, 72%) as a pale yellow liquid. 
1H-NMR (300 MHz, CDCl3): δ = 7.79–7.77 (m, 1H), 7.74–7.70 (m, 1H), 7.34–7.18 (m, 7H), 4.56 
(tdd, J = 9.1, 7.3, 5.0 Hz, 1H), 4.32 (dd, J = 9.3, 8.5 Hz, 1H), 4.16–4.08 (m, 1H), 3.25 (dd, J = 
13.7, 5.0 Hz, 1H), 2.71 (dd, J = 13.7, 9.0 Hz, 1H), 2.37 (s, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 164.1 (Cq), 138.0 (Cq), 138.0 (Cq), 132.1 (CH), 129.2 (CH), 128.8 
(CH), 128.5 (CH), 128.2 (CH), 127.6 (Cq), 126.5 (CH), 125.3 (CH), 71.8 (CH2), 67.8 (CH), 41.8 
(CH2), 21.2 (CH3).  
IR (neat): 3060, 3027, 2920, 2897, 1646, 1355, 1193, 971, 705 cm-1.  
MS (EI) m/z (relative intensity): 251 ([M+] 3), 160 (100), 132 (35), 119 (10), 105 (45), 91 (27), 
77 (6).  
HR-MS (ESI) m/z calcd for C17H18NO
+ [M+H+] 252.1388, found 252.1388.  
The analytical data are in accordance with those reported in the literature.[226] 
Synthesis of 4-Phenyl-2-(m-tolyl)-4,5-dihydrooxazole (117cb) 
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The general procedure E was followed using 4-phenyl-4,5-dihydrooxazole (116c) (37 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol). After stirring at 28 °C 
under 254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 5/1) yielded 117cb (37 mg, 62%) as a pale yellow liquid. 
1H-NMR (400 MHz, CDCl3): δ = 7.91–7.90 (m, 1H), 7.85–7.82 (m, 1H), 7.39–7.26 (m, 7H), 5.38 
(dd, J = 10.1, 8.1 Hz, 1H), 4.79 (dd, J = 10.1, 8.4 Hz, 1H), 4.28 (t, J = 8.3 Hz, 1H), 2.40 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 164.9 (Cq), 142.4 (Cq), 138.1 (Cq), 132.3 (CH), 129.1 (CH), 
128.7 (CH), 128.3 (CH), 127.6 (CH), 127.4 (Cq), 126.7 (CH), 125.5 (CH), 74.8 (CH2), 70.1 (CH), 
21.2 (CH3).  
IR (neat): 3059, 3029, 2963, 2898, 1645, 1355, 1190, 1069, 699 cm-1.  
MS (EI) m/z (relative intensity): 237 ([M+] 50), 207 (100), 192 (15), 179 (10), 165 (15), 119 
(25), 89 (35), 77 (6).  
HR-MS (EI) m/z calcd for C16H15NO
+ [M+] 237.1154, found 237.1150.  
The analytical data are in accordance with those reported in the literature.[226] 
Competition Experiments 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol), 
1-iodo-3-methoxybenzene (19h) (146 mg, 0.63 mmol) and 
1-iodo-3-(trifluoromethyl)benzene (19g) (170 mg, 0.63 mmol). After stirring at 28 °C under 
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254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 40/1 → 20/1 → 10/1) yielded 93ah (26 mg, 43%) and 93ag (21 mg, 30%). 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol), 
5-phenylthiazole (93f) (40 mg, 0.25 mmol) and 1-iodo-3-methylbenzene (19b) (109 mg, 
0.50 mmol). After stirring at 28 °C under 254 nm irradiation for 16 h, purification by column 
chromatography on silica gel (n-pentane/Et2O: 30/1 → 20/1) yielded 93ab (10 mg, 18%) and 
93fb (8 mg, 13%). 
H/D Exchange Experiment 
 
To a pre-dried 10 mL quartz tube were added benzo[d]thiazole (93a) (34 mg, 0.25 mmol), CuI 
(9.5 mg, 20 mol %), tert-butan(ol-d) (56 mg, 3.0 equiv), LiOtBu (60 mg, 0.75 mmol), and Et2O 
(1.0 mL) under a N2 atmosphere. The tube was sealed tightly and stirred under 254 nm 
irradiation in a Luzchem LZC-ICH2 photoreactor for 16 h at ambient temperature (28 °C). 
Afterwards, the reaction mixture was filtrated through a pad of silica gel and washed with 
9. Analytical Data 
- 207 - 
 
Et2O (20 mL). The solvent was removed under reduced pressure and the H/D ratio was 
determined to be 48/52 as estimated by 1H-NMR using 1,3,5-trimethoxybenzene as internal 
standard. In another reaction under aforementioned reaction conditions without copper(I) 
iodide the same H/D ratio was observed. 
Radical Blocking Experiment 
 
The general procedure E was followed using benzo[d]thiazole (93a) (34 mg, 0.25 mmol), 
1-iodo-3-methylbenzene (19b) (273 mg, 1.25 mmol), and galvinoxyl (21 mg, 20 mol %; 
105 mg, 100 mol %; and 316 mg, 300 mol %, respectively). After stirring at 28 °C under 
254 nm irradiation for 16 h, purification by column chromatography on silica gel 
(n-pentane/Et2O: 100/1 → 50/1 → 30/1) yielded 93ab (38 mg, 67%; 25 mg, 44%; and 0 mg, 
0% respectively).
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DFT  Density functional theory 
DG  Directing group 
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m (NMR) multiplet 
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Me  Methyl 
mol.  Molecular 
M.p. Melting point 
NMP  N-Methyl-2-pyrrolidone 
NMR  Nuclear magnetic resonance 
NOE  Nuclear overhauser effect 
NOESY  Nuclear overhauser enhancement and exchange spectroscopy 
o-  ortho 
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p-  para 
p-cymene  4-Isopropyltoluene 
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SPO  Secondary phosphine oxide 
t (NMR) triplet 
tBu  tert-Butyl 
tAm  tert-Amyl 
TFA  Trifluoroacetic acid 
TFAA  Trifluoroacetic anhydride 
THF  Tetrahydrofurane 
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